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Abstract 
 
This dissertation mainly contains two parts: one is C-X (C, O, S) bond formation through 
gold(I) catalysis, one is new applications via gold(I/III) redox catalysis.  
In first part, gold(I) catalysts would be introduced and their general applications, then the 
TA-Au species will be emphasized including the design, synthesis, characters and their 
application in catalysis. The applications are well developed during the past decade in our group, 
but here only involves three examples regarding C-C, C-O and C-S bond formations. From these 
effective applications, the unique stability and reactivity of TA-Au will be studied and explained, 
which is the reason and value of TA-Au discovery. 
In second part, gold(I/III) redox catalysis will be presented through two application 
examples: cross-coupling of terminal alkynes, multiple bond di-functionalization. The most 
challenging part for coupling reactions is the competition between homo-coupling and cross-
coupling products, while in our project, we have successfully developed a new method to 
selectively obtain cross-coupling as major product to homo-coupling product (ratio 12:1). Later 
on, we found a new method to achieve gold (I/III) redox cycle by using mild oxidant diazonium 
salt instead of PIDA or Selectfluor strong oxidant. The new mild and efficient method have 
largely extended the application of gold(I/III) redox catalysis into organic synthesis. 
In sum, the new gold catalysts and catalysis methods reported here are important to the 
development of gold catalysis field, which are critical and useful to help people understand the 
			 viii	
reason of applying noble gold species as catalysts, and the advantages that other metals do not 
have.
			 1	
					
Chapter 1: Introduction of gold catalysis 
 
1.1 Why we use gold as catalyst?  
 
Gold has been broadly used in human life from very early time.  Thousands of years ago, 
people started using gold as money by shaping it into coins or nuggets. This long history has also 
proved the excellent durability and stability. Later, people tried to use gold for other application, 
like souvenirs, jewelry, and even dental medicine (Figure 1). The wide applications have proved 
the importance of gold in people’s life, and indicated the excellent stability and inert reactivity as 
well. Thus, metallic gold could be used in biocompatible area although ionic gold is toxic and 
not suitable.1 
 
 
Figure 1. Gold in life 
 
Unlike stoichiometric gold chemistry, the applications of gold catalysis in reactions were not 
well developed. Gold as one of the 81 nonradioactive elements should receive much attention in 
chemistry reactions as well. The reason for that is probably for the inert reactivity of gold that 
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only dissolves in aqua regia or very strong oxidants, and the cation gold is not stable enough for 
general reactions catalysis. Moreover, another reason for limiting gold’s broad application is 
gold’s high value. People regards gold as valuable metal and tend to believe that they cannot 
afford it, not mention to use it as reactions’ catalyst. The fact is, however, many banks do not 
reserve gold as monetary insurance anymore and they tend to sell their storage to the market. In 
this way, gold’s price is decreasing in the past couple years, and even cheaper than other popular 
metal catalysts such as rhodium and platinum. Besides, another important factor should be 
considered as well: gold is usually efficient as catalysts and the loading can be lower than 1%.2 
The present of gold catalysts bring new opportunities for chemistry transformations, and 
therefore, it has caught much attention from chemistry society. The good Lewis acidity of gold 
cation and its corresponding active intermediates lead to the special catalysis activity. During the 
time of gold catalysts developing, more and more investigation of transformations and catalysis 
mechanism have been reported to help chemists understand gold and its complexes properties.3
 
 
1.2 The beginning of gold catalysis 
 
The first gold(I) catalyzed homogeneous catalysis reaction was reported by Ito and Hayashi 
in 1986. Ten years later, the first gold(I) catalyzed alkyne activation reaction was reported by 
Teles and Tanaka, which suggested the potential of applying gold(I) in organic synthesis.4 After 
another two decades fast development, a myriad of gold catalysis application has been developed 
and a broad range of gold(I) complexes have been considered as the most effective tools for 
alkyne activation, formations of carbon-carbon and carbon-heteroatom bonds.5 As one of the 
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most effective catalyst toward π-bonds, the reason behind the function is relativistic effects:6 
contraction of 6s orbital and expansion of 5d orbital, which give the theoretical support for π-
acidity of gold catalysis (Figure 2).  
 
Figure 2. Relativistic effects of gold and its increased p-acidity 
 
Gold has three oxidation states, gold(0), gold(I) and gold(III). Gold(I) species are usually the 
most active and popular catalysts, but all gold(I) species need to be stabilized with ligands.7 
Otherwise, it will be converted into gold(0) or gold(III). For the early examples of stoichiometric 
catalysis reactions, such as using gold(III) catalyzed oxidative coupling to synthesize fused 
diporphyrins, and thioesters hydrolysis.  
 
 
Figure 3. Gold catalyzed hydration by Teles and Tanaka 
 
In 1986, Ito and Hayashi first reported that gold(I) catalysis was applied in homogeneous 
reactions. Not much progress was made until one decade after, the first example was conducted 
by Teles and Tanaka (Figure 3), which is alkynes activation through gold(I) activation.8 This 
(Ph3P)AuMe (0.2 mol%)
H2SO4 (50 mol%)
H2O/MeOH, 60 oC
99% (GC)
Me
H
Me
O
Me
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result is significantly important for the field of gold catalysis, because it showed the great 
potential of applying gold(I) as effective catalysts, and thus set up the foundation for latter 
formation of carbon-carbon and carbon-heteroatom bonds. The super good selectivity of gold(I) 
toward alkyne is attributed to relativistic effects. Compared with other late transition metals such 
as Pt(II) and Ag(I), only gold shows the wide application in synthetic field due to the good p-
acidity.  
  
 
1.3 Gold(I) catalyst geometry and categories 
 
From geometry viewpoint, gold(I) species majorly have two coordination sites and form a 
linear geometry (Figure 4). A great number of gold(I) complexes were reported, and most of 
them are with two coordination sites, although some of those complexes have more than two 
coordination sites. Due to the relativistic effects of the gold, the energy gap between 6s and 5d 
orbitals, and result in the expansion of 5d orbital. Moreover, the s, p and d could have 
hybridization to form s/d or s/p orbital, which is favorable to linear geometry complexes. The 
two coordination sites gold complexes have better stability than any other isoelectronic forms 
like in other metal complexes.9 
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Figure 4. Gold(I) species and triazole ligands 
 
Myriad of gold(I) complexes with single X-ray crystals have been reported and studied. 
Different forms of gold catalysts provide different catalytic capability, for example the 
commercial available gold salts AuCl and AuCl3 could catalyze some reactions but the 
applications are limited. The gold(I) catalysts stabilized with phosphines or N-hetercyclic 
carbenes ligands provide more diversity and wider applications.10  
The real Au(I) species are normally released inside the reaction by treating with sliver salt to 
remove the chloride. The reason for that is most gold complexes are not air and water stable 
especially when having SbF6−, PF6−, or BF4− as counter ions. The known naked gold complex is 
usually indicated in mechanism cycles.11 Although lacking the bench stable and isolable [AuL]+ 
in lab research, Shi’ group reported a new approach of make bench stable [LAuL]+ by applying 
strong another ligand like triazole to stabilize the [Au]+ complexes (Figure 4c). After removing 
chloride from gold(I), the active gold species will be generated in situ, and meanwhile an 
unreactive chloride-bridged gold species [LAuClAuL]+ will be formed. These unreactive gold 
species may partially provide the potential reasons for some surprising results in gold catalyzed 
reactions. 
			 5	
 
Figure 5. Gold catalysis categories 
 
Two forms of gold complexes are usually applied in catalysis, [LAuL’]+X- and [LAuX], 
which are convenient for use in reactions (Figure 5). Both forms are having weak coordination 
with neutral ligand, and the ligand will then be exchanged with unsaturated substrates when 
entering catalytic cycles. Subsequently, the energy of ligands and substrates exchanging should 
be considered when proposing mechanism, especially when deciding which step is the rate 
determining. Like in Figure 6, the L’ ligand is usually a weak coordination and neutral ligand for 
gold stabilization, which N-heterocycles or similar compounds are frequently employed.12 
The ligands in gold(I) complexes can help tune the properties of gold complexes, and thus 
change the reactivity when using to activate alkynes, alkenes and allenes. For example, N-
heterocyclic carbenes (NHC) ligands have stronger electron donating capability than phosphite 
ligands, so the NHC-Au catalysts will be less electrophilic than the latter ones (Figure 6). Of 
course, the electronic properties of the gold center could also be tuned by using electronic 
withdrawing or donation substrates on the ligands. The size of the ligands will increase or 
decrease the cone angle of the catalysts, and the coordinating with substrates and attacking 
direction from nucleophiles will be much differenct from size varying.13 
Au
L
X Cationic gold(I): 
LAuCl + AgX 
LAuMe + acid
cyclization
rearrangements
hydroalkoxylation/
hydroaminoaloxylation
ring expansion
cross couplings
cycloaddition
total synthesisoxyarylation
hydrothiolation/
hydrosilylation
heterocyclic
synthesis
hydroamination/
hydroarylation/
hydroimination
glycosylations
			 6	
 
 
Figure 6. Increase in electrophilicity with decreased donating ligand  
 
Some weak coordinating ligands like Me2S are used for preparing of gold(I) catalysts, which 
Me2S is acted as both a ligand and reductant with commercial available gold(III) salts 
(NaAuCl4). In chiral gold catalysts, chiral ligands have promoted the fast development of 
efficient asymmetric transformations. The [NHC-Au]+ complexes are good examples for the 
applications.  Notably, conteranion effects are of great utilities in gold catalysis. When treating 
phenylacetylene with 2-methylstyrene and [t-BuXPhosAu(NCMe)]Y as catalyst, an interesting 
yield increasing trend were found when using different Y: OTf− < NTf2− < BF4− < BF4− < BARF 
(BARF = 3,5-bis(trifluoromethyl)phenylborate). Especially when using steric hinder and 
noncorrdinating anion BARF, the yields are improved around 10-30%. The possible reason is 
that the formation of unreactive digold species is largely diminished in the reaction. 
 
 
 1.4 General mechanism of gold(I) catalysis 
Homogeneous gold(I) catalysis provides a lot of opportunities for chemist to achieve their 
carbon-carbon/hetero bond formation under mild condition and without toxic waste generated. 
The discovery gold(I) catalysts have accomplished huge amount of new applications in different 
transformations. Also, many groups even applied the gold catalysis in total synthesis steps, 
AuCl
N N ArAr
Au
NCPh
SbF6
tButBu
NCMe
SbF6
O
tBu
tBu P Au NCPh
3
SbF6
electrophilicity
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especially in the final several steps, since gold catalysis provides gentle condition with high 
catalytic efficiency. From mechanism point of view, there are many proposals from literatures. 
Although there is not exact proof and evidence for the mechanism cycle, the proposed 
intermediates did provide enough suggestions and hypothesis to help researchers understand 
their complicated relationships between substrates and products.   
 
Figure 7. Gold(I) activated multiple bonds 
 
The general form is [AuL]+ coordinating with alkynes to form a π-complexes (Figure 7). 
Then, gold(I) activated alkynes will be subjected to nucleophilic Markovnikov attack to form 
trans-alkenyl-gold intermediates. This mode also can be used for alkene and arene activations 
when having nucleophiles attacking toward π-bonds.14  
 
 
Figure 8. Representative catalytic cycle of gold(I) catalysis 
 
Nu = O, N, C, S...
Reactivity: alkyne > allene >> alkene
LAu
Nu
[Au]
trans-additionR2
R1 R1 R2
Nu
H
R1 R2
H+
Nu
AuI
L-Au
AuL
Nu
Nu
AuL
vinylgold
H+
Nu
π-complex
AuI
catalytic cycle
complexation
nucleophilic addition
protodeauration
R
R
R
H
R
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A commonly representative catalytic cycle is attached here (Figure 8).15 Without catalysts, 
substrates would not react with any nucleophiles (NuH). After gold(I) activating alkynes by 
coordination, the NuH will rapidly react with gold(I) species and subsequently attack the 
activated alkyne to form a vinylgold type intermediate. The active vinyl gold intermediate is 
carrying a positive charge due to the new vinyl bond formation, and thus the proton from NuH 
should be removed and the proton may help release gold(I) catalyst back to catalytic cycle. 
Therefore, the final step of the cycle is a new double bond forming by protodeauration process.   
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Chapter 2: 1,2,3-triazole (TA) as a ligand for gold catalysts 
 
2.1 Gold catalysts with TA as a ligand 
The broad application of gold catalysis in homogeneous phase has successfully demonstrated 
the great capability of cationic gold(I) catalysis.16 Although gold catalysts mostly offer good 
reactivity toward alkynes activation, the poor stability limited the application in some harsher 
condition reactions for some less reactive substrates.17 Gold mirror and gold nanoparticles are 
usually the form from gold complexes decomposition. Sometimes, heating up is necessary for 
reactions initiation. Thus, gold catalysts with good reactivity and stability are highly desired and 
will help open a new temperature ranges for less reactive alkyne and alkene substrates. 
 
 
Figure 9. 31P NMR chemical shifts of the different Au(I) complexes at 28°C 
 
31P NMR can be a good indicator in studying the electronic effect among all TA-Au 
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complexes, because the chemical shift is directly related to the electronic effect and also related 
with the catalyst reactivity. A summary of 31P chemical shift from different TA-Au complexes is 
listed in the Figure 9. The most electronic deficient cationic gold catalyst PPh3AuNTf2 show 
chemical shift at 28.80 ppm, while the most stable catalyst PPh3AuCl containing covalent bond 
showed very downfield chemical shift at 34.31 ppm.  
By comparing all type of ligands, N-heterocyclic carbenes (NHCs) have been well studied 
and proved as good ligands choice, which improved catalysts stability due to the function of 
metal-ligand donating-accepting electrons. Moreover, counteranion Tf2N- has been studied that it 
may help stabilize catalysts stability and will not decrease the gold catalysts reactivity since 
Tf2N- may only form dynamic gold-nitrogen coordination. Our group applied substituted 1,2,3-
NH-triazole derivatives as new type of ligands for gold(I) species, and found out increased 
stability.  Compared with NHC ligands, simple 1,2,3-NH-triazole is cheaper and easier to be 
synthesized. Moreover, it has nitrogen σ-donor and same time possess lower LUMO antibonding 
orbitals to accept metal back-bonding. 
 
Figure 10. VT NMR spectra of (A) 2b and (B) 3d 
Showing dynamic exchange of triazole-Au binding with different kinetics. 
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As shown in Figure 10, we may observe two broad peaks at room temperature, which 
suggested the dynamic exchange between two isomers of N1 and N2  in solution. At low 
temperature, the kinetic exchange was very slow and almost stopped at the equilibrium point, so 
we can see clearly two peaks in the figure. Due to the steric effect from C4-phenyl group, the N3 
isomer cannot be formed. In contrast, although both H and Au could coordinate with triazole and 
form six regioisomers, cationic gold complex presents only one sharp peak at room temperature 
since all isomers are fast to exchange. Notably, the fast exchange will be slow down and show 
separated 31P signals at low temperature and will show different regioisomer peaks.  
 
 
Figure 11. Gold catalysts reactivity comparison  
Reaction process profile: (a) 5% 1a, rt; (b) 5% 1a, 80 °C; (c) 5% 1b, 80 °C; (d) 5% 1c, 80 °C; (e) 
5% 3a + 5% benzotriazole, 80 °C; (f) 5% 3a, 80 °C; (g) 1% 2a, 2% H3PO4 ·12WO3, 80 °C; (h) 
5% 2a, 7% H3PO4 ·12WO3, 80 °C. 
 
Based on our study, the benzotriazole Au complexes tend to bond at N1 position at low 
temperature -55 and -60 °C, which are not suitable for the NMR study. Similarly, 2a and 3a-c 
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possess same functionality, which will further affect the stability and catalytic capability of the 
gold complexes. In order to prove our hypothesis that the dynamic coordination between triazole 
and gold cation will improve the stability of gold complexes, and thus increase the catalytic 
efficiency of gold catalysts. A series of experiments were carried out with hydroamination 
between internal alkyne and aniline for demonstrate our proposal. 
In order to explorer our proposal that the dynamic bonding between triazole-gold would 
definitely help stabilize gold catalysts, even in 80-100 oC. Our exploration started from simple 
hydroamination of internal alkyne and aniline, and different gold(I) catalysts were compared 
with the hydroamination model (Figure 11.). As the reaction would not happen without heating 
up, the reaction carried out at around 80 oC. As expected, without triazole ligand, all gold(I) 
catalysts suffered from fast decomposition and low catalytic efficiency, even relatively more 
stable IPr-gold catalyst. In contrast, with triazole stabilized gold catalysts have significantly 
improved reactivity in the reaction with good yield of product, although anionic type triazole-
gold catalysts were not effective due to the low reactivity. Interestingly, when adding excess 
triazole ligand into the reaction, the reaction rate is decreased, which also suggested the 
coordination between triazole and gold(I) cation is competing with alkyne substrates. 
In sum, triazole-gold coordination study provides a new ligand for gold cation and forms 
thermally stable gold complexes that is suitable for variable-temperature change, and thus 
provide a wider range for gold catalysis applications. The new triazole gold complexes could be 
further applied in more challenging transformations including intermolecular internal alkyne 
hydroamination. Based on these investigations, it is hopefully that this new catalysis system 
could facilitate gold(I) homogeneous catalysis into broader application such as total synthesis 
and pharmaceutical field.  
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2.2 TA-gold catalyst properties and synthesis 
 
In the past several years, our group developed a series of triazole gold catalyzed 
transformations, as shown in the Figure 12. First, triazole can be a X-type ligand boding with 
gold to form stabilized gold catalyst. For example, in 2010, we found that the Hashmi phenol can 
be synthesized via TA-Au, which other cationic gold species are not stable enough for the 
transformation.  
Second, triazole as a L type ligand could stabilize gold catalysts and activate triple bond to 
achieve a series of nucleophilic addition. Examples include: asymmetric synthesis of substituted 
allenes in 2011, Schmittel cyclization in 2012, alkyne hydroboration in 2014 and Dienals 
synthesis in 2015. 
 
Figure 12. Some TA-gold catalysis work from Shi group 
 
Third, as every advantage has two sides, the increased stability involves another issue of 
reactivity. The decreased reactivity limited the broad application of triazole gold catalysts until 
Hashmi Phenol Synthesis
Org. Lett. 2010, 12,  344
Asymmetric Synthesis of Substituted Allenes
Org. Lett. 2011, 13, 2618
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we later found a bimetallic catalysis system: the corporation of triazole gold and Lewis acid. This 
application successfully achieved many transformations by forming C-C or C-Hetero atom bond. 
Examples from 2013 to current were presented in the figure attached, including intermolecular 
C-C, C-O and C-S bond formation. 
As triazole gold has been proved the usefulness in gold catalysis field, and has been widely 
applied in many interesting transformations, so the methods for efficiently synthesizing different 
triazole ligands are important and should be well developed. As we all know, Click chemistry 
has been well developed long time ago, while other methods for triazole synthesis seems still 
limited. In the past several years, our group has developed a series of methods to efficiently 
synthesize different types of triazoles.  
 
 
Figure 13. Some TA-gold catalysis work from Shi group 
 
In Figure 13, 4,5-disubstituted-1,2,3-NH-triazoles were successfully synthesized by a Lewis 
base facilitated reaction from three components.18 This applied mild condition was proved easy 
and efficient in 25 different triazole derivatives in good to excellent yields, which provided 
convenient way to prepare triazole derivatives by easily converting C-4 vinyl group. 
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Figure 14. Three efficient approaches to synthesize N-2 arylation triazoles 
 
Triazole N-2 arylation could hugely enlarge the scope of N-2 substituted triazoles. As shown 
in Figure 14, our group latterly developed three different methods to achieve N-2 arylation by 
using SNAr method, aryl amidation by copper(I), and boronic acid coupling via copper(II) 
catalyst.19 These approaches largely broaden the triazoles scope as effective ligands for different 
transition metals.  
 
 
2.3 Interesting fluorescence active TA-gold complexes	
 
2.3.1 Introduction 
Photoactive molecules are useful in many fields including chemistry, bioscience and 
materials, etc. Molecules with fluorophores are brought much attention in the past two decades 
and they were widely applied as clinical- or bio-sensors and new photoactive materials. There 
are two factors that could change the prosperities of fluorophore: one is structure, and one is 
chemical environment. In some metal complex fluorophores, the function between ligands and 
metal are critical, for example, in [Ru(bpy)3]2+, the bipyridine ligands form a ‘closed core’ 
environment which could strength metal to ligand charge transfer (MLCT). In contrast, rather 
than ‘closed core’ bonding form, metal complexes with open coordination are rare existed 
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because of the easy photo quenching process. 
Gold(I) chemistry has been well developed in the past two decades for the good p-acidity in 
multiple bond activation. Due to the special linear geometry of gold(I) species forming only open 
type coordination, however, there have not any fluorescence active gold complexes been 
reported. The research on fluorescent gold catalysts should be quite useful if applying them into 
gold catalysis reactions. In this report, therefore, we discovered a series of N-fused triazole 
(NTF) gold complexes, which are not only bench stable compounds but are fluorescence active 
as well.   
 
 
Figure 15. Fluorescence active metal complexes 
 
Our group has studied 1,2,3-triazole many years, and found out it has good coordination 
capability toward transition metals. Interestingly, there is big difference between N1 and N2 
coordination site in 1,2,3-triazole, especially the N2 aryl-1,2,3-triazole (NAT) offered good 
fluorescence emission in the area of UV/blue, while no fluorescence emission observed in N1 
aryl triazoles. The reason for that only happen in N2 triazole is co-planar intramolecular charger 
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transfer (PICT), which should be potentially further studied in metal complexes. In our previous 
research, TA-Au could be used in alkyne activation catalysis with excellent stability and 
reactivity compared with other cationic gold(I) species. Intrigued by those studies, we are 
planning to further investigate the fluorescence active gold complexes, and it is hopefully that 
the results here could help the mechanism study and understanding.  
 
2.3.2 Synthesis and properties of fluorescence active TA-gold complexes 
As shown in Figure 16, we can know that N-1 aryl triazole may have good coordination with 
gold, but the it does not have any emission. In contrast, the N-2 aryl triazole (NAT-1) has strong 
emission, but it cannot make good coordination with gold due to the steric effect. When treated 
NAT-1 with [PPh3Au]+, we can see a big chemical shift on H-5 proton in 1H NMR spectra, 
which showed evidence of interaction between the NAT-1 and gold metal. We thus tried to 
isolate the formed complex, but it failed due to the bad stability.  
 
 
Figure 16. Coordination of NAT with gold cation 
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Actually, triazoles are usually good ligand to transition metals including gold cation, while in 
this experiment it is likely that the TA-Au complex was not formed. From the 31P NMR 
comparison, the mixture of NAT-1 and gold showed almost same chemical shift as [PPh3Au]+ 
alone. Moreover, fluorescence emission between the triazole ligand and the complex are very 
similar. Based on all these studies, there is almost no interaction between the triazole ligand and 
gold metal, or too interaction to be effective.  
 
 
Figure 17. N-Fused-triazole: coordination and emission 
 
In order to discover useful fluorescence active and stable TA-Au complexes, we designed a 
new N-fused triazole 7 (Figure 17). The two aromatic rings were connected by a carbon bridge, 
which could help form conjugated fused ring system. N-1 position on the triazole ring is 
convenient to bind with gold without big steric hindrance. Based on these hypothesis, we 
planned to synthesize the triazole and also explore its property. 
 
2.3.3 Design and synthesis of NFT 7 and complex 8 
As shown in the figure, synthesis of NFT 7 was started from commercial available starting 
material 2-iodo benzoic acid, which was latterly reduced to benzyl alcohol 10. By treating with 
PBr3 and following by SN2 azide substitution, the azide product 11 was obtained in 82% yield in 
N
N
N
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H N
N
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+
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N-binding site
optical active 
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two steps. Ligand NFT 7 was synthesized in one more step by employing Sonogashira coupling 
and azide-alkyne Huisgen cycloaddition in 53% yield. Complex 8a was synthesized by mixing 
ligand 7 and [PPh3-Au]+ under literature method. Both structures of compound 7 and 8a were 
further confirmed by X-ray crystallography.  
 
 
Figure 18. Synthetic route to triazole gold complex 
a) BH3 in THF (2.0 equiv), THF (0.50 M), 0 oC; b) PBr3 (1.8 equiv), DCM (0.40M), 25 oC, then 
NaN3, (2.0 equiv), DMSO (0.20 M), 60 oC; c) phenylacetylene (1.5 equiv), Et3N (6.0 equiv), CuI 
(7.0 mol%), Pd(PPh3)2Cl2 (3.5 mol%), DMF (0.14 M), 25 oC, then 120 oC; d) PPh3AuCl (1.0 
equiv), AgOTf (1.0 equiv), DCM (0.10 M), 25 oC. 
 
From the crystal structures, we observed that the dihedral angles of 4-phenyl ring and the 
triazole ring are 36.4° and 37.0° in ligand 7 and complex 8a respectively. The bond length of 
Au-N bond is 2.065 Å, which is almost same as the bond length in TA-Au (2.063 Å). 
Additionally, the 31P NMR chemical shift is at d 29.6 ppm, which is shifted to downfield 
compared with [PPh3-Au]+.  All above data strongly support that there is a strong interaction 
between the NFT 7 ligand and gold, and should be stable TA-Au complexes forming as 
hypothesized. 
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2.3.4 Property study of NFT 7 and complex 8 
With the purpose of studying optical properties of these gold complexes, we synthesized a 
series of [L-Au]+. To our pleased, these gold triazole complexes have fluorescence character, and 
the corresponding results were presented in Table 1. 
 
Table 1. Optical properties of ligand 7 and complexes 8a,d 
 
 Ex  
lmax (nm) 
Em  
lmax (nm) 
Φb,c 
(x10-3) 
Intensity  
[x103] 
Stokes 
Shift 
7 285 368 0.69 4.45 83 
8a 285 342 1.1 8.31 57 
8b 285 362 0.96 8.16 77 
8c 263 342 0.75 5.96 79 
8d 285 368 0.75 5.28 83 
8e 293 356 0.87 6.74 63 
8f 293 368 0.95 5.79 75 
aSample information: 1.0x10-5 M in Acetonitrile. bQuantum yields (F) were determined based on 
1.0x10-5 M 9,10-Diphenylanthracene in cyclohexane (F=0.90) except 3c. cQuantum yields (F) 
were determined based on 1.0x10-5 M Naphthalene in cyclohexane (F=0.23). dCalculated photo 
emission integration from the original spectra. 
 
The ligand 7 has good fluorescence property. In contrast, all gold complexes 8a-8f showed 
stronger fluorescence emission and higher quantum yield, which are a series of new optical 
active gold complexes. Meanwhile, the improved optical activity and the change of excitation 
lmax and emission lmax proved that the ligand and metal gold have electron transferring effect 
N
N
N Au R
+
TfO-
8a: R = PPh3; 
8b: R = P(Ph-p-F)3;
8c: R = P(Ph-p-OMe)3;
8d: R = P(OAr)3, Ar = 2,4-di-t-Bu;
8e: R = IPr;
8f: R = PEt3;
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between them. Notably, all gold complexes in the table are stable complexes, which could be 
potentially applied into optical research.  
 
2.3.5 Conclusion 
In this report, we have developed a new type of fluorescence active gold complexes. The 
optical active NATs ligand could not be applied towards gold complex due to the bad stability. 
Therefore, a new designed N-fused triazole was synthesized and proved with good fluorescence 
activity. The strong coordination of NFT with different [L-Au]+ were literally prepared, and all 
of those complexes have improved fluorescence emission and increased quantum efficiency. 
This study provided a new series of fluorescence active gold complexes, and they could be 
prepared with simple steps of synthesis. It is hopefully that these optical active complexes could 
be used for real application like fluorescence-on/off sensor devices.  
 
 
2.3.6 Experimental data 
I. General Methods and Materials 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out 
under an atmosphere of nitrogen using oven/flame-dried glassware. Unless otherwise noted, all 
commercial reagents and solvents were obtained from the commercial provider and used without 
further purification. Chemicals were purchased from Acros and used as received. Gold 
complexes were synthesized from HAuCl4, which was purchased from Strem. 1H NMR, 13C 
NMR, 31P NMR, and 19F NMR spectra were recorded on Varian 600 MHz and Agilent 400 MHz 
spectrometers. Chemical shifts were reported relative to internal tetramethylsilane (δ 0.00 ppm) 
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or CDCl3 (δ 7.26 ppm) for 1H and CDCl3 (δ 77.0 ppm) for 13C. Flash column chromatography 
was performed on 230-430 mesh silica gel.  
 
UV absorption spectra: 
Absorption spectra were recorded on a Shimadzu UV-1800 UV spectrophotometer in 10 mm 
path length quartz cuvettes. All samples were measured from the 10-5 M solution in Acetonitrile 
with the wavelength range between 250 nm and 600 nm. 
Fluorescence excitation and emission spectra: 
The fluorescence spectra were obtained in 10 mm path length quartz cuvettes using 
Shimadzu RF-5301 PC spectrofluorophotometer with a slit width of 2.5 nm. The emission 
spectra were obtained from the 10-5 M solution in Acetonitrile with an excitation wavelength at 
254 nm or 310 nm and the excitation spectra were recorded with the emission wavelength λmax 
which depended on different gold complexes. 
 
Quantum yield: 
Quantum yields (F) were determined by using an integrated emission area and comparing 
that value to the area measured for the standard Naphthalene when excited at 276 nm (F=0.23) in 
cyclohexane. Quantum yields were calculated by using the following equation, where Φ is the 
quantum yield. Int is the area of emission peak, A represents absorbance at the excitation 
wavelength and n is reflective index of the solvent. The subscript reference is the respective 
values of the standard Naphthalene. 
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Procedure for preparation of NFT 7 
 
To a solution of the benzoic acids (5 mmol) 5 in dry THF (10 mL) at 0 °C was slowly added 
BH3 in THF solution (1M, 2.0 equiv) over a period of 15-20 min and then the mixture was 
vigorously stirred at room temperature for an additional period of 5 h. The reaction was carefully 
quenched with the mixture of THF/H2O (1:1). The aqueous phase was extracted with ether and 
the combined organic layers were dried (MgSO4), and concentrated in vacuum and then purified 
by silica gel chromatography with a mixture of hexanes and ethyl acetate as the eluent to afford 
the product alcohols 10 in 97% yield.  
To solution of benzyl alcohols 10 in DCM at 5 °C was added PBr3 (1.8 equiv) portionwise. 
The reaction mixture was allowed to warm to r.t., agitated for 2h, and concentrated in vacuo. The 
residue was passed a short silica gel chromatography to obtain crude 11 without further 
purification. Then, NaN3 (2.0 equiv) was added to a stirred solution of crude 11 in DMSO (0.20 M) 
at r.t. The reaction mixture was stirred at r.t. for 3 h. The reaction was extracted and washed with 
DCM and water. Combined organic layers were dried over MgSO4, then purified by silica gel 
chromatography, 82% yield in total. 
A mixture of ortho-iodobenzyl azide 11 (2.0 mmol), (PPh3)2PdCl2 (0.070 mmol), CuI (0.14 
mmol) and triethylamine (12 mmol) was stirred in DMF (14 ml) under an argon atmosphere for 1 
h. Phenylacetylene (3.0 mmol ) was then added and the mixture stirred at room temperature for 
Φ = Φreference x
Int x Areference x n2
Intreference x A x nreference2
OH
I
N3
I
10 11
CO2H
I
9
97%
N
N
N
Ph
a)
82%
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7
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12 h followed by heating at 120 oC for another 10 h. DMF was evaporated under reduced 
pressure and the residue was washed by water (100 ml)and extracted with ethyl acetate (3 x 40 
ml). The combined organic layers were dried (MgSO4), filtered and the solvent removed in 
vacuo. The residue was purified by chromatography on silica gel to obtain the desired NFT 7. 
 
General Procedure for preparation of gold complex 8a-8f 
 
 
 
A 20 mL screw-cap vial was charged with R-AuCl (0.5 mmol) and NFT 7 (1.0 equiv.) in dry 
DCM (5 mL), followed by the addition of AgOTf (1.0 equiv.). The vial was allowed to stir at 
ambient temperature. After 4h, the reaction mixture was filtered through two celite pads and 
concentrated in vacuum to give the product as white foam. Pure white powder was obtained via 
recrystallization through diffusion of hexanes into DCM solution of crude product. 
 
II. Compounds Characterization 
 
2,4-diphenyl-2H-1,2,3-triazole 1 (NAT-1): (known compound, See: Yan W, Wang Q, Lin Q, Li 
M, Petersen JL, Shi X. Chem Eur J, 2011, 17: 5011-5018). 1H-NMR (400 MHz; CDCl3): δ  8.14 
(d, J = 7.8 Hz, 2H), 8.05 (s, 1H), 7.90 (d, J = 7.3 Hz, 2H), 7.48 (dt, J = 11.9, 7.7 Hz, 4H), 7.37 
N
N
N
Ph
7
>95% for all the cases
N
N
N Au R
+
TfO-
8a: R = PPh3; 
8b: R = P(Ph-p-F)3;
8c: R = P(Ph-p-OMe)3;
8d: R = P(OAr)3, Ar = 2,4-di-t-Bu;
8e: R = IPr;
8f: R = PEt3;
RAuCl/AgOTf (1 equiv.)
N
N
N
Ph
NAT-1
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(dt, J = 14.4, 7.3 Hz, 2H). 13C-NMR (101 MHz; CDCl3): δ 148.9, 132.6, 130.1, 129.3, 128.96, 
128.84, 127.4, 126.2, 118.8. 
 
 
(2) 1H-NMR (400 MHz; CDCl3): δ  8.61 (s, 1H), 8.08-8.06 (m, 2H), 7.97-7.94 (m, 2H), 7.56 
(ddd, J = 9.7, 4.3, 2.0 Hz, 3H), 7.51-7.45 (m, 17H), 7.43 (t, J = 1.8 Hz, 1H). 13C-NMR (101 
MHz; cdcl3): δ 149.7, 139.3, 134.27, 134.10, 133.96, 132.58, 132.55, 129.57, 129.53, 129.1, 
128.7, 127.2, 126.53, 126.41, 121.4. 31P NMR (162 MHz; CDCl3): δ 28.3. 
  
TA-Au: (known compound, See: Wang D, Cai R, Sharma S, Jirak J, Thummanapelli SK, 
Akhmedov NG, Zhang H, Liu X, Petersen JL, Shi X. J Am Chem Soc, 2012, 134: 9012-9019). 
 
 
N-fused-triazole 7 (NFT-7):  (known compound, See: Fiandanese V, Marchese G, Punzi A, 
Iannone F, Rafaschieri GG. Tetrahedron, 2009, 48: 3112-3115). 1H-NMR (400 MHz; CDCl3): δ  
N
N
N
Au
PPh3
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OTf
N
N
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OTf
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N
N
N
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7
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7.92 (d, J = 7.5 Hz, 2H), 7.85 (d, J = 7.5 Hz, 1H), 7.51 (t, J = 7.5 Hz, 3H), 7.43-7.38 (m, 3H), 
5.32 (s, 2H). 13C-NMR (101 MHz; cdcl3): δ 141.1, 139.4, 139.0, 131.3, 128.91, 128.79, 128.4, 
128.19, 128.16, 127.0, 124.2, 121.3, 51.0.  
 
 
 (8a) 1H NMR (400 MHz, CDCl3): δ  7.96-7.94 (m, 2H), 7.79 (d, J = 7.6 Hz, 1H), 7.73-7.71 (m, 
1H), 7.61-7.58 (m, 5H), 7.52 (td, J = 7.7, 2.8 Hz, 7H), 7.49-7.43 (m, 7H), 5.79 (s, 2H); 13C NMR 
(101 MHz, CDCl3): δ 141.4, 140.5, 139.8, 134.15, 134.09, 133.95, 132.83, 132.79, 132.76, 130.7, 
130.5, 129.72, 129.63, 129.2, 128.4, 127.4, 127.1, 126.4, 125.7, 125.1, 121.3, 53.9. 31P NMR 
(162 MHz; CDCl3): δ 29.7.  
 
 
 (8b) 1H NMR (400 MHz, CDCl3): δ  7.99 (dd, J = 6.4, 3.1 Hz, 2H), 7.72 (d, J = 7.5 Hz, 1H), 
7.66 (d, J = 7.5 Hz, 1H), 7.60-7.57 (m, 3H), 7.54 (dd, J = 7.6, 1.3 Hz, 1H), 7.49 (dd, J = 7.7, 6.8 
Hz, 1H), 5.64 (s, 2H). 13C NMR (101 MHz, CD3CN): δ 149.1, 146.6, 144.4, 141.4, 141.0, 140.0, 
139.7, 137.2, 130.7, 130.3, 129.6, 129.21, 129.16, 128.2, 127.2, 126.0, 124.7, 122.7, 121.4, 119.5, 
53.9. 31P NMR (162 MHz; CD3CN): δ -39.0.  
N N
N
Au PPh3
8a
OTf
N N
N
Au P(Ph-penta-F)3
8b
OTf
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(8c) 1H NMR (400 MHz, CDCl3): δ  7.94 (d, J = 7.0 Hz, 2H), 7.79 (d, J = 7.6 Hz, 1H), 7.73 (d, J 
= 7.5 Hz, 1H), 7.67-7.47 (m, 6H), 7.35 (dd, J = 13.0, 8.7 Hz, 6H), 7.01-6.99 (m, 6H), 5.76 (s, 
2H), 3.86 (s, 10H). 13C NMR (101 MHz, CDCl3): δ 162.88, 162.85, 141.3, 140.5, 139.8, 135.51, 
135.45, 135.36, 130.7, 130.5, 129.7, 129.2, 128.4. 31P NMR (162 MHz; CDCl3): δ 25.5 
 
 
(8d) 1H NMR (400 MHz, CDCl3): δ  7.83-7.81 (m, 1H), 7.64-7.62 (m, 3H), 7.56-7.51 (m, 2H), 
7.48 (t, J = 1.8 Hz, 3H), 7.45-7.39 (m, 3H), 7.33 (dd, J = 8.5, 1.4 Hz, 3H), 7.12 (dd, J = 8.5, 2.5 
Hz, 3H), 5.81 (s, 2H), 1.43 (s, 28H), 1.30 (s, 27H). 13C NMR (101 MHz, CDCl3): δ 149.0, 
146.98, 146.92, 140.8, 139.7, 139.26, 139.19, 130.60, 130.42, 129.7, 129.0, 128.0, 127.2, 125.8, 
125.41, 125.37, 124.3, 121.0, 119.08, 118.99, 54.1, 35.1, 34.7, 31.4. 31P NMR (162 MHz; 
CDCl3): δ 94.2  
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(8e) 1H NMR (400 MHz, CDCl3): δ  7.76 (d, J = 7.6 Hz, 1H), 7.59 (t, J = 7.8 Hz, 2H), 7.53-7.42 
(m, 5H), 7.40-7.32 (m, 7H), 7.30-7.26 (m, 3H), 5.54 (s, 2H), 2.52 (t, J = 6.8 Hz, 5H), 1.22 (dd, J 
= 17.2, 6.8 Hz, 26H). 13C NMR (101 MHz, CDCl3): δ 168.6, 145.5, 141.1, 140.1, 139.5, 133.3, 
131.1, 130.4, 130.0, 129.5, 129.1, 127.6, 126.7, 125.6, 125.2, 124.7, 124.4, 120.8, 53.6, 28.8, 
24.5, 23.9.  
 
 
(8f) 1H NMR (400 MHz, CDCl3): δ  7.91 (dd, J = 7.5, 2.0 Hz, 2H), 7.75 (dd, J = 15.4, 7.3 Hz, 
2H), 7.63-7.62 (m, 3H), 7.57-7.48 (m, 2H), 5.69 (s, 2H), 1.99 (dq, J = 10.5, 7.7 Hz, 6H), 1.20 (dt, 
J = 19.5, 7.6 Hz, 9H). 13C NMR (101 MHz, CDCl3): δ 141.1, 140.3, 139.8, 130.6, 130.3, 129.6, 
129.2, 128.2, 127.3, 125.8, 125.0, 121.2, 53.4, 17.6, 17.2, 9.14, 9.13. 31P NMR (162 MHz; 
CDCl3): δ 30.3.  
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III. ORTEP Drawing of the Crystal Structures 
 
Figure S1. Perspective view of the molecular structure of C15H11N3 with the atom labeling 
scheme for the non-hydrogen atoms. The thermal ellipsoids are scaled to enclose 30% 
probability. The CCDC No. is 1036906. 
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Figure 2S.   Perspective view of the molecular structure of [Au(C15H11N3)PPh3][SO3CF3] with 
the atom labeling scheme.  The thermal ellipsoids are scaled to enclose 30% probability. The 
CCDC No. is 1036907. 
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IV. Fluorescence Data 
 
 Ex λmax (nm) Em λmax (nm) Φ (x10-3) Intensity [x103] Stokes Shift (nm) 
7 285 368 0.69 4.45 83 
8a 285 342 1.1 8.31 57 
8b 285 362 0.96 8.16 77 
8c 263 342 0.75 5.96 79 
8d 285 368 0.75 5.28 83 
8e 293 356 0.87 6.74 63 
8f 293 368 0.95 5.79 75 
   
N
N
N Au R
+
TfO-
8a: R = PPh3; 
8b: R = P(Ph-p-F)3;
8c: R = P(Ph-p-OMe)3;
8d: R = P(OAr)3, Ar = 2,4-di-t-Bu;
8e: R = IPr;
8f: R = PEt3;
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V. 31P NMR Analysis 
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Chapter 3: C-X (C, O, S) bond formations through TA-gold catalysis 
 
3.1 C-C bond formation introduction 
As we all know, the cyclopentene structure is useful building block with great potential in 
chemistry applications. An efficient synthetic method through VCP rearrangement to 
cyclopentenes can be helpful and critical for organic synthesis.20 Previously reported methods 
were very limited to applications due to the harsh conditions (heating up to 60-100 oC) or 
conditional VCP substrate scopes (Figure 19).  
 
Figure 19. Vinylcyclopropane rearrangement 
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In fact, these methods did not offer an effective way of making cyclopentenes. Nevertheless, 
Louie’s group reported that using carbene nickel catalyst may achieve the desired cyclopentene 
product from regular VCP without heating needed, which method is the only effective way 
reported so far.  
A critical factor for cyclopentenes synthesis from VCP is how to effectively build up VCP 
molecules. Classic and popular methods include using carbene chemistry with 1,3-diene 
compounds or application of dicarbonyl compounds.21 Although these methods seem simple and 
easy operable, none of them can be achieved through one step or one pot reactions. It should be 
meaningful if a one pot reaction can be developed from reactive VCPs directly forming desired 
cyclopentenes, and thus we focused on what we discovered and carried out the experiments. 
 
3.1.1 TA-Au and Lewis acid synergistic catalysis system 
TA-Au catalysts were found more stable than normal gold catalyst, which is still alive even 
at 80 oC. Due to the good stability, TA-Au catalysts were usually considered as inert gold 
catalysts. As shown in Figure 20, however, the successful application of enyne cyclization 
proved that TA-Au could be direct good catalysts in some circumstance like a combination of 
Ga(OTf)3. The exact function of Ga(OTf)3 in the system was not fully clear so far, but there are 
two possibilities. The first one is that [Ga] has a good coordination with TA so that forcing the 
active [Au] dissociated from TA, and therefore make the reaction happen. The second-guessing 
is that [Au] and [Ga] are both bonding with TA tightly forming a di-metal complex, which may 
be the real catalyst in the system. 
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Figure 20. TA-Au catalyzed enyne cyclization 
 
In 2004, we successfully employed this catalysis system into an intermolecular type 
Nakamura reaction. The first example of Nakamura reaction was developed in 2003 by using 
Lewis acid In(OTf)3 as catalyst, which brought much attention because it involved an 
intermolecular type C-C bond formation between 1,3-dicarbonyl compounds and unactivated 
alkynes. The high temperature (140 oC) condition largely limited its wide applications. Unlike 
the intermolecular type reaction, the intramolecular type (Conia-ene reaction) was catalyzed by 
using Au(I) catalyst, and it could be achieved in high yield even at room temperature. Obviously, 
the intermolecular type reaction is much challenging (in Figure 21).  
 
 
Figure 21. Gold catalyzed Nakamura reaction 
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3.1.2 C-C bond formation between 1,3-dicarbonyl compounds and alkynes 
If most gold(I) catalysts suffered either low reactivity (TA-Au) or low stability (cationic Au), 
can we make some gold catalysts with a combination of reactivity and stability. As mentioned 
before, a synergistic co-catalysis system brought our attention, and we thus carried out a detailed 
screening table with specific designed experiments. Finally, we accomplished the transformation 
through a gentle condition and solved this problem.  
 
 
Figure 22. Lewis acid-promoted VCP rearrangement 
 
The vinylcyclopropane (VCP) substrate was achieved through our catalysis system as well 
when using dicarbonyl and cyclopropane acetylene, but the product concentration was low and 
going lower until completely disappear from the reaction mixture. Meanwhile, we realized there 
is another component accumulating. With the curiosity, we thus isolated the new component and 
identified the structure via X-ray crystal analysis. As shown in the figure, we achieved the 
desired cyclopentene derivatives from VCP in a one pot reaction. From mechanism view, the 
cyclopentene structure was possibly formed through vinylcyclopropane rearrangement under the 
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catalysis of Lewis Acid, and the mechanism will be further discussed later. 
Table 2. Summary of reaction condition screeninga 
 
Entry gold cat (5 mol %)b additive (mol %) Time (h) 
convnc 
(%) 
yield (%)c 
14 14a 15 
1 PPh3AuCl/AgOTf - 8  0 0 0 0 
2 XPhosAuCl/AgOTf - 8  40 20 13 0 
3 [XPhosAu(TA-H)]OTf - 8 0 0 0 0 
4 [XPhosAu(TA-H)]OTf Ga(OTf)3 (5) 8 70 12 10 30 
5 [XPhosAu(TA-H)]OTf Ga(OTf)3 (10) 8 76 0 0 55 
6 [PPh3Au(TA-H)]OTf Ga(OTf)3 (10) 8 90 0 0 47 
7 Ph3PAuNTf2 Ga(OTf)3 (10) 8 88 0 0 30 
8 XPhosAuCl Ga(OTf)3 (10) 8 45 0 0 11 
9 XPhosAuOTf Ga(OTf)3 (10) 8 100 0 0 40 
10 [IPrAu(TA-H)]OTf Ga(OTf)3 (10) 8 78 0 0 36 
11d [(ArO)3PAu(TA-H)]OTf Ga(OTf)3 (10) 6 100 0 0 76 
12 [(ArO)3PAu(TA-Me)]OTf Ga(OTf)3 (10) 6 100 0 0 90 
13 [(ArO)3PAu(TA-Me)]OTf AgOTf (10) 6 0 0 0 0 
14 [(ArO)3PAu(TA-Me)]OTf Cu(OTf)2 (10) 6 71 25 17 14 
15 [(ArO)3PAu(TA-Me)]OTf In(OTf)3 (10) 6 100 0 0 49 
16 [(ArO)3PAu(TA-Me)]OTf Sc(OTf)3 (10) 6 100 0 0 39 
17 [(ArO)3PAu(TA-Me)]OTf Yb(OTf)3 (10) 6 100 31 29 11 
18 - Ga(OTf)3 (10) 6 0 0 0 0 
19 - TfOH (10) 6 0 0 0 0 
a Reaction conditions: 13 (0.2 mmol), 12 (2.0 equiv), catalyst and additives in CDCl3 (0.4 mL), 
45 °C, 6-8 h; b TA-H = benzotriazole, TA-Me = N1-methylbenzotriazole; c  Determined by 1H 
NMR using p-xylene as internal standard. d Ar = 2,4-di-tert-butylphenyl. 
 
In order to rationalize the rearrangement, we screened the conditions. Compounds 14 and 
14a are slowly interconvertible even in natural solvent, and they are finally reaching an 
equilibrium in a ratio of 2:1. Either applying of acid or heat could speed up the interconversion 
of 14 and 14a. Ring expansion will happen if there is Lewis Acid in the reaction, but it will not 
happen if using gold catalyst alone. The combination of using [Au] and [Ga] gave higher 
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reaction efficiency, which is potentially owing to [Au] acting as an p-acid in the reaction. Dry 
solvent is necessary for better reaction yield and less hydration product.  
Based on about experimental results, we screened out different reaction conditions. It is no 
ring expansion reaction happened if using gold(I) alone. 5% loading of Ga(OTf)3 could help the 
ring expansion happen, which means Lewis Acid [Ga] is important for this transformation. A 
better reaction yield was obtained if using 10% loading of [Ga] due to the higher reaction rate 
and less side reactions. Different types of primary ligand were tested, cationic gold (entry 7) was 
too reactive and unstable so that no good yield was obtained although the conversion is 88%. 
During the comparison of different TA-Au, more electronic deficient gold(I) provided better 
reaction result, and it may be because gold is stronger p-acid and has better reactivity.  A dozen 
of different Lewis Acid were compared, and Ga(OTf)3 still offered the best result. If only using 
Lewis Acid or Acid without gold (entries 18 and 19), there would be no reaction happening. 
 
3.1.3 Substrates scope 
With the optimal condition in hand, we thus developed the substrates scope. Different 
dicarbonyl compounds were explored first, almost all of them worked pretty well and gave in 
good to excellent yields. 15d and 15f need longer reacting time due to conbonyl conjugated with 
Oxygen and phenyl ring substitute groups. As we excepted, 15g was also working good because 
the ring expansion could only happen in vinyl position.  
Other reactive and bulky substitutes could also be well tolerated, but internal type of alkynes 
offered only modest reaction result (15l) or even no reaction happened (15m). Compound 15n is 
the only product in the reaction because the big and stable conjugated system. The products 
structures were double confirmed with X-ray analysis like after compound 8a coupling with 
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amine. 
Table 3. Reaction scopea,b,c 
 
a Reaction conditions: 2 (0.2 mmol), 1 (2.0 equiv), catalyst and additives in CDCl3 (0.4 mL), 45 
°C, 6 h; b Isolated yield. c TA-Me = N1-methylbenzotriazole; d Reaction time in parenthesis.  
 
3.1.4 Proposed mechanism 
For the purpose of studying mechanism, we synthesized substituted cyclopropylacetylenes 
for this reaction. From the orbital overlapping view, the reaction could not undergo a concerted 
pathway. The products from above two reactions gave only stereospecific isomers 15o and 15p, 
and the other isomers were not formed, which suggested that symmetry-allowed [1,3]-
sigmatropic concerted alkyl shift is not possible at here. Otherwise, the stereochemistry will be 
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inverted due to the recombination of suprafacial orbitals. Therefore, a stepwised mechanism 
should be conclusive. Compound structures of 15o and 15p were analyzed by using both 1D and 
2D NMR data, which could be found in spectra section. 
 
 
Figure 23. Reactions with substituted cyclopropylacetylenes 
a Reaction conditions: 13 (0.2 mmol), 12a or 12b (2.0 equiv), catalyst and additives in CDCl3 
(0.4 mL), 45°C, 6 h; b Isolated yield; c TA-Me = N1-methyl benzotriazole.  
 
3.1.5 Kinetic study  
A series of kinetic studies were also carried out for the purpose of reaction mechanism 
understanding (in Figure 24). Nakamura products 14 and 14a were first observed and reach the 
highest concentration about an hour, then both of them converted into cycloptene 15 in the 
following several hours. The observed results here were fully accordant to our analysis in the 
article, which products 14 and 14a were intermediates in this reaction and cycloptene 15 are the 
final product. 
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Figure 24. Kinetic studies 
 
 
Figure 25. Kinetic studies from intermediates 14 & 14a 
 
 
The Nakamura reaction products 14 and 14a were synthesized with strictly timing, and they 
were successfully isolated separately with >95% purity by quick chromatography at low 
temperature. We started two experiments same time with two pure products 14 and 14a. 
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Obviously, no matter which starting material 14 or 14a begin with, both of two compounds will 
show up in the reaction in minutes at 45 oC. Compound 14 and 14a will quickly reach a balance 
at concentration ratio of 2:1, and literally converted into final product 15 through ring expansion 
process (in Figure 25). 
 
3.1.6 Conclusion 
In summary, a one pot efficient and effective method for cyclopentenes synthesis was 
developed by bimetal catalysis system (triazole-gold and gallium) from simple and widely 
available starting materials cyclopropane alkynes and 1,3-dicarbonyl compounds. Through 
kinetic and mechanism investigations, the reaction undergoes a Nakamura type addition first 
followed by Lewis Acid assisted ring expansion (VCP rearrangement). It is hopefully that this 
simple and efficient synthesis could be applied in practical field and natural product synthesis. 
 
 
3.1.7 Experimental data 
I. General Methods and Materials 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out 
under an atmosphere of nitrogen using oven/flame-dried glassware. Unless otherwise noted, all 
commercial reagents and solvents were obtained from the commercial provider and used without 
further purification. Chemicals were purchased from Acros and AKSci used as received. Gold 
complexes were synthesized from HAuCl4, which was purchased from Strem. 1H NMR, 13C 
NMR, 31P NMR, and 19F NMR spectra were recorded on Agilent 400 MHz spectrometers. 
Chemical shifts were reported relative to internal tetramethylsilane (δ 0.00 ppm) or CDCl3 (δ 
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7.26 ppm) for 1H and CDCl3 (δ 77.0 ppm) for 13C. Flash column chromatography was performed 
on 230-430 mesh silica gel. HRMS were recorded on Q-TOF B5125 spectrometer.  
 
General procedure for Nakamura reaction product 14. (Procedure A) 
 
A 4-dram vial was charged with 2,4-pentadione (20.6 µL, 0.2 mmol) and 
cyclopropylacetylene (0.4 mmol, 2 equiv.) in dry DCM (0.4 mL), followed by the addition of 
catalysts (ArO)3PAu(TA)OTf (11.3 mg, 5 mol%) and Ga(OTf)3 (10.3 mg, 10 mol%). The vial 
was allowed to stir at 45 oC and monitored by TLC. The reaction was quenched after 60 to 90 
minutes. The reaction mixture was directly purified by flash chromatography on silica gel (ethyl 
acetate/hexane = 1:20, V/V) to give desired addition product in yield 73%. 
 
General procedure for product 14a. (Procedure B) 
 
A 4-dram vial was charged with 2,4-pentadione (20.6 µL, 0.2 mmol) and 
cyclopropylacetylene (0.4 mmol, 2 equiv.) in dry DCM (0.4 mL), followed by the addition of 
catalysts (ArO)3PAu(TA)OTf (11.3 mg, 5 mol%) and Ga(OTf)3 (10.3 mg, 10 mol%). The vial 
was allowed to stir at 45 oC and monitored by TLC. The reaction was quenched after 3 hours. 
The reaction mixture was directly purified by flash chromatography on silica gel (ethyl 
acetate/hexane = 1:15, V/V) to give desired addition product in yield 30%. 
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General procedure for ring expansion product 15. (Procedure C) 
 
A 4-dram vial was charged with 2,4-pentadione (20.6 µL, 0.2 mmol) and 
cyclopropylacetylene (0.4 mmol, 2 equiv.) in dry DCM (0.4 mL), followed by the addition of 
catalysts (ArO)3PAu(TA)OTf (11.3 mg, 5 mol%) and Ga(OTf)3 (10.3 mg, 10 mol%). The vial 
was allowed to stir at 45 oC and monitored by TLC. After the reaction was completed (about 6 h), 
the reaction mixture was directly purified by flash chromatography on silica gel (ethyl 
acetate/hexane = 1:20, V/V) to give desired addition product. 
 
General procedure for ring expansion product 15o and 15p. (Procedure D) 
 
        A 4-dram vial was charged with 2,4-pentadione (20.6 µL, 0.2 mmol) and 
cyclopropylacetylene (0.4 mmol, 2 equiv.) in dry DCM (0.4 mL), followed by the addition of 
catalysts (ArO)3PAu(TA)OTf (22.6 mg, 10 mol%) and Ga(OTf)3 (20.6 mg, 20 mol%). The vial 
was allowed to stir at 45 oC and monitored by TLC. After the reaction was completed (about 6 h), 
the reaction mixture was directly purified by flash chromatography on silica gel (ethyl 
acetate/hexane = 1:20, V/V) to give desired addition product. 
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General procedure for product 8a. (Procedure E) 
 
        A 4-dram vial was charged with 15c (392mg, 2 mmol) and 2,4-Dinitrophenylhydrazine 
(476mg, 2.4 mmol,) in absolute EtOH (4 mL). The vial was allowed to stir and reflux around 8 h. 
The precipitate was collected by filtration and washed via cool EtOH, and then the solid was 
further purified by flash chromatography on silica gel (ethyl acetate/hexane = 1:12, V/V) to give 
desired product in yield 80%. 
 
General Procedure for preparation of gold complex 
 
 
          A 20 mL screw-cap vial was charged with (ArO)3PAuCl (355 mg, 0.5 mmol) and 1-
Methyl-benzotriazole (1.1 equiv.) in dry DCM (10 mL), followed by the addition of AgOTf 
(1.05 equiv.). The vial was allowed to stir at ambient temperature. After 4h, the reaction mixture 
was filtered through two celite pads and concentrated in vacuo to give the product as white foam. 
Pure white powder was obtained via recrystallization through diffusion of hexanes into DCM 
solution of crude product. 
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II. Compounds Characterization 
 
[(ArO)3PAu(TA-Me)]OTf 
1H-NMR (400 MHz; CDCl3): δ 8.15 (dd, J = 8.6, 0.7 Hz, 1H), 7.75-7.71 (m, 1H), 7.58-7.54 (m, 
4H), 7.48 (dd, J = 8.5, 1.4 Hz, 3H), 7.31-7.25 (m, 4H), 4.59 (s, 3H), 1.51 (s, 27H), 1.33 (s, 28H). 
13C-NMR (101 MHz; CDCl3): δ 49.3, 147.10, 147.03, 143.1, 139.43, 139.36, 134.1, 130.0, 128.6, 
125.97, 125.91, 124.5, 122.5, 119.30, 119.27, 119.21, 115.0, 113.1, 53.5, 37.0, 35.2, 34.8, 31.3, 
30.6  
31P-NMR (81 MHz; CDCl3): δ 94.23 
19F-NMR (376 MHz; CDCl3): δ -94.23 
 
 
3-(1-cyclopropylvinyl)-4-hydroxypent-3-en-2-one (14) was obtained through Procedure A in 
73% isolated yield as light yellow oil. 3% of 4a contained. 
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1H-NMR (400 MHz; CDCl3): δ 5.25 (d, J = 1.9 Hz, 1H), 4.88 (d, J = 1.9 Hz, 1H), 2.07 (s, 6H), 
1.61-1.55 (m, 1H), 0.74-0.70 (m, 2H), 0.35-0.31 (m, 2H). 
 13C-NMR (101 MHz; CDCl3): δ 190.8, 145.8, 115.6, 111.9, 23.4, 17.7, 6.0. 
HRMS Calculated for C10H14O2H [M+H]+: 167.106, Found: 166.0987. 
 
 
3-(1-cyclopropylethylidene)pentane-2,4-dione (14a) was obtained through Procedure B in 
35% isolated yield as light yellow oil. 2% of 3a contained. 
1H-NMR (400 MHz; CDCl3): δ 2.40 (s, 3H), 2.26 (s, 3H), 1.85 (td, J = 6.7, 3.1 Hz, 1H), 0.89-
0.81 (m, 4H). 
13C-NMR (101 MHz; CDCl3): δ 203.1, 199.2, 152.8, 141.5, 31.9, 31.0, 16.1, 14.1, 7.0. 
HRMS Calculated for C10H14O2H [M+H]+: 167.106, Found: 166.0988. 
 
 
1,1'-(2-methylcyclopent-2-ene-1,1-diyl)diethanone (15a) was obtained through Procedure C 
in 90% isolated yield as light yellow oil.  
1H-NMR (400 MHz; CDCl3): δ 5.77 (s, 1H), 2.47-2.43 (m, 2H), 2.36 (t, J = 6.8 Hz, 2H), 2.17 (s, 
6H), 1.79 (d, J = 1.5 Hz, 3H). 
13C-NMR (101 MHz; CDCl3): δ 206.9, 137.5, 132.4, 80.7, 31.6, 30.5, 27.0, 14.5. 
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HRMS Calculated for C10H14O2H [M+H]+: 167.0994, Found: 167.1061. 
 
 
Methyl 1-acetyl-2-methylcyclopent-2-enecarboxylate (15b) was obtained through Procedure 
C in 74% isolated yield as light yellow oil.  
1H-NMR (400 MHz; CDCl3): δ 5.72 (dd, J = 2.3, 0.8 Hz, 1H), 3.77 (s, 3H), 2.63 (ddd, J = 13.3, 
8.3, 5.1 Hz, 1H), 2.44-2.36 (m, 2H), 2.25 (ddd, J = 13.1, 8.4, 5.5 Hz, 1H), 2.19 (s, 3H), 1.84-1.82 
(m, 3H), 1.59 (s, 1H). 
13C-NMR (101 MHz; CDCl3): δ 205.0, 172.2, 137.4, 132.2, 74.7, 52.3, 32.8, 30.4, 26.6, 14.8. 
HRMS Calculated for C10H14O3H [M+H]+: 183.0943, Found: 183.1001. 
 
 
Ethyl 1-acetyl-2-methylcyclopent-2-enecarboxylate (15c) was obtained through Procedure C 
in 70% isolated yield as light yellow oil.  
1H-NMR (400 MHz; CDCl3): δ 5.70 (d, J = 1.5 Hz, 1H), 4.23 (q, J = 7.1 Hz, 2H), 2.62 (ddd, J = 
13.3, 8.4, 5.1 Hz, 1H), 2.42-2.34 (m, 2H), 2.22 (td, J = 8.7, 4.8 Hz, 1H), 2.18 (s, 3H), 1.82 (t, J = 
1.9 Hz, 3H), 1.29 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz; CDCl3): δ 204.3, 170.9, 136.7, 131.2, 73.8, 60.4, 32.0, 29.6, 25.9, 14.0, 
13.31, 13.27. 
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HRMS Calculated for C11H16O3H [M+H]+: 197.1099, Found: 197.1175. 
 
 
Dimethyl 2-methylcyclopent-2-ene-1,1-dicarboxylate (15d) was obtained through Procedure 
C in 62% isolated yield as light yellow oil.  
1H-NMR (400 MHz; CDCl3): δ 5.67 (t, J = 1.8 Hz, 1H), 3.75 (s, 6H), 2.51 (dd, J = 7.5, 6.1 Hz, 
2H), 2.39-2.35 (m, 2H), 1.85 (t, J = 1.9 Hz, 3H). 
13C-NMR (101 MHz; CDCl3): δ 171.3, 136.9, 131.5, 67.6, 52.1, 33.8, 30.1, 14.2. 
HRMS Calculated for C10H14O4Na [M+Na]+: 220.9990, Found: 221.0779. 
 
 
1-(1-benzoyl-2-methylcyclopent-2-en-1-yl)ethanone (15e) was obtained through Procedure C 
in 61% isolated yield as light yellow oil.  
1H-NMR (400 MHz; CDCl3): δ 7.78-7.76 (m, 2H), 7.55-7.51 (m, 1H), 7.44-7.40 (m, 2H), 5.80 (t, 
J = 1.1 Hz, 1H), 2.85 (ddd, J = 13.4, 8.6, 4.6 Hz, 1H), 2.54-2.47 (m, 2H), 2.34 (ddd, J = 13.6, 
9.0, 6.4 Hz, 1H), 2.22 (s, 3H), 1.85 (t, J = 1.9 Hz, 3H). 
13C-NMR (101 MHz; CDCl3): δ 206.7, 199.8, 138.6, 135.9, 133.1, 132.6, 129.3, 128.8, 79.8, 
33.7, 31.3, 28.1, 15.4. HRMS Calculated for C15H16O2H [M+H]+: 229.1150, Found: 229.1232. 
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Ethyl 1-benzoyl-2-methylcyclopent-2-enecarboxylate (15f) was obtained through Procedure 
C in 52% isolated yield as light yellow oil.  
1H-NMR (400 MHz; CDCl3): δ 7.85 (d, J = 7.8 Hz, 2H), 7.53 (t, J = 7.3 Hz, 1H), 7.43 (t, J = 7.7 
Hz, 2H), 5.76 (d, J = 0.9 Hz, 1H), 4.12 (dt, J = 7.1, 3.5 Hz, 2H), 3.09 (ddd, J = 13.2, 8.8, 4.5 Hz, 
1H), 2.53 (ddt, J = 9.0, 4.7, 2.3 Hz, 1H), 2.42-2.35 (m, 1H), 2.28 (ddd, J = 13.4, 8.9, 4.8 Hz, 1H), 
1.86 (d, J = 1.9 Hz, 3H), 1.05 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz; CDCl3): δ 197.4, 172.5, 138.3, 135.9, 132.94, 132.92, 131.91, 131.89, 
128.85, 128.72, 72.5, 61.6, 34.2, 31.2, 15.2, 14.13, 14.10. 
HRMS Calculated for C16H18O3Na [M+Na]+: 281.1244, Found: 281.1143. 
 
 
1-(1-(cyclopropanecarbonyl)-2-methylcyclopent-2-en-1-yl)ethanone (15g) was obtained 
through Procedure C in 86% isolated yield as light yellow oil.  
1H-NMR (400 MHz; CDCl3): δ 5.74 (d, J = 1.5 Hz, 1H), 2.54-2.38 (m, 4H), 2.18 (s, 3H), 1.97-
1.91 (m, 1H), 1.85 (t, J = 1.8 Hz, 3H), 1.08-1.05 (m, 2H), 0.94-0.90 (m, 2H), 5.74 (d, J = 1.5 Hz, 
1H), 2.54-2.38 (m, 4H), 2.18 (s, 3H), 1.97-1.91 (m, 1H), 1.85 (t, J = 1.8 Hz, 3H), 1.08-1.05 (m, 
2H), 0.94-0.90 (m, 2H). 
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13C-NMR (101 MHz; CDCl3): δ 209.5, 207.2, 138.1, 132.8, 81.2, 32.1, 31.0, 28.2, 19.0, 15.5, 
12.27, 12.10. 
HRMS Calculated for C12H16O2H [M+H]+: 193.1150, Found: 193.1222. 
 
 
1,1'-(2-methylcyclopent-2-ene-1,1-diyl)bis(propan-1-one) (15h) was obtained through 
Procedure C in 88% isolated yield as light yellow oil.  
1H-NMR (400 MHz; CDCl3): δ 5.74 (t, J = 1.8 Hz, 1H), 2.54-2.34 (m, 9H), 1.78 (q, J = 1.9 Hz, 
3H), 1.07 (t, J = 7.2 Hz, 6H). 
13C-NMR (101 MHz; CDCl3): δ 210.5, 138.5, 132.5, 80.9, 33.0, 32.2, 31.1, 15.3, 8.5. 
HRMS Calculated for C12H18O2H [M+H]+: 195.1307, Found: 195.1375. 
 
 
1-(1-(furan-2-carbonyl)-2-methylcyclopent-2-en-1-yl)ethanone (15i) was obtained through 
Procedure C in 55% isolated yield as light yellow oil.  
1H-NMR (400 MHz; CDCl3): δ 7.25 (s, 1H), 7.20 (dd, J = 3.6, 0.8 Hz, 1H), 6.50 (dd, J = 3.6, 1.7 
Hz, 1H), 5.77 (d, J = 1.5 Hz, 1H), 2.72-2.66 (m, 1H), 2.50-2.45 (m, 2H), 2.39-2.34 (m, 1H), 2.22 
(s, 3H), 1.80-1.78 (m, 3H). 
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13C-NMR (101 MHz; CDCl3): δ 205.8, 188.0, 151.7, 145.8, 137.4, 132.6, 117.9, 112.3, 78.4, 
32.7, 30.8, 27.1, 14.8. HRMS Calculated for C13H14O3H [M+H]+: 219.0946, Found: 219.1012. 
 
 
1,1'-(2-methylcyclopent-2-ene-1,1-diyl)bis(2-methylpropan-1-one) (15j) was obtained 
through Procedure C in 48% isolated yield as light yellow oil.  
1H-NMR (400 MHz; CDCl3): δ 5.77 (d, J = 1.6 Hz, 1H), 2.80 (dt, J = 13.4, 6.7 Hz, 2H), 2.46-
2.41 (m, 4H), 1.73 (t, J = 1.9 Hz, 3H), 1.10 (s, 12H). 
13C-NMR (101 MHz; CDCl3): δ 214.6, 138.7, 132.7, 82.2, 37.9, 31.8, 31.5, 31.3, 31.0, 20.84, 
20.69, 15.3. 
HRMS Calculated for C13H14O3H [M+H]+: 223.1696, Found: 223.1684. 
 
 
1-(1-acetyl-2-methylcyclopent-2-en-1-yl)-3-methylbutan-1-one (15k) was obtained through 
Procedure C in 82% isolated yield as light yellow oil.  
1H-NMR (400 MHz; CDCl3): δ 5.74 (dd, J = 2.3, 1.5 Hz, 1H), 2.45-2.40 (m, 3H), 2.34-2.30 (m, 
2H), 2.21-2.17 (m, 1H), 1.77 (t, J = 1.1 Hz, 3H), 0.90 (dd, J = 14.7, 6.6 Hz, 7H). 
13C-NMR (101 MHz; CDCl3): δ 208.4, 206.6, 137.6, 132.1, 80.6, 47.7, 31.4, 30.4, 27.3, 23.5, 
22.3, 22.1, 14.5.  
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HRMS Calculated for C13H20O2H [M+H]+: 209.1463, Found: 209.1536. 
 
 
1,1'-(2-benzylcyclopent-2-ene-1,1-diyl)diethanone (15l) was obtained through Procedure C in 
28% isolated yield as light yellow oil.  
1H-NMR (400 MHz; CDCl3): δ 7.30 (t, J = 7.7 Hz, 3H), 7.18 (dd, J = 7.5, 5.0 Hz, 3H), 5.98 (d, J 
= 2.3 Hz, 1H), 3.96 (s, 2H), 3.00 (ddd, J = 11.5, 5.5, 3.0 Hz, 2H), 2.28 (s, 3H), 2.18 (s, 3H). 
13C-NMR (101 MHz; CDCl3): δ 203.8, 203.0, 144.5, 137.3, 128.7, 127.8, 126.8, 122.2, 74.2, 
43.4, 30.50, 30.37, 29.5, 23.6. HRMS Calculated for C16H18O2H [M+H]+: 243.1307, Found: 
243.1096. 
 
 
2-(1-cyclopropylethylidene)-1,3-diphenylpropane-1,3-dione (15n) was obtained through 
Procedure C in 86% isolated yield as yellow solid.  
1H-NMR (400 MHz; CDCl3): δ 8.02-7.94 (m, 4H), 7.53-7.39 (m, 6H), 1.73 (tt, J = 8.2, 5.4 Hz, 
1H), 1.54 (s, 3H), 0.81-0.71 (m, 4H). 
13C-NMR (101 MHz; CDCl3): δ 195.7, 195.3, 150.5, 138.0, 137.63, 137.58, 133.18, 133.11, 
129.75, 129.59, 128.39, 128.38, 16.5, 14.4, 6.5. 
HRMS Calculated for C20H18O2H [M+H]+: 290.1328, Found: 290.1307. 
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1,1'-(2-methyl-5-phenylcyclopent-2-ene-1,1-diyl)diethanone (15o) was obtained through 
Procedure D in 43% isolated yield as light yellow oil.  
1H-NMR (400 MHz; CDCl3): δ 5.90 (t, J = 1.2 Hz, 1H), 4.30 (dd, J = 8.4, 5.0 Hz, 1H), 2.98-2.91 
(m, 1H), 2.66-2.60 (m, 1H), 2.27 (s, 3H), 1.85 (d, J = 1.6 Hz, 2H).  
13C-NMR (101 MHz; CDCl3): δ 206.4, 205.4, 161.51, 161.35, 141.4, 137.8, 132.4, 128.5, 127.3, 
49.8, 39.5, 30.0, 28.2, 15.6, 0.1. 
HRMS Calculated for C16H18O2H [M+H]+: 243.1307, Found: 243.1372. 
 
 
2,4-dimethyl-5-phenylcyclopent-2-ene-1,1-diyl)diethanone (15p) was obtained through 
Procedure D in 30% isolated yield as light yellow oil.  
1H-NMR (400 MHz; CDCl3): δ 7.28-7.16 (m, 6H), 5.82 (t, J = 1.7 Hz, 1H), 3.94 (d, J = 8.4 Hz, 
1H), 3.13 (ddd, J = 8.5, 4.5, 2.2 Hz, 1H), 2.31 (s, 3H), 1.74 (dd, J = 2.4, 1.5 Hz, 3H), 1.59 (s, 
3H), 1.10 (d, J = 6.8 Hz, 3H). 
13C-NMR (101 MHz; CDCl3): δ 206.9, 206.3, 138.9, 138.2, 136.3, 129.0, 128.6, 127.4, 87.1, 
58.6, 44.1, 30.1, 29.4, 19.1, 15.9. 
HRMS Calculated for C17H20O2H [M+H]+: 256.1463, Found: 256.1462. 
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7-hydroxy-3-(1-hydroxyethylidene)-4methyleneheptan-2-one (15a’) was obtained through 
Procedure C as light yellow oil.  
1H-NMR (400 MHz; CDCl3): δ 5.59-5.54 (m, 1H), 5.35-5.32 (m, 1H), 3.42 (dt, J = 13.0, 6.6 Hz, 
3H), 2.40-2.36 (m, 2H), 2.17-2.14 (m, 2H), 2.02 (d, J = 7.3 Hz, 8H). 
13C-NMR (101 MHz; CDCl3): δ 190.2, 190.0, 132.9, 132.6, 129.9, 128.7, 70.08, 70.00, 30.1, 
29.1, 25.1, 23.1, 22.8. HRMS Calculated for C10H16O3H [M+H]+: 184.1131, Found: 183.1397. 
 
 
Ethyl 1-(1-(2-(2,4-dinitrophenyl)hydrazono)ethyl)-2-methylcyclopent-2-enecarboxylate (8a) 
was obtained through Procedure E in 90% isolated yield as yellow solid.  
1H-NMR (400 MHz; CDCl3): δ 11.07 (s, 1H), 9.16 (d, J = 2.6 Hz, 1H), 8.33 (ddd, J = 9.6, 2.6, 
0.7 Hz, 1H), 7.87 (d, J = 9.6 Hz, 1H), 5.77 (dd, J = 2.3, 0.8 Hz, 1H), 4.28 (q, J = 7.1 Hz, 2H), 
2.77 (ddd, J = 13.3, 8.4, 4.9 Hz, 1H), 2.43 (ddt, J = 31.2, 5.0, 2.4 Hz, 2H), 2.20-2.13 (m, 1H), 
2.08 (s, 3H), 1.89 (d, J = 1.6 Hz, 3H), 1.33 (t, J = 7.1 Hz, 3H). 
13C-NMR (101 MHz; CDCl3): δ 172.3, 156.5, 144.9, 138.1, 137.8, 131.3, 129.8, 129.1, 123.1, 
116.2, 69.6, 61.0, 33.7, 30.0, 14.8, 14.0. 
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HRMS Calculated for C17H20O6H [M+H]+: 377.1383, Found: 377.1460. 
 
 
(2-ethynylcyclopropyl)benzene (12a): (known compound, See: Li C, Pati K, Lin G, Sohel A, 
Hung H, Liu R. Angew. Chem. Int. Ed. 2010, 49, 9891). 
 
 
((1S,3R)-2-ethynyl-3-methylcyclopropyl)benzene (12b) was obtained through same procedure 
as synthesis of 12a. (See: Li C, Pati K, Lin G, Sohel A, Hung H, Liu R. Angew. Chem. Int. Ed. 
2010, 49, 9891).  
1H-NMR (400 MHz; CDCl3): δ 7.27-7.22 (m, 2H), 7.18-7.14 (m, 1H), 7.05-7.02 (m, 2H), 1.95 
(d, J = 2.2 Hz, 1H), 1.84 (t, J = 5.2 Hz, 1H), 1.65 (ddd, J = 8.4, 4.8, 2.2 Hz, 1H), 1.42 (dd, J = 
8.6, 5.7 Hz, 1H), 1.33 (s, 3H). 
13C-NMR (101 MHz; CDCl3): δ 140.8, 128.3, 126.0, 125.7, 83.4, 67.0, 33.6, 22.3, 17.1, 14.3. 
HRMS Calculated for C17H20O6H [M+H]+: 158.1013, Found: 158.1214. 
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(Cyclopropylethynyl)benzene (12l) (known compound, See: Li C, Pati K, Lin G, Sohel A, 
Hung H, Liu R. Angew. Chem. Int. Ed. 2010, 49, 9891) 
 
 
III. ORTEP Drawing of the Crystal Structures 
 
 
Figure 1.  Perspective view of the molecular structure of C17H20N4O6 with the atom labeling 
scheme for the non-hydrogen atoms.  The thermal ellipsoids are scaled to enclose 30% 
probability. The CCDC No. is 1434824.  
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3.2 C-O bond formation: O-vinylation of 1,3-diketones 
 
3.2.1 Introduction 
Encouraged by TAAu and LA assisted C-C bond formation, we extended our study into other 
C-X bond formations. Vinyl ether is a very common and useful building block in chemistry 
synthesis. Many methods have been reported before including alcohols addition to alkynes, 
elimination reactions, esters’ olefination and cross-coupling reactions catalyzed by transition 
metals. However, most of those methods are not general and their application are relatively 
limited. For example, most alcohols addition to alkynes required intra-molecular type reactions 
with low energy barrier. In this section, we will discuss a general and effective method for the 
synthesis of vinyl ether by using our TA-Au catalysis system. The biggest challenge for inter 
type addition to alkynes is the competition with H2O hydration. It is reasonable and possible to 
obtain good yield if pre-dry the solvent enough and operate the experiments carefully. 
Nevertheless, a more practical and efficient method is highly desirable for the direct O-
nucleophiles addition to alkynes.  
 
3.2.1 Challenging and opportunity 
As literature reported, water addition is favorable mainly because the formation of an active 
gold intermediate [L-Au-(H2O)]+, which process can happen with p-acid activation same time. 
Based on above consideration, we have to tune to find out the optimal gold catalyst if we want to 
avoid water addition faster than other O-nucleophiles. TA-Au catalysts were well studied in the 
past several years in our group, and we thus planned to screen out a series of gold catalysts and 
try to achieve the goal. 
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Figure 26. Intermolecular O-addition to alkyne: challenge and opportunity 
 
We initiated our experiments with simple starting materials 1,3-cyclohexanedione and 
phenylacetylene for the gold catalysts evaluation. As indicated in the table, triphenylphosphine 
gold chloride/silver chloride was first tested, which gave moderate yield 59% of desired product 
and 17% of hydration product. Carbene and more electron rich type gold catalysts were screened 
out, and XPhosAuCl/AgCl offered the best result with 85% of 18. When comparing entries 1, 3, 
5 with entries 2, 4, 6, TA-Au catalysts apparently provided better yield of desired product 18 and 
less hydration product 19. We further increased the equivalent of 2a in order to speed up the 
reaction efficiency, and we successfully achieved the desired product with almost quantitive 
yield.  
To our delighted, the reaction could undergo nicely without precaution or extra dry solvent 
condition. The experiment has been repeated multiple times under opening to air and untreated 
solvent at room temperature. The TA-Au catalyst double proved our beginning hypothesis that 
TA-Au could prevent the water hydration due to the special TA ligand effect. Besides, the 
reaction can be fully converted and still gave excellent isolation yield even with 1% of gold 
catalyst loading, which demonstrated high efficiency of this reaction. 
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Table 4. Screening of gold catalysts.a,b 
 
Entry  [Au] cat. 17 (eq.) loading time Conv. of 17 (%) Yield of 18 (%) Yield of 19 (%) 
1 PPh3AuCl/AgOTf 1.0 5% 17 81 59 17 
2 PPh3Au(TA)OTf 1.0 5% 17 82 63 11 
3 IPrAuCl/AgOTf 1.0 5% 17 100 55 34 
4 IPrAu(TA)OTf 1.0 5% 17 64 50 5 
5 XPhosAuCl/AgOTf 1.0 5% 10 100 76 22 
6 XPhosAu(TA)OTf 1.0 5% 10 100 85 12 
7 XPhosAu(TA)OTf 1.2 5% 10 100 99 n.d. 
8 XPhosAu(TA)OTf 1.2 3% 17 100 99 n.d. 
9 XPhosAu(TA)OTf 1.2 1% 20 100 98 (95) n.d. 
a General conditions: 1 (0.2 mmol), 2a (1 or 1.2 equiv), and catalyst in CDCl3 (0.4 mL), rt. b 
Yield and conversion are determined by using 1,3,5-trimethoxybenzene as the internal standard. 
Isolated yield is given in parenthesis. 
 
For the purpose of exploring substrates scope, we carried out our experiments with other type 
of starting materials. To our surprise, much lower yield could be obtained if using DCM/DCE as 
the solvent instead of CDCl3. Then we re-check the reaction again, and compared with and 
without base wash solvent difference. We found out that the very small amount of acid inside the 
solvent is crucial for the reaction, and the function of acid may be for the final protodeauration 
step. Other type acids were latterly screened out, and both catalytic amount of HOTf or Cu(OTf)2 
could give perfect reaction result, but there is no reaction happening if using those acid alone. 
This evidence suggested that a combined function from TA-Au and acid is important for the gold 
catalysis, and also proved the special catalytic function of TA-Au. Based on the experiments 
above, we finally choose Cu(OTf)2 as the optimal condition since it easier to weigh and 
manipulate.  
 
OH
Ph
CDCl3 (0.5 M), rt, 17h Ph
OAu cat.
18 19
O O PhO
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3.2.2 Substrate scopes 
With the optimal condition in hand, we further explored the substrates scope. On the one 
hand, a big group of aromatic alkynes were first tested, and no matter which position the 
substitute group at, they all offered good reaction yield. More electron rich substituted substrates 
are likely giving better reaction than the poor substrates substrates, which may be because the 
better alkyne electron density lead to better coordination. In entries 7 and 8, the thiofuran and 
ethynylferrocene could be well tolerated, so this method definitely offered more general and 
gentle reaction condition compared with previously reported ways.  
 
 
Figure 27. Acid as the critical additive for optimal performance 
 
On the other hand, a series of aliphatic alkynes were also studied. Different size of rings 
substrates provided good yield of product, and even the cyclopropane type of compound could 
also give good yield without much decomposition and side reactions. The conjugated enyne 
system could attend this reaction, and give corresponding conjugated diene products.  
  Besides, internal alkynes were carried out for the purpose of broad substrate scope. Internal 
alkynes are always less reactive when compared with terminal alkynes. As we predicted, most of 
them are not attending the reaction at all, and only the methyl phenyl alkyne gave two 
regioisomers around 30% yield in total after 2 days of heating up.  
OH
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16 17
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treated with K2CO3
Solvent Conversion of 16
DCM 95%
additive
1% HOTf
DCM
100%;
(18,  98% 
isolated yield)
1% Cu(OTf)2
			 62	
Table 5.  Reaction scope of alkynes 
 
aGeneral conditions: 16 (0.4 mmol), 17 (1.2 equiv), 1 mol % XPhosAu(TA)OTf and 1 mol % 
Cu(OTf)2 in dry DCM (0.8 mL), rt. bIsolated yield. c16 (0.4 mmol), 17 (2 equiv), 18 mol % 
XPhosAu(TA)OTf and 3 mol % Cu(OTf)2. 
 
We also picked up other cyclo-diketones for this test, and they are all worked pretty well 
although heating up sometimes are necessary due to the bad solubility of 1,3-cyclopentadione in 
DCM at room temperature. From this study, the acyclic type of 1,2-diketones and 1,2-diketones 
are not working in our catalysis system, and the reason potentially is that they have 
intramolecular H-bond blocked the reaction activity. 
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Table 6. Reaction scope with aliphatic alkyne 
 
aGeneral conditions: 16 (0.4 mmol), 17 (2 equiv), 1 mol % XPhosAu(TA)OTf and 1 mol % 
Cu(OTf)2 in dry DCM (0.8 mL), rt. bIsolated yield. cA ratio of 1:0.4 is observed for 
terminal/internal alkene mixtures. Combined yield. 
 
 
Figure 28. Reactions of internal alkyne and other O-nucleophiles 
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3.2.3 Conclusion 
In sum, we developed a new gold(I) catalysis for the formation of O-vinylation between 
cyclic 1,3-diketones and terminal alkynes.  The condition is easy operable and well tolerated to 
different functional groups even other metals, which suggest that this is a new general and 
efficient synthetic method. A broad scope of aromatic and aliphatic alkynes has been tested, 
giving good to excellent yield of O-addition products. Meanwhile, this report further proved the 
high efficiency of our TA-Au with Lewis acid (Cu(OTf)2) assisted system, and successfully 
avoided the hydration byproduct, which also provided great potential applications of this bimetal 
catalysis system. It is hopefully that our new method and new catalysis system will be further 
applied into other transformations and total synthesis field.  
 
 
3.2.4 Experimental data 
I. General Methods and Materials 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out 
under an atmosphere of nitrogen using oven/flame-dried glassware. Unless otherwise noted, all 
commercial reagents and solvents were obtained from the commercial provider and used without 
further purification. All gold complexes were synthesized from HAuCl4, which was purchased 
from Strem. XPhos was purchased from Acros and used as received (stored at 4oC and handled 
in glovebox). 1H NMR and 13C NMR spectra were recorded on Varian/Agilent 400 MHz 
spectrometers. Chemical shifts were reported relative to internal tetramethylsilane (d 0.00 ppm) 
or CDCl3 (d 7.26 ppm) for 1H and CDCl3 (d 77.0 ppm) for 13C. Flash column chromatography 
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was performed on 230-430 mesh silica gel. HRMS were recorded on LTQ-FTUHRA 
spectrometer.  
 
 
Representative procedure for Gold-catalyzed O-Vinylation of 1,3-Cyclic Diketone 
 
A 4 mL screw-cap vial was charged with 1,3-cyclohexanedione (46 mg, 0.4 mmol) and alkyne 
(0.8 mmol, 1.2 equiv.) in dry DCM (0.8 mL), followed by the addition of catalysts 
XPhosAu(TA)OTf (3.7 mg, 1 mol%) and Cu(OTf)2 (1.4 mg, 1 mol%). The vial was allowed to 
stir at rt and monitored by TLC. After the reaction was completed (about 24 h), the reaction 
mixture was directly purified by flash chromatography on silica gel (ethyl acetate/hexane = 1:3, 
V/V) to give desired addition product. 
Procedure for Synthesis of XPhosAu(TA)OTf 
 
A 20 mL screw-cap vial was charged with XPhosAuCl (355 mg, 0.5 mmol) and 1H-
benzotriazole (1.1 equiv.) in dry DCM (5 mL), followed by the addition of AgOTf (1.05 equiv.). 
The vial was allowed to stir at ambient temperature. After 4h, the reaction mixture was filtered 
through two celite pads and concentrated in vacuo to give the product as white foam. Pure white 
powder was obtained via recrystallization through diffusion of hexane into DCM solution of 
crude product. 
DCM (0.5 M), 24 h, rt
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For the synthesis of Ph3PAu(TA)OTf and IPrAu(TA)OTf, see: Duan, H.; Sengupta, S.; Petersen, 
J. L.; Akhmedov, N.; Shi, X. J. Am. Chem. Soc. 2009, 131, 12100-12102; Wang, D.; Cai, R.; 
Sharma, S.; Jirak, J.; Thummanapelli, S. K.; Akhmedov, N. G.; Zhang, H.;Liu, X.; Petersen, J. 
L.; Shi, X. J. Am. Chem. Soc. 2012, 134, 9012-9019.  
 
 
II. Compounds Characterizaton  
 
 
1H-NMR (400 MHz, CDCl3) δ 7.43 (d, J = 7.2 Hz, 2H), 7.35 (t, J = 7.5 Hz, 2H), 7.24-7.20 (t, J = 
7.2 Hz, 1H), 5.91 (d, J = 1.2 Hz, 1H), 5.24 (d, J = 1.2 Hz, 1H), 2.00 (s, 6H); 13C-NMR (100 
MHz, CDCl3) δ 191.3, 143.5, 139.6, 128.7, 128.2, 125.9, 118.4, 113.9, 23.6; HRMS Calculated 
for C13H14O2Na [M+Na]+: 225.0886, Found: 225.0888.  
 
 
1H-NMR (400 MHz, CDCl3) δ 7.43 (d, J = 7.2 Hz, 2H), 7.35 (t, J = 7.5 Hz, 2H), 7.24-7.20 (t, J = 
7.2 Hz, 1H), 5.91 (d, J = 1.2 Hz, 1H), 5.24 (d, J = 1.2 Hz, 1H), 2.00 (s, 6H); 13C-NMR (100 
MHz, CDCl3) δ 191.3, 143.5, 139.6, 128.7, 128.2, 125.9, 118.4, 113.9, 23.6; HRMS Calculated 
for C13H14O2Na [M+Na]+: 225.0886, Found: 225.0888.  
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7.2 Hz, 1H), 5.91 (d, J = 1.2 Hz, 1H), 5.24 (d, J = 1.2 Hz, 1H), 2.00 (s, 6H); 13C-NMR (100 
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for C13H14O2Na [M+Na]+: 225.0886, Found: 225.0888.  
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for C13H14O2Na [M+Na]+: 225.0886, Found: 225.0888.  
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for C13H14O2Na [M+Na]+: 225.0886, Found: 225.0888.  
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1H-NMR (400 MHz, CDCl3) δ 7.43 (d, J = 7.2 Hz, 2H), 7.35 (t, J = 7.5 Hz, 2H), 7.24-7.20 (t, J = 
7.2 Hz, 1H), 5.91 (d, J = 1.2 Hz, 1H), 5.24 (d, J = 1.2 Hz, 1H), 2.00 (s, 6H); 13C-NMR (100 
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for C13H14O2Na [M+Na]+: 225.0886, Found: 225.0888.  
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MHz, CDCl3) δ 191.3, 143.5, 139.6, 128.7, 128.2, 125.9, 118.4, 113.9, 23.6; HRMS Calculated 
for C13H14O2Na [M+Na]+: 225.0886, Found: 225.0888.  
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7.2 Hz, 1H), 5.91 (d, J = 1.2 Hz, 1H), 5.24 (d, J = 1.2 Hz, 1H), 2.00 (s, 6H); 13C-NMR (100 
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1H-NMR (400 MHz, CDCl3) δ 7.43 (d, J = 7.2 Hz, 2H), 7.35 (t, J = 7.5 Hz, 2H), 7.24-7.20 (t, J = 
7.2 Hz, 1H), 5.91 (d, J = 1.2 Hz, 1H), 5.24 (d, J = 1.2 Hz, 1H), 2.00 (s, 6H); 13C-NMR (100 
MHz, CDCl3) δ 191.3, 143.5, 139.6, 128.7, 128.2, 125.9, 118.4, 113.9, 23.6; HRMS Calculated 
for C13H14O2Na [M+Na]+: 225.0886, Found: 225.0888.  
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MHz, CDCl3) δ 191.3, 143.5, 139.6, 128.7, 128.2, 125.9, 118.4, 113.9, 23.6; HRMS Calculated 
for C13H14O2Na [M+Na]+: 225.0886, Found: 225.0888.  
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7.2 Hz, 1H), 5.91 (d, J = 1.2 Hz, 1H), 5.24 (d, J = 1.2 Hz, 1H), 2.00 (s, 6H); 13C-NMR (100 
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1H-NMR (400 MHz, CDCl3) δ 7.43 (d, J = 7.2 Hz, 2H), 7.35 (t, J = 7.5 Hz, 2H), 7.24-7.20 (t, J = 
7.2 Hz, 1H), 5.91 (d, J = 1.2 Hz, 1H), 5.24 (d, J = 1.2 Hz, 1H), 2.00 (s, 6H); 13C-NMR (100 
MHz, CDCl3) δ 191.3, 143.5, 139.6, 128.7, 128.2, 125.9, 118.4, 113.9, 23.6; HRMS Calculated 
for C13H14O2Na [M+Na]+: 225.0886, Found: 225.0888.  
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MHz, CDCl3) δ 191.3, 143.5, 139.6, 128.7, 128.2, 125.9, 118.4, 113.9, 23.6; HRMS Calculated 
for C13H14O2Na [M+Na]+: 225.0886, Found: 225.0888.  
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7.2 Hz, 1H), 5.91 (d, J = 1.2 Hz, 1H), 5.24 (d, J = 1.2 Hz, 1H), 2.00 (s, 6H); 13C-NMR (100 
MHz, CDCl3) δ 191.3, 143.5, 139.6, 128.7, 128.2, 125.9, 118.4, 113.9, 23.6; HRMS Calculated 
for C13H14O2Na [M+Na]+: 225.0886, Found: 225.0888.  
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1H-NMR (400 MHz, CDCl3) δ 7.43 (d, J = 7.2 Hz, 2H), 7.35 (t, J = 7.5 Hz, 2H), 7.24-7.20 (t, J = 
7.2 Hz, 1H), 5.91 (d, J = 1.2 Hz, 1H), 5.24 (d, J = 1.2 Hz, 1H), 2.00 (s, 6H); 13C-NMR (100 
MHz, CDCl3) δ 191.3, 143.5, 139.6, 128.7, 128.2, 125.9, 118.4, 113.9, 23.6; HRMS Calculated 
for C13H14O2Na [M+Na]+: 225.0886, Found: 225.0888.  
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MHz, CDCl3) δ 191.3, 143.5, 139.6, 128.7, 128.2, 125.9, 118.4, 113.9, 23.6; HRMS Calculated 
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1H-NMR (400 MHz, CDCl3) δ 7.43 (d, J = 7.2 Hz, 2H), 7.35 (t, J = 7.5 Hz, 2H), 7.24-7.20 (t, J = 
7.2 Hz, 1H), 5.91 (d, J = 1.2 Hz, 1H), 5.24 (d, J = 1.2 Hz, 1H), 2.00 (s, 6H); 13C-NMR (100 
MHz, CDCl3) δ 191.3, 143.5, 139.6, 128.7, 128.2, 125.9, 118.4, 113.9, 23.6; HRMS Calculated 
for C13H14O2Na [M+Na]+: 225.0886, Found: 225.0888.  
 
 
III. ORTEP Drawing of the Crystal Structure 
 
 
Figure S1.  Perspective view of the molecular structure of the (C6H5N3)Au[P(C6H11)2(C6H4(C6H2(i-C3H7)3))+ cation 
with the atom labeling scheme. The thermal ellipsoids are scaled to enclose 30% probability. 
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3.3 C-S bond formation: a-substituted vinyl sulfone synthesis 
 
3.3.1 Introduction 
C-S bond formation is important in organic synthesis due to the wide application of sulfur 
contained drugs and bio-active molecules. Vinyl sulfones are one of the important molecules 
among those sulfur contained compounds, which have been widely applied as substrates for the 
synthesis of protease and bioactive inhibitors.22 One of important character of vinyl sulfone is 
that it can be used as Michael acceptor for addition to form a series of derivative. Generally 
speaking, a-vinyl sulfone should be better acceptor for Michael addition since it has less 
hindered structures for different nucleophiles attack. Nevertheless, most reported literatures still 
applied b-vinyl sulfones as the addition substrates. The most likely reason is a-vinyl sulfone that 
is harder to be synthesized and obtained efficiently. 
 
 
Figure 29. Literature synthesis of vinylsulfone 
 
Previously reported ways can be mainly summarized into three types: 1) elimination reaction 
by using substituted a- or b-vinyl sulfones, 2) through vinyl sulfides by oxidation reactions, 3) 
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by using a series of olefination reactions like Wittig or Julia name reactions. Most of those 
methods are not very convenient and efficient because they required either multiple steps of 
synthesis or toxic material catalysis or bad regioselectivity (Figure 29). 23  In comparison, 
transition metals assisted alkynes or alkenes addition could help build C-S bond effectively, 
which will generate b-vinyl sulfones and give anti-Markovnikov addition product. Indisputably, 
methods for synthesis of a-vinyl sulfones are rare, or suffering limited substrates scope or bad 
a/b sulfone selectivity. Therefore, we are developed a new method that could effectively 
synthesize a-vinyl sulfones catalyzed via our TA-Au catalysis system with excellent 
regioselectivity. 
 
 
Figure 30. Rationale for gold-catalyzed C-S bond formation 
 
It is hard to find proper sulfur source for this reaction and at the meanwhile keep the catalyst 
activity. Finding proper p-acid catalysts for activation of alkynes is challenging too, although we 
learned that gold(I) is always good p-acid for alkyne activation. Sulfur nucleophiles could easily 
form stable Au-S complex and immediately quench the reactivity of gold catalysts. Meanwhile, 
sulfur is a good electronic donor that can be easily oxidized with other oxidation reagent like 
metal cations.24 Sulfoxides are too strong oxygen nucleophiles so that catalysts will form O-M 
bond or lead metal catalysts decomposed quickly. Based on these consideration, we choose 
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sulfinic acid as our beginning nucleophile with three considerations. First, sulfinic acid has one 
oxygen on sulfur and is not very basic as sulfur; second, sulfinic acid is not a strong acid with 
mild acidity, which may be good for the alkyne addition; third, there are more chance to have the 
nucleophilic attack from sulfur instead of oxygen due to the soft character of the sulfur (in 
Figure 30). 
 
3.3.2 Condition screening 
We thus carried out our experiments with the simple starting materials: p-toluenesulfinic 
acid and phenylacetylene (in Table 7), and with a series of different p-philic Lewis acid. From 
the screening table, we can tell [Ph3PAuCl]/AgX offed the best result compared with other 
catalysts (PtCl2, AuCl3, Ga(OTf)3, In(OTf)3 and AgSbF6). Among those transition metals, only 
silver catalyzed reaction formed little product, and thus, we tried to screen different sliver salts. 
No big improvements were obtained after many tests. Later on, we tested many different primary 
ligands including electronic deficient (carbene iPr-Au) and rich (XPhos-Au) ligands, and some 
slightly better results were obtained. The bulky and electron rich ligand XPhos gave the best 
result, which guide us to use another bulkier and electron richer ligand BrettPhos. To our 
pleased, a better 76% yield was obtained. These results showed us that a bulky and electron rich 
ligand should be helpful for the catalysis because the gold cationic center can be easier stabilized 
and give better and longer reactivity.  
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Table 7. Condition optimizationa 
 
entry catalyst[b] additive time yield (%)[c] 
1 5% Ph3PAuCl/AgOTf - 6h 11 
2 10% PtCl2 - 18h 0 
3 10% AuCl3 - 18h 0 
4 10% Ga(OTf)3 - 18h 0 
5 10% In(OTf)3 - 18h 0 
6 10% AgSbF6 - 18h 6 
7 5% Ph3PAuCl/AgBF4 - 6h 14 
8 5% Ph3PAuCl/AgSbF6 - 6h 18 
9 5% Ph3PAuNTf2 - 6h 13 
10 5% IPrAuCl/AgOTf - 6h 22 
11 5% IPrAuNTf2 - 6h 25 
12 5% XPhosAuCl/AgOTf - 6h 44 
13 5% XPhosAuNTf2 - 6h 46 
14 5% XPhosAuCl/AgSbF6 - 6h 59 
15 5% BrettPhosAuCl/AgOTf - 6h 66 
16 5% BrettPhosAuNTf2 - 6h 68 
17 5% BrettPhosAuCl/AgSbF6 - 6h 76 
18 5% BrettPhosAu(TA)OTf - 6h 32 
19 5% BrettPhosAu(TA)OTf 5% Ga(OTf)3 6h 80 
20 5% BrettPhosAu(TA)OTf 10% Ga(OTf)3 6h 91 	  
aReaction conditions: 22 (0.2 mmol), 24 (1.4 equiv), gold catalyst (5 mol%), and additive (if applicable) 
in dry DCE (0.8 mL) under argon atmosphere. bX-=TfO-, Tf2N-, SbF6-. cThe yield was determined by 1H 
NMR spectroscopy using 1,3,5-trimethoxybenzene as the internal standard. DCE=1,2-dichloroethane, 
TA=1H-benzotriazole, Tf=trifluoromethanesulfonyl. 
 
From our previous study, we found that 1,2,3-triazole (TA) stabilized gold catalyst worked 
very well in some reactions due to the good reactivity and stability. We also employed TA-Au in 
the reaction, and as we expected that the reaction was not very good due to the weak reactivity of 
the gold catalyst. However, with the combination of Ga(OTf)3 present in the reaction, the result 
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is much better than other catalysis systems, and a slightly increased amount of Ga(OTf)3 offered 
91% yield of product. Additionally, we also did the comparison when using Ga(OTf)3, and there 
was no reaction happened which excluded the potential that Ga(OTf)3 could catalyze this 
reaction alone.   
 
Table 8. Scope of Alkynesa 
 
aGeneral conditions: 22 (0.2 mmol), 24 (0.4 mmol), [BrettPhosAu(TA)]OTf (5 mol%), and Ga(OTf)3 (10 
mol%) in DCE (0.8 mL) under argon atmosphere. Yields of isolated products are given. bYields 
determined by 1H NMR spectroscopy with 1,3,5-trimethoxybenzene as the internal standard. cContains 
<5% of an impurity. d[BrettPhosAuNTf2] was used. eGa(OTf)3 (20 mol%) and [BrettPhosAu(TA)]OTf 
(10 mol%). fGa(OTf)3 (30 mol%) and [BrettPhosAu(TA)]OTf (15 mol%). 
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With the optimal condition in hand, we explored the substrates scope (in Table 8). First, 
different alkynes were tested including aromatic and aliphatic alkynes. Obviously, there are big 
difference between the electronic poor and rich alkynes. More electronic rich aromatic alkynes 
provided better yields than electron poor ones. Not only para-substituted, but meta- and ortho-
positions also provided good yields of vinyl sulfones, which suggested that a broad range of 
substrates can be accessed via this method. Heteroaromatic alkynes were also tested and 
provided desired products. To our surprised, the enyne substrate could also be tolerated in this 
reaction, which highly marked the mild condition environment of the catalysis system.  
 
Table 9. Scope of Alkynes (continued) 
 
 
Aliphatic alkynes were tested (in Table 8), and gave relatively lower yield due to the weaker 
reactivity, but the yield could be further increased if using higher catalysts loading and 
temperature. Besides, more complicated starting materials worked nicely in this reaction and 
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offered corresponding products. Owing to the good tolerability, this method has provided more 
potentials for its applications in the synthetic field and even in natural product synthesis (in 
Table 9). For internal alkynes, there were no reaction promoted. The result from X-ray 
crystallography analysis offered us firm evidence that the regioselectivity of the nucleophilic 
addition. 
 
 
Figure 31. One-pot synthesis of vinyl sulfones starting from sodium sulfinates 
 
At the same time, different sulfinic acids were also tested to evaluate this method. Due to the 
bad stability of sulfinic acids, however, we have to convert all sulfinic acids into sodium salts. In 
this way, this method will not be affected by the limitation of substrates anymore. The sodium 
salts with addition of acid may generate corresponding sulfinic acid in situ (in Figure 31), and 
then complete the reaction. After screening of different acids, trifluoroacetic acid could be used 
for the formation of sulfinic acids in situ, and will not affect TA-Au and Ga(OTf)3 catalysis 
system.  
Different sulfinic acid were tested by using the one pot catalysis system. The first several 
sulfinic acid salts are commercial available, and they all provided modest to good yield. With 
halogen substituted aromatic sulfinic salts have to be synthesized in lab (see SI), and they could 
also be applied to give corresponding results. Heterocyclic alkyne could be tolerated in this 
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reaction and give 82% yield of product. Notably, the aliphatic sulfinic acid salts also worked 
although they gave slightly lower yields. 
 
Table 10. Scope of Sulfinic Acidsa 
 
aGeneral reaction conditions: 25 (0.2 mmol), TFA (0.24 mmol), 24 (0.3 mmol), [BrettPhosAu(TA)]OTf 
(5 mol%) and Ga(OTf)3 (10 mol%) in DCE (0.8 mL), Ar, 45 oC. Yields of isolated products are given. [b] 
Yields determined by 1H NMR spectroscopy with 1,3,5-trimethoxybenzene as the internal standard. [c] 
25 was used instead of sodium sulfinate and TFA; reaction run at RT. 
 
 
Figure 32. Diels-Alder reaction between 2-sulfonyl diene & N-methyl maleimide 
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With the curiosity of exploring utility of a-substituted vinyl sulfones, we chose the classic 
Diels-Alder reaction as a model (in Figure 32). The reaction was carried out with 2-sulfonyl 
diene and N-methyl maleimide to afford the tricyclic ring system, and to our delighted, the 
product maintained excellent endo selectivity, which proved the great potential of broad utility of 
a-substituted vinyl sulfones. 
 
 
Figure 33. Comparison of the aza-Michael addition with a- or b-vinyl sulfone 
 
Generally, we successfully discovered the method of a-vinyl sulfones, which can be Michael 
addition receptor and are better efficiency then b-vinyl sulfones. Moreover, we also compared 
the two types of vinyl sulfones reactivates, and both of them reacted with amine morpholine (in 
Figure 33). In a-vinyl sulfone reaction, a quantitative yield was obtained in room temperature, 
but, in contrast, b-vinyl sulfone has not reaction happened. From this experiment, we can tell the 
big different reactivity between those two vinyl sulfones, which a-vinyl sulfone is much better. 
Therefore, a-vinyl sulfones could more potentially be applied in synthetic field for useful 
molecules. 
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3.3.4 Conclusion 
We successfully developed a gold catalyzed a-vinyl sulfone synthesis method from sulfinic 
acid and terminal alkynes. This method provided an easy way to build up C-S bond through 
homogenous gold catalysis with a co-catalyst Ga(OTf)3, which further proved the great 
efficiency of designed TA-Au and Lewis acid catalysis system. The extension application of 
Michael addition reaction demonstrated that a-vinyl sulfones have higher reactivity than b-vinyl 
sulfones as nucleophile acceptors in the addition reactions.  
 
 
3.3.5 Experimental data 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out 
under an atmosphere of nitrogen using oven/flame-dried glassware. Unless otherwise noted, all 
commercial reagents and solvents were obtained from the commercial provider and used without 
further purification. BrettPhosAuCl was purchased from Aldrich and used as received. Gallium 
triflate was purchased from Strem and used as received. 1H NMR, 13C NMR, 31P NMR, and 19F 
NMR spectra were recorded on Agilent 400 MHz spectrometers. Chemical shifts were reported 
relative to internal tetramethylsilane (δ 0.00 ppm) or CDCl3 (δ 7.26 ppm) for 1 H and CDCl3 (δ 
77.0 ppm) for 13C. Flash column chromatography was performed on 230-430 mesh silica gel.  
 
I. General procedure for α-vinyl sulfone synthesis 
 
R
5 mol% BrettPhosAu(TA)OTf
10 mol% Ga(OTf)3
dry DCE (0.25M)
rt-45oC, Ar
S
O
OH R
S
O
O
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A 1-dram vial was charged with alkyne (0.3 or 0.4 mmol) and benzenesulfinic acid (0.2 mmol, 
28.8 mg) in dry DCE (0.8 mL), followed by the addition of catalysts BrettPhosAu(TA)OTf (10.1 
mg, 5 mol%) and Ga(OTf)3 (10.4 mg, 10 mol%). The vial was purged with argon for at least 1 
min and tightly capped. The reaction mixture was allowed to stir at rt or 45o C. After the reaction 
was completed (8-36 h), the reaction mixture was directly purified by flash chromatography on 
silica gel (hexane/ethyl acetate = 12:1 to 8:1, V/V) to give desired addition product. 
 
One-pot procedure for α-vinyl sulfone synthesis 
 
A 1-dram vial was charged with TFA (1.2 equiv.) in dry DCE (0.8 mL) and followed by the 
addition of corresponding sulfinic acid (0.2 mmol, 28.8 mg). The vial was briefly stirred and 
added phenylacetylene (0.3 mmol), and the catalysts BrettPhosAu(TA)OTf (10.1 mg, 5 mol%) 
and Ga(OTf)3 (10.4 mg, 10 mol%). After being purged with argon for at least 1 min, the reaction 
mixture was allowed to stir at 45 oC. After the reaction was completed (12 h), the reaction 
mixture was directly purified by flash chromatography on silica gel (hexane/ethyl acetate = 12:1 
to 8:1, V/V) to give desired addition product. 
 
 
 
 
 
Ph
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II. Compounds Characterization  
 
23ba synthesized with 5 mol% BrettPhosAu(TA)OTf, 10 mol% Ga(OTf)3, 1.5 equiv. alkyne, rt, 
8h, in DCE. 91% NMR yield, colorless oil.  
1H-NMR (400 MHz, CDCl3) δ 7.70-7.68 (m, 2H), 7.55-7.50 (m, 1H), 7.42-7.38 (m, 2H), 7.34-
7.24 (m, 5H), 6.63 (s, 1H), 5.96 (s, 1H).  
13C-NMR (100 MHz, CDCl3) δ 150.9, 138.7, 133.3, 132.4, 129.3, 129.1, 128.8, 128.3, 128.2, 
125.9.  
HRMS Calculated for C14H12O2SNa [M+Na]+ : 267.0456, Found: 267.0451. 
 
23bb, synthesized with 5 mol% BrettPhosAuNTf2, 2 equiv. alkyne, 45o C, 36h, in DCE. 69% 
isolated yield (~5% impurity noted), yellow oil.  
1H-NMR (400 MHz, CDCl3) δ 7.71-7.69 (m, 2H), 7.55-7.50 (m, 1H), 7.42-7.39 (m, 2H), 7.29-
7.26 (m, 2H), 6.80- 6.77 (m, 2H), 6.57 (s, 1H), 5.91 (s, 1H), 3.78 (s, 3H).  
13C-NMR (100 MHz, CDCl3) δ 160.4, 150.5, 138.9, 133.3, 130.5, 128.8, 128.3, 125.1, 124.6, 
113.7, 55.2.  
HRMS Calculated for C15H14O3SNa [M+Na]+ : 297.0561, Found: 297.0556. 
 
S
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23bc, synthesized with 5 mol% BrettPhosAu(TA)OTf, 10 mol% Ga(OTf)3, 2 equiv. alkyne, 45o 
C, 36h, in DCE. 50% isolated yield, colorless oil. 1 H-NMR (400 MHz, CDCl3) δ 7.71-7.68 (m, 
2H), 7.58-7.53 (m, 3H), 7.46-7.42 (m, 4H), 6.70 (s, 1H), 6.01 (s, 1H). 13C-NMR (100 MHz, 
CDCl3) δ 150.0, 138.3, 136.1, 133.7, 130.4, 129.5, 129.1, 128.3, 127.1, 125.9 (q, J = 3.8 Hz). 
HRMS Calculated for C15H11F3O2SNa [M+Na]+ : 335.0330, Found: 335.0324. 
 
 
23bd, synthesized with 5 mol% BrettPhosAu(TA)OTf, 10 mol% Ga(OTf)3, 1.5 equiv. alkyne, rt, 
24h, in DCE. 80% isolated yield, yellow oil.  
1H-NMR (400 MHz, CDCl3) δ 7.73-7.70 (m, 2H), 7.55-7.51 (m, 1H), 7.43-7.39 (m, 2H), 7.30-
7.24 (m, 4H), 6.58 (s, 1H), 5.95 (s, 1H), 1.28 (s, 9H).  
13C-NMR (100 MHz, CDCl3) δ 152.5, 150.8, 138.9, 133.3, 129.4, 128.8, 128.7, 128.3, 125.6, 
125.2, 34.6, 31.1.  
HRMS Calculated for C18H20O2SNa [M+Na]+ : 323.1082, Found: 323.1077. 
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23be, synthesized with 5 mol% BrettPhosAu(TA)OTf, 10 mol% Ga(OTf)3, 2 equiv. alkyne, rt, 
24h, in DCE. 76% isolated yield, colorless oil.  
1H-NMR (400 MHz, CDCl3) δ 7.69-7.67 (m, 2H), 7.56-7.52 (m, 1H), 7.44-7.40 (m, 2H), 7.33-
7.29 (m, 2H), 6.99- 6.93 (m, 2H), 6.63 (s, 1H), 5.94 (s, 1H).  
13C-NMR (100 MHz, CDCl3) δ 164.5, 150.0, 138.5, 133.5, 131.1 (d, J = 8.3 Hz), 128.9, 128.3, 
126.0, 115.5, 115.3.  
HRMS Calculated for C14H11FO2SNa [M+Na]+ : 285.0361, Found: 285.0356. 
 
23bf, synthesized with 5 mol% BrettPhosAu(TA)OTf, 10 mol% Ga(OTf)3, 1.5 equiv. alkyne, rt, 
14h, in DCE. 84% isolated yield, colorless oil.  
1H-NMR (400 MHz, CDCl3) δ 7.71-7.68 (m, 2H), 7.55-7.51 (m, 1H), 7.43-7.39 (m, 2H), 7.15-
7.12 (m, 2H), 7.10- 7.08 (m, 1H), 6.60 (s, 1H), 5.94 (s, 1H), 2.28 (s, 3H).  
13C-NMR (100 MHz, CDCl3) δ 151.0, 138.7, 138.0, 133.3, 132.3, 130.0, 129.7, 128.8, 128.4, 
128.1, 126.2, 125.7, 21.3.  
HRMS Calculated for C15H14O2SNa [M+Na]+ : 281.0612, Found: 281.0607. 
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23bg, synthesized with 5 mol% BrettPhosAu(TA)OTf, 10 mol% Ga(OTf)3, 2 equiv. alkyne, rt, 
24h, in DCE. 62% NMR yield, colorless oil.  
1H-NMR (400 MHz, CDCl3) δ 7.68-7.66 (m, 2H), 7.56-7.52 (m, 1H), 7.43-7.39 (m, 2H), 7.30-
7.27 (m, 2H), 7.23- 7.16 (m, 2H), 6.63 (s, 1H), 5.96 (s, 1H).  
13C-NMR (100 MHz, CDCl3) δ 149.9, 138.4, 134.2, 133.6, 129.6, 129.6, 129.5, 129.3, 129.1, 
129.0, 128.4, 127.3, 126.6.  
HRMS Calculated for C14H11ClO2SNa [M+Na]+ : 301.0066, Found: 301.0061. 
 
23bh, synthesized with 5 mol% BrettPhosAu(TA)OTf, 10 mol% Ga(OTf)3, 1.5 equiv. alkyne, rt, 
14h, in DCE. 85% isolated yield, colorless to light orange solid.  
1H-NMR (400 MHz, CDCl3) δ 7.61-7.53 (m, 3H), 7.41-7.37 (m, 2H), 7.21 (td, J = 7.6, 1.2 Hz, 
1H), 7.09-7.02 (m, 2H), 6.92 (dd, J = 7.6, 0.8 Hz, 1H), 6.73 (s, 1H), 5.80 (s, 1H), 1.91 (s, 3H).  
13C-NMR (100 MHz, CDCl3) δ 149.9, 138.2, 137.6, 133.5, 131.5, 130.6, 130.0, 129.2, 128.8, 
128.8, 126.9, 126.9, 125.1, 19.2.  
HRMS Calculated for C15H14O2SNa [M+Na]+ : 281.0612, Found: 281.0607. 
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23bi, synthesized with 5 mol% BrettPhosAu(TA)OTf, 10 mol% Ga(OTf)3, 2 equiv. alkyne, 45o 
C, 24h, in DCE. 59% NMR yield, light brown oil. 1 H-NMR (400 MHz, CDCl3) δ 7.77-7.75 (m, 
2H), 7.54-7.50 (m, 2H), 7.44-7.40 (m, 2H), 7.22 (dd, J = 5.0, 3.0 Hz, 1H), 7.11 (dd, J = 5.0, 1.4 
Hz, 1H), 6.54 (s, 1H), 6.05 (s, 1H). 13C-NMR (100 MHz, CDCl3) δ 145.7, 139.0, 133.4, 132.0, 
128.9, 128.0, 127.5, 126.1, 125.9, 124.5. HRMS Calculated for C12H10O2S2Na [M+Na]+ : 
273.0020, Found: 273.0015. 
 
 
23bj, synthesized with 5 mol% BrettPhosAu(TA)OTf, 10 mol% Ga(OTf)3, 2 equiv. alkyne, 45o 
C, 24h, in DCE. 74% NMR yield, light yellow oil.  
1H-NMR (400 MHz, CDCl3) δ 7.86-7.83 (m, 2H), 7.76 (m, 1H), 7.59-7.55 (m, 1H), 7.50-7.46 
(m, 2H), 7.34 (t, J = 2.0 Hz, 1H), 6.48 (s, 1H), 6.46 (dd, J = 6.0, 0.8 Hz, 1H), 6.03 (s, 1H).  
13C-NMR (100 MHz, CDCl3) δ 143.3, 142.7, 142.4, 139.2, 133.5, 129.1, 128.0, 123.5, 117.4, 
109.6.  
HRMS Calculated for C12H10O3SNa [M+Na]+ : 257.0243, Found: 257.0244. 
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23bk, synthesized with 5 mol% BrettPhosAu(TA)OTf, 10 mol% Ga(OTf)3, 2 equiv. alkyne, 45o 
C, 14h, in DCE. 78% isolated yield (~5% impurity noted), pale yellow oil.  
1H-NMR (400 MHz, CDCl3) δ 7.82-7.80 (m, 2H), 7.59-7.46 (m, 3H), 6.31 (s, 1H), 5.98-5.96 (m, 
1H), 5.75 (s, 1H), 2.04-1.95 (m, 4H), 1.57-1.51 (m, 2H), 1.48-1.42 (m, 2H).  
13C-NMR (100 MHz, CDCl3) δ 151.9, 139.6, 133.1, 132.2, 129.6, 128.8, 128.0, 122.7, 28.2, 
25.5, 22.4, 21.2.  
HRMS Calculated for C14H16O2SNa [M+Na]+ : 271.0769, Found: 271.0763. 
 
 
23al, synthesized with 10 mol% BrettPhosAu(TA)OTf, 20 mol% Ga(OTf)3, 2 equiv. alkyne, rt, 
36h, in toluene. 71% isolated yield (~5% impurity noted), colorless oil.  
1H-NMR (400 MHz, CDCl3) δ 7.72 (d, J = 8.0 Hz, 2H), 7.30 (d, J = 8.0 Hz, 2H), 6.32 (s, 1H), 
5.72 (s, 1H), 2.41 (s, 3H), 2.28-2.21 (m, 1H), 1.70-1.58 (m, 6H), 1.22-1.05 (m, 6H).  
13C-NMR (100 MHz, CDCl3) δ 156.2, 144.2, 136.2, 129.7, 128.1, 121.9, 38.2, 33.7, 26.4, 25.6, 
21.6.  
HRMS Calculated for C15H20O2SNa [M+Na]+ : 287.1082, Found: 287.1080. 
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23bm, synthesized with 10 mol% BrettPhosAu(TA)OTf, 20 mol% Ga(OTf)3, 2 equiv. alkyne, 
45o C, 14h, in DCE. 70% isolated yield, colorless oil.  
1H-NMR (400 MHz, CDCl3) δ 7.92-7.89 (m, 2H), 7.63-7.59 (m, 1H), 7.54-7.50 (m, 2H), 6.25 (s, 
1H), 5.50 (t, J = 0.8 Hz, 1H), 1.62-1.55 (1, 2H), 0.72-0.68 (m, 2H).  
13C-NMR (100 MHz, CDCl3) δ 152.8, 139.5, 133.4, 129.0, 128.4, 120.1, 10.8, 7.2.  
HRMS Calculated for C11H12O2SNa [M+Na]+ : 231.0456, Found: 231.0450. 
 
 
23an, synthesized with 10 mol% BrettPhosAu(TA)OTf, 20 mol% Ga(OTf)3, 2 equiv. 1-
trimethylsilylpropane, 45o C, 24h, in DCE. 85% isolated yield, colorless oil. 1 H-NMR (400 
MHz, CDCl3) δ 7.78, 7.75 (m, 2H), 7.33 (dd, J = 8.0, 8.0 Hz, 2H), 6.24 (d, J = 0.8 Hz, 1H), 5.68 
(dd, J = 3.2, 1.6 Hz, 1H), 2.44 (s, 3H), 1.95 (d, J = 0.8 Hz, 3H). 13C-NMR (100 MHz, CDCl3) δ 
146.4, 144.5, 135.4, 129.8, 128.3, 123.7, 21.6, 16.3. HRMS Calculated for C10H12O2SNa 
[M+Na]+ : 219.0456, Found: 219.0450. 
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23ao, synthesized with 10 mol% BrettPhosAu(TA)OTf, 20 mol% Ga(OTf)3, 2 equiv. alkyne, 
45o C, 30h, in toluene. 87% isolated yield (~5% impurity noted), colorless oil.  
1H-NMR (400 MHz, CDCl3) δ 7.72 (d, J = 8.4 Hz, 2H), 7.29 (d, J = 8.4 Hz, 2H), 6.31 (s, 1H), 
5.67 (s, 1H), 2.41 (s, 3H), 2.08 (d, J = 8.0 Hz, 2H), 1.41 (quint, J = 7.6 Hz, 2H), 1.24-1.17 (m, 
4H), 0.80 (t, J = 6.8 Hz, 3H).  
13C-NMR (100 MHz, CDCl3) δ 150.8, 144.4, 135.8, 129.7, 128.2, 122.4, 31.0, 29.0, 27.1, 22.2, 
21.6, 13.9.  
HRMS Calculated for C14H20O2SNa [M+Na]+ : 275.1082, Found: 275.1076. 
 
 
23ap, synthesized with 10 mol% BrettPhosAu(TA)OTf, 20 mol% Ga(OTf)3, 2 equiv. alkyne, 
45o C, 24h, in toluene. 82% isolated yield, colorless oil.  
1H-NMR (400 MHz, CDCl3) δ 7.74 (d, J = 7.6 Hz, 2H), 7.32 (d, J = 8.0 Hz, 2H), 6.38 (s, 1H), 
5.84 (s, 1H), 3.66 (t, J = 6.4 Hz, 3H), 2.45-2.42 (m, 5H), 0.83 (s, 9H), 0.02 (s, 6H).  
13C-NMR (100 MHz, CDCl3) δ 147.4, 144.4, 135.9, 129.8, 128.3, 124.9, 60.9, 32.7, 25.8, 21.6, 
18.2, -5.4.  
HRMS Calculated for C17H28O3SSiNa [M+Na]+ : 363.1421, Found: 363.1423. 
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23bq, synthesized with 10 mol% BrettPhosAuNTf2, 2 equiv. alkyne, rt, 36h, in DCE. 54% 
isolated yield, colorless oil.  
1H-NMR (400 MHz, CDCl3) δ 7.60-7.56 (m, 3H), 7.43-7.39 (m, 2H), 7.34-7.32 (m, 2H), 7.22-
7.18 (m, 1H), 6.98 (d, J = 8.0 Hz, 2H), 6.75 (s, 1H), 5.92 (s, 1H), 4.93 (d, J = 8.4 Hz, 1H), 4.75 
(m, 2H), 4.17-4.13 (m, 1H), 2.07- 2.01 (m, 1H), 1.41 (s, 9H), 0.90 (d, J = 6.8 Hz, 3H), 0.80 (d, J 
= 6.8 Hz, 3H)  
13C-NMR (100 MHz, CDCl3) δ 171.9, 155.6, 148.5, 137.8, 135.2, 133.8, 131.5, 131.0, 129.7, 
129.3, 129.0, 128.9, 128.1, 127.8, 64.1, 58.5, 31.2, 28.3, 19.0, 17.4.  
HRMS Calculated for C25H31O6NSNa [M+Na]+ : 496.1764, Found: 496.1767. 
 
23br, synthesized with 10 mol% BrettPhosAu(TA)OTf, 20 mol% Ga(OTf)3, 2 equiv. alkyne, 
45o C, 24h, in DCE. 86% isolated yield, white solid.  
1H-NMR (400 MHz, CDCl3) δ 7.74-7.71 (m, 2H), 7.55-7.51 (m, 1H), 7.44-7.40 (m, 2H), 7.15 
(d, J = 8.0 Hz, 1H), 7.06-7.02 (m, 2H), 6.54 (s, 1H), 5.92 (s, 1H), 2.82 (dd, J = 8.8, 4.0 Hz, 2H), 
2.48 (dd, J = 18.8, 8.8 Hz, 1H), 2.38- 2.22 (m, 2H), 2.17-19.1 (m, 4H), 1.65-1.37 (m, 6H), 0.88 
(s, 3H).  
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13C-NMR (100 MHz, CDCl3) δ 220.6, 150.8, 141.2, 139.0, 136.6, 133.3, 129.9, 239.5, 128.9, 
128.4, 126.3, 125.6, 125.3, 50.5, 47.9, 44.3, 37.9, 35.8, 31.5, 29.2, 26.3, 25.5, 21.6, 13.8.  
HRMS Calculated for C26H28O3SNa [M+Na]+ : 443.1651, Found: 443.1655. 
 
 
23as, synthesized with 15 mol% BrettPhosAu(TA)OTf, 30 mol% Ga(OTf)3, 2 equiv. alkyne, 
45o C, 24h, in DCE: toluene (1:1). 62% NMR yield, white solid.  
1H-NMR (400 MHz, CDCl3) δ 7.74 (d, J = 8.0 Hz, 2H), 7.34 (d, J = 8.0 Hz, 2H), 6.35 (s, 1H), 
5.71 (s, 1H), 5.37- 5.36 (m, 1H), 4.63-4.54 (m, 1H), 2.45 (s, 3H), 2.29-2.21 (m, 5H), 2.03-1.93 
(m, 2H), 1.87-1.78 (m, 3H), 1.52-1.08 (m, 25H), 1.01 (s, 3H), 0.91 (d, J = 8.0 Hz, 3H), 0.87 (d, J 
= 0.8 Hz, 3H), 0.85 (d, J = 0.8 Hz, 3H), 0.67 (s, 3H).  
13C-NMR (100 MHz, CDCl3) δ 172.7, 150.3, 144.5, 139.5, 135.7, 135.5, 129.8, 128.3, 122.7, 
122.7, 77.2, 73.9, 56.6, 56.1, 53.4, 50.0, 42.3, 39.7, 39.5, 38.1, 36.9, 36.6, 36.1, 35.8, 34.1, 31.9, 
31.8, 28.8, 28.2, 28.0, 27.8, 26.8, 24.3, 24.1, 23.8, 22.8, 22.6, 21.6, 21.0, 19.3, 18.7, 11.8.  
HRMS Calculated for C41H62O4SNa [M+Na]+ : 673.4261, Found: 673.4265. 
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23aa, synthesized according to the general procedure. 86% NMR yield, yellow oil.  
1H-NMR (400 MHz, CDCl3) δ 7.56 (d, J = 7.2 Hz, 2H), 7.34-7.26 (m, 5H), 7.19 (d, J = 8.0 Hz, 
2H), 6.59 (d, J = 1.2 Hz, 1H), 5.92 (d, J = 1.2 Hz, 1H), 2.36 (s, 3H).  
13C-NMR (100 MHz, CDCl3) δ 150.9, 144.2, 135.5, 132.4, 129.4, 129.1, 128.9, 128.2, 128.1, 
125.4, 21.4.  
HRMS Calculated for C15H14O2SNa [M+Na]+ : 281.0612, Found: 281.0607. 
 
 
23ca, synthesized according to the one-pot procedure. 79% isolated yield, colorless oil.  
1H-NMR (400 MHz, CDCl3) δ 7.62-7.58 (m, 2H), 7.35-7.25 (m, 5H), 6.87-6.84 (m, 2H), 6.57 (s, 
1H), 5.89 (s, 1H), 3.82 (s, 3H).  
13C-NMR (100 MHz, CDCl3) δ 163.4, 151.4, 132.7, 130.6, 130.1, 129.2, 129.1, 128.2, 124.9, 
114.1, 55.5.  
HRMS Calculated for C15H14O3SNa [M+Na]+ : 297.0561, Found: 297.0557. 
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23da, synthesized according to the one-pot procedure. 83% isolated yield, colorless oil.  
1H-NMR (400 MHz, CDCl3) δ 7.70-7.66 (m, 2H), 7.36-7.26 (m, 5H), 7.09-7.04 (m, 2H), 6.63 (d, 
J = 1.6 Hz, 1H), 5.95 (d, J = 1.6 Hz, 1H).  
13C-NMR (100 MHz, CDCl3) δ 164.3, 150.9, 132.3, 131.2, 131.1, 129.4, 129.1, 128.3, 125.9, 
116.3, 116.0.  
HRMS Calculated for C14H11FO2SNa [M+Na]+ : 285.0361, Found: 285.0357. 
 
 
23ea, synthesized according to the one-pot procedure. 68% isolated yield, colorless oil.  
1H-NMR (400 MHz, CDCl3) δ 7.62-7.59 (m, 2H), 7.38-7.26 (m, 7H), 6.64 (s, 1H), 5.98 (s, 1H).  
13C-NMR (100 MHz, CDCl3) δ 150.7, 140.1, 137.2, 132.2, 129.8, 129.5, 129.2, 129.1, 128.4, 
126.3.  
HRMS Calculated for C14H11ClO2SNa [M+Na]+ : 301.0066, Found: 301.0061. 
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23fa, synthesized according to the one-pot procedure. 82% isolated yield, pale yellow solid.  
1H-NMR (400 MHz, CDCl3) δ 7.41-7.31 (m, 5H), 6.91 (s, 1H), 6.68 (s, 1H), 6.09 (s, 1H).  
13C-NMR (100 MHz, CDCl3) δ 149.5, 134.6, 132.6, 131.6, 129.7, 128.9, 128.5, 127.3, 126.8.  
HRMS Calculated for C12H8Cl2O2SNa [M+Na]+ : 340.9240, Found: 340.9235. 
 
 
23ga, synthesized according to the one-pot procedure. 70% isolated yield (~5% impurity noted), 
colorless oil.  
1H-NMR (400 MHz, CDCl3) δ 7.64-7.61 (m, 2H), 7.46-7.41 (m, 3H), 6.54 (s, 1H), 6.03 (s, 1H), 
2.80 (s, 3H).  
13C-NMR (100 MHz, CDCl3) δ 150.0, 132.5, 129.8, 128.8, 128.6, 125.9, 40.6.  
HRMS Calculated for C9H10O2SNa [M+Na]+ : 205.0299, Found: 205.0294. 
 
 
23ha, synthesized according to the one-pot procedure. 73% isolated yield, colorless oil.  
1H-NMR (400 MHz, CDCl3) δ 7.65-7.62 (m, 2H), 7.44-7.39 (m, 3H), 6.53 (s, 1H), 6.09 (s, 1H), 
2.93 (sept, J = 6.8 Hz, 1H), 1.25 (d, J = 6.8 Hz, 3H).  
13C-NMR (100 MHz, CDCl3) δ 147.2, 133.0, 129.6, 128.8, 128.6, 127.9, 51.1, 14.8. HRMS 
Calculated for C11H14O2SNa [M+Na]+ : 233.0612, Found: 233.0607. 
23ga
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23ia, synthesized according to the one-pot procedure. 82% NMR yield, yellow oil.  
1H-NMR (400 MHz, CDCl3) δ 7.63-7.60 (m, 2H), 7.44-7.39 (m, 3H), 6.43 (s, 1H), 5.95 (s, 1H), 
2.26-2.19 (m, 1H), 1.15-1.10 (m, 2H), 0.92-0.87 (m, 2H).  
13C-NMR (100 MHz, CDCl3) δ 149.7, 132.9, 129.5, 128.9, 128.6, 125.2, 29.5, 5.5. HRMS 
Calculated for C11H12O2SNa [M+Na]+ : 231.0456, Found: 231.0450. 
 
Procedure for synthesis of BrettPhosAu(TA)OTf 
A 20 mL screw-cap vial was charged with BrettPhosAuCl (308 mg, 0.4 mmol) and 1H-
benzotriazole (48 mg, 1.0 equiv.) in dry DCM (8 mL), followed by the addition of AgOTf (103 
mg, 1.05 equiv.). The vial was allowed to stir at ambient temperature. After 4h, the reaction 
mixture was filtered through two celite pads and concentrated in vacuo to give the product as 
white foam. White powder was obtained via recrystallization through diffusion of hexanes into 
DCM solution of crude product. 
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III. Derivatization of α-Substituted Vinyl Sulfone  
1. Diels-Alder reaction 
 
A seal tube was charged with 2-sulfonyl-1,3-diene 23bj (0.1 mmol) and N-methyl maleimide (2 
eq.) in dry toluene (1.0 mL), capped and allowed to stir at 100 oC for 1.5 days. Crude NMR was 
taken to determine the dr value (>20:1). The reaction mixture was directly purified by flash 
chromatography on silica gel to give desired product in 80% yield as pale solid. The 
stereochemistry of 27 is determined via a series of NMR experiments.  
 
1H-NMR (400 MHz, CDCl3) δ 7.81-7.79 (m, 2H), 7.62-7.58 (m, 1H), 7.54-7.51 (m, 2H), 3.51 
(dt, J = 15.2, 5.2 Hz, 1H), 3.31 (dd, J = 16.0, 1.6 Hz, 1H), 3.12 (td, J = 8.4, 1.6 Hz, 1H), 3.02 (dd, 
J = 8.4, 5.2 Hz, 1H), 2.52 (s, 3H), 3.51 (ddd, J = 16.0, 8.0, 4.0 Hz, 1H), 2.38-2.27 (m, 3H), 1.94-
1.59 (m, 4H), 1.41-1.31 (m, 1H).  
13C-NMR (100 MHz, CDCl3) δ 177.5, 177.0, 156.8, 141.2, 133.1, 131.4, 129.1, 127.4, 42.9, 
40.5, 39.7, 36.3, 25.3, 24.5, 23.7, 20.8, 20.3.  
HRMS Calculated for C19H21O4NSNa [M+Na]+ : 382.1089, Found: 382.1084.  
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2. Michael addition 
 
A 1-dram vial was charged with α-vinyl sulfone 23aa (0.1 mmol), and morpholine (1.05 eq.) in 
MeOH (2 mL) and allowed to stir at ambient temperature for 20h. The reaction mixture was 
directly purified by flash chromatography on silica gel (hexane/ethyl acetate = 6:1, V/V) to give 
desired product in 95% yield as white solid. The use of 8 as the Michael receptor under identical 
condition gave no conversion at all.  
 
1H-NMR (400 MHz, CDCl3) δ 7.43 (d, J = 8.4 Hz, 2H), 7.31-7.23 (m, 3H), 7.19-7.15 (m, 4H), 
4.30 (dd, J = 8.4, 4.4 Hz, 1H), 3.48 (t, J = 4.4 Hz, 1H), 3.44 (d, J = 4.8 Hz, 1H), 3.11 (dd, J = 
13.6, 8.8 Hz, 1H), 2.41-2.30 (m, 4H).  
13C-NMR (100 MHz, CDCl3) δ 144.4, 135.0, 132.5, 129.9, 129.2, 128.9, 128.6, 128.4, 69.1, 
66.6, 56.8, 53.4, 21.5.  
HRMS Calculated for C19H23O3NSNa [M+Na]+ : 368.1296, Found: 368.1296. 
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IV. ORTEP Drawing of the Crystal Structure 
 
 
Figure S1. Perspective view of the molecular structure of C15H14SO2 with the atom labeling 
scheme provided for the non-hydrogen atoms. The thermal ellipsoids are scaled to enclosed 30% 
probability. 
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Chapter 4: Gold(I)/(III) redox catalysis 
 
4.1 Introduction and advantages 
Organic transformations usually involve carbon-carbon bond formations, which is an 
important part for developing new chemistry. For coupling reactions, application of transition 
metals in homogeneous condition have been well developed for both homo- and cross-coupling 
reactions.25 Notably, palladium-catalyzed coupling reactions including Mizoroki-Heck, Negishi, 
and Suzuki-Miyaura reactions have paved a way for organic chemists to explorer more and 
broader applications in synthetic chemistry field, and therefore these applications were 
recognized with Nobel Prize in Chemistry in 2010. The mechanism for these reactions is usually 
undergoing Mn/Mn+2 redox cycles, which metals will be firstly oxidized and then reduced via 
reductive elimination process. Besides the application in palladium, other metals such as nickel, 
rhodium, copper and iron have also provided important applications with similar reactivity.26 
 
Figure 34. Gold (I/III) redox catalysis cycle 
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Gold catalyzed coupling reactions are not well developed. Gold has two charge forms: +1 
and +3, but hardly to convert between each other during an oxidation/redox reaction due to the 
high oxidation potential (E0 = +1.41 V).27 Generally, gold is considered as a neutral carbophilic 
p-acid, and thus it can activate double and triple bonds towards nucleophiles attacking. Due to 
the high redox potential, nevertheless, the necessary process from gold(I) to gold(III) is 
challenging towards catalytic coupling reactions.  
So far, alkylgold(I) complexes have been successfully applied in coupling reactions with 
simple alkyl iodides. The gold(I) catalyzed homogeneous suzuki-Miyaura and Sonoga-shira 
reactions have been reported by reacting with aryl iodides, while the mechanism was still 
questioned. Another approach for gold catalyzed coupling was by using of external oxidant to 
achieve gold(I/III) catalytic cycle at homogeneous condition, which mechanism was proposed in 
the figure.28 Compared with the coupling reactions by organic halide assisted oxidative addition, 
both coupling partners coordinated with metal and underwent ligand exchange step 
(transmetalation) before final reductive elimination. In gold redox reactions, gold could undergo 
same process and couple with partners such as organoboronic acids. One of the fragment would 
be delivered and complete transformation via gold catalysis.    
 As literatures reported, gold(III) catalysts could selectively functionalize C(sp2)-H under 
mild condition to form different derivatives, which formed an active intermediate arylgold(III) 
complex.29 The reaction is efficient enough to accomplish without the requirement of arenes pre-
activation. Alternatively, gold could coordinate on alkenes, allenes and alkynes and the 
nucleophiles will come in to attack activated multiple bonds to give addition products. Notably, 
protodeauration will be replaced by oxidative coupling step in all three multiple bonds hydro-
functionalization type reactions. Based on this concept, more and more new developed 
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transformations were reported in recent years via gold(III) redox catalysis, including carbon-
carbon or hetero atom bond formation. 
 
 
4.2 Cross-coupling of terminal alkynes 
 
4.2.1 Introduction 
Conjugate diynes and polyynes are useful and important synthetic units in organic chemistry 
and material field. 30  Unsymmetrical diynes are critical and more important than symmetric 
diynes due to the large variety. Previous reported methods usually applied Glaser-Hay and 
Cadiot-Chodkiewica coupling reactions (in Figure 35). 31  Glaser-Hay employed Cu or Ni 
catalysts but is not providing good performance of desired product because of the competition of 
homocoupling product. Moreover, Cadiot-Chodkiewica coupling reaction requires alkynes 
prefunctionalization,32 and it is not convenient for use and will increase the cost of this reaction. 
Therefore, hetero-coupling of terminal alkynes are challenging but highly desired. In this 
chapter, a new method of synthesis of unsymmetrical alkynes will be introduced by using gold 
catalysis system, which method is much simple and practical than previous reported coupling 
reactions. 
The main issue for hetero-coupling reaction is homo-coupling product, while it is difficult to 
minimize the potential after C-H alkynylation. In [Cu] and [Pd] catalysis reactions, the 
intermediates from disproportionation of [LM(CCR)2]n+ are too reactive to selectively forming 
desired product.33 In order to achieve high yield of heterocoupling product, a special metal 
acetylide is important to avoid the byproducts from transmetalation/disproportionation. Recent 
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studies have proved that strong oxidant could oxidize Au(I) to Au(III) by using PIDA or 
Selectfluor.34 Moreover, Dean Toste group recently reported that Au(III) intermediates can go 
reductive elimination quickly, and the elimination process will be accelerated by using different 
ligands.35 Based on these important foundations, we dare to make hypothesis that gold redux 
might be potentially applied for the achievement of alkyne cross-coupling reactions.     
 
Figure 35. Gold-catalyzed Oxidative Alkyne Cross-Coupling 
 
4.2.2 Condition screening 
An important factor of metal acetylide formation is the different electronic alkynes. As we all 
know, gold cation is great p-acid, which is easier and faster when forming metal acetylide than 
other metals. We therefore postulated that gold could has this differentiation capability with 
different electronic alkynes. This hypothesis was proved by our previous studies like shown in 
the figure.  
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Figure 36. Substrate-dependent gold acetylide formation 
 
A reactivity test was carried out with two types of terminal alkynes: one is electronic rich, 
one is electronic deficient. When they are mixed with 1:1 ratio and treated with 1 equivalent of 
gold catalyst, Ph3PAuOAc is favored to react with aliphatic alkyne to form acetylides over 
aromatic alkyne. This study showed us that there is a reacting difference between different types 
of alkynes when forming gold acetylides, which should be further applied into cross-coupling 
reactions.  
 
 
Figure 37. Kinetics Comparison of Cu and Au Systemsa 
a Conditions: Left: 1 (0.1 mmol), 2 (0.13 mmol), CuCl (15 mol %), TMEDA (15 mol %), acetone (0.3 
M), 50 oC; Right: 1 (0.1 mmol), 2 (0.13 mmol), AuCl3 (5 mol %), Phen (5 mol %), CH3CN (0.3 M), 50 
oC. 
 
Moreover, kinetic study was explored by comparing [Cu] and [Au] in the coupling reaction. 
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Obviously, in Au catalysis system the desired cross coupling product is much more than 
homocoupling product (3:1), while in Cu catalyzed reaction, heterocoupling and homocoupling 
products ratio is 1.3:1.  
 
Table 11. Condition optimizationa 
 
entry cat. (%) Ligand (%) time convn (%)b 
yield (%) 32a:33a 
32a 33a  
1 None - 8 h 100 0 0 - 
2 AuCl3 (5) - 2 h 60 trace trace - 
3 AuCl3 (5) Phen (5) 2 h 88 60 13 4.6 
4 CuCl (15) TMEDA (15) 2 h 100 45 27 1.6 
5 (PPh3)2PdCl2 (3) Phen (5) 2 h 60 0 0 - 
6 Ph3PAuCl (5) Phen (5) 2 h 100 67 15 4.5 
7 Ph3PAuBr (5) Phen (5) 1 h 100 77 11 7.0 
8 Ph3PAuNTf2 (5) Phen (5) 1 h 100 65 10 6.5 
9 IPrAuCl (5) Phen (5) 2 h 18 trace trace - 
10 dppm(AuCl)2 (2.5) Phen (5) 1 h 100 67 13 5.2 
11 dppm(AuBr)2 (2.5) Phen (5) 30 min. 100 72 9 8.0 
12 dppm(AuBr)2 (2.5) py (5) 2 h <10 trace trace - 
13 dppm(AuBr)2 (2.5) bpy (5) 2 h 63 43 10 4.3 
14 dppm(AuBr)2 (2.5) Phen (10) 30 min. 100 81 9 9.0 
15c dppm(AuBr)2 (2.5) Phen (10) 15 min. 100 83 7 12 
16 dppm(AuBr)2 (1) Phen (4) 45 min. 100 80 9 8.2 
HF
+
H
MeMe
OH
MeMe
OH
F
[Au] cat., ligand
2 equiv. PhI(OAc)2
CH3CN, 50 oC
30
31 32a
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a Reaction conditions: 30 (0.1 mmol), 31 (0.13 equiv.), catalyst (5 mol %) and ligand (5 mol %) in 
CH3CN (0.3 mL), 50 oC, 2 h; b Determined by 19F NMR using benzotrifloride as internal standard; c 
Solvent: CH3CN/1,4-dioxane (3:1). 5% ArC(O)CH2OAc was detected from alkyne 30 oxidation by 
PhI(OAc)2 along with some un-identified decomposition products. 
 
When using AuCl3 and PhI(OAc)2 to catalyze the reaction, the conversion can only reach 
60% and no coupling products observed, even heated up to 50 oC. However, the application of 
Phen ligand will hugely improve the reaction rate (88%) and obtain heterocoupling product in 
60% yield. With this interesting result, detailed conditions screening was carried out and 
summarized in the table. 
The screening started with different metal catalysts with standard reaction conditions (Using 
PhI(OAc)2 as oxidant, MeCN as the solvent in 50 oC). [Cu] catalyst, as mention above, still gave 
poor selectivity. [Pd] catalyst could not catalyze the reaction. Precatalysts gold(I) species could 
further improve the conversion of the reaction, and bromide counter ion offered slightly better 
yield. Cationic Ph3PAuNTf2 and cabene IPrAuCl were both tested, but the digold catalysts 
offered better selectivity and reactivity. Other ligand like pyridine were tested, offering much 
lower conversion and almost no yield, while in bipyridine assisted reaction is different providing 
43% product yield. The mono-nitrogen and di-nitrogen ligand comparison suggested the 
importance of di-nitrogen coordination of the ligand. To our surprise, other oxidants were also 
screened out (see SI), but only PhI(OAc)2 gave the good result and other oxidants like 
Selectfluor offered trace amount of products. In the end, the optimal condition was certain, 
which is using digold species with Phen as the ligand and PhI(OAc)2 as the oxidant, offering 
good selectivity of heterocoupling and homocoupling products (12:1). 
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4.2.3 Substrate scopes 
With the optimal condition in hand, we developed our substrate scope. A series of aromatic 
alkynes were first tested, and both electron-rich and –deficient alkynes offered good to excellent 
yields with desired diynes. With halogen-substituted aromatic alkynes (32e, 32f, 32g) also 
provided desired diynes products with good yields, which highlighted the orthogonal reactivity 
of gold and proved the reaction underwent oxidative addition and reductive elimination pathway.  
Moreover, different heteroaromatic alkynes were checked under our condition, including 
pyridine, thiophene and indole, which all gave good yield of desired products.  
 
Table 12. Generalitya, b 
 
a General reaction conditions: R1-alkyne (0.2 mmol), R2-alkyne (0.26 mmol, 1.3 equiv.), 2.5 mol% 
dppm(AuBr)2, 10 mol% Phen and PhI(OAc)2 (0.4 mmol, 2 equiv) in CH3CN/1,4-Dioxane (0.6 mL/0.2 
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mL), 50 oC; b Isolated yield; c R1-alkyne (0.26 mmol, 1.3 equiv), R2-alkyne (0.2 mmol, 1 equiv), the yield 
was calculated based on R1-alkyne. 
 
The mild condition can tolerate a lot of different functional groups, such as primary alcohol, 
carboxylic acid, amide, silyl ester and 1,2,3-triazole that all can be well reacted. Other reactive 
functional groups like vinyl ether, propargyl ester and alkyne ester can be well applied in good 
yields. In order to test the potential of application into practical field, we prepared several 
terminal alkynes derived from natural products, including estrone, sugar and amino acid. To our 
delighted, they provided acceptable yield, which highly stressed the great potential of application 
into practical synthesis field, even into natural products synthesis.     
 
 
Figure 38. Synthetic Utility 
 
The desired diynes are quite useful, which can be easily converted into other useful 
compounds. In Figure 38A, heteroaromatic molecules could be easily accessed by using 
previously reported methods. In Figure 38B, gram scale diynes can be obtained to prove the 
practical applications. Polyynes are useful building block in synthesis field. In Figure 38C, 
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multiple units of terminal alkynes could couple with each other and form polyynes with good 
yield.  
Although many examples showed that gold catalyzed C-C bond formation through gold 
(I/III) oxidative conditions. However, there are some arguments regarding the real mechanism: 
whether by gold (I/III) redox catalysis or gold (I) species catalyzed alone through alkyne 
activation. With the purpose of verifying the reaction mechanism, we carried out a series of 
experiments by using 1.0 eq of AuCl3 catalyst without additional oxidant.  
 
4.2.4 Mechanism discussion 
As shown in Figure 39A, entry A showed us that the reaction could not happen if using 
AuCl3 alone. When adding Phen as ligand into the reaction, a small amount of diyne was 
detected (<5%). The yield could be largely improved if adding some NaOAc salt into the 
reaction, and the potential reaction is that the acetate ion could help facilitate the reductive 
elimination process. From the entries A to D, we proved that the reaction does undergo reductive 
elimination process, and both phen ligand and acetate ion are critical for the heterocoupling.  
The proposed mechanism is showing in Figure 39B, the key for the heterocoupling product 
formation is gold monoacetylide formation. There are two possibilities to form the 
monoacetylide, one is oxidation happening first and then forming Au(I) acetylide, and one is 
forming Au(I) acetylide first then to be oxidized. From Figure 39A, entry C showed us that the 
ratio 3a:4a is 4:1, which is much lower than ratio 12:1 when using gold (I) catalyst. This may 
exclude the possibility of pathway A, and favor the pathway B in the mechanism. Additionally, 
the support from selectively forming aliphatic gold (I) species suggested the fast reaction rate 
and therefore, provided strong evidence for the late oxidation pathway B. The importance of 
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applying Phen as ligand and acetate ion is obvious, which they should help the reductive 
elimination process after the dialkynylgold (III) species formed. The exact mechanism, 
especially the dimer gold species involved, is still undergoing on our research schedule. 
 
 
Figure 39. Mechanistic Implication 
 
4.2.5 Conclusion 
In sum, a new method of cross-coupling of terminal alkynes is reported here by gold (I/III) 
redox catalysis process. Notably, this method is simple and convenient for use with high 
catalysis efficiency since no large amount of coupling partner excess or alkynes 
prefunctionalization required. More importantly, the excellent tolerability and broadness 
application further highlighted the strength of this method. The brief mechanism studies showed 
that the Phen ligand and acetate ion are both important for the cross-coupling catalysis. It is 
hopefully that this method for alkynes cross-coupling could be applied into industrial field or 
natural product synthesis for practical applications purpose. 
MeMe
OH
F
B) Proposed catalytic cycle involving Au(I)/Au(III) acetylide
AuI
AuIIIL
X
L
X
X
X
AuIIIL
X
X
R1
[O]
reductive elimination
R1
R2
AuIL R1
R1 [O]
pathway A
pathway B
A) Stoichiometric reactions
A: AuCl3 (1 eq.)
B: AuCl3 (1 eq.), Phen (1 eq.) 
C: AuCl3 (1 eq.), NaOAc (3 eq.), Phen (1 eq.)
D: AuCl3 (1 eq.), NaOAc (3 eq.)
30 31 (1.3 eq.)
0%
<5%
65%
12%
n.a.
n.a.
4:1
2:1
conditions yield 32a:33a ratio
X = OAc, (Br, Cl)
60 oC, 10 min
CH3CN
X
AuIII
L
R1R2
			 112	
4.2.6 Experimental data 
 
I. General Methods and Materials 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out under an 
atmosphere of nitrogen using oven/flame-dried glassware. Unless otherwise noted, all 
commercial reagents and solvents were obtained from the commercial provider and used without 
further purification. Dppm(AuBr)2 was purchased from Aldrich and used as received. Phen was 
purchased from AK Scientific and used as received. AuCl3 was purchased from Alfa Aesar and 
used as received. 1H NMR, 13C NMR, 31P NMR, and 19F NMR spectra were recorded on 
Agilent 400 MHz or Varian 600 MHz spectrometers. Chemical shifts were reported relative to 
internal tetramethylsilane (δ 0.00 ppm) or CDCl3 (δ 7.26 ppm) for 1H and CDCl3 (δ 77.0 ppm) 
for 13C. Flash column chromatography was performed on 230-430 mesh silica gel. 
 
II. General Procedures 
A. General procedure for condition screening 
 
In a dried glass tube, catalyst (0.005 mmol, 5 mol %) and ligand (0.005 mmol, 5 mol %) were 
dissolved in CH3CN (0.3 mL). Then PhI(OAc)2 (0.2 mmol, 2.0 equiv.) was added. Then alkynes 
31 (0.13 mmol, 1.3 equiv.) and 30 (0.1 mmol, 1.0 equiv.) were added rapidly, and the reaction 
mixture was stirred at 50 ℃ for 0.5-8 h. After the reaction completed, the reaction was filtrate 
through a pad of silica gel. After evacuation of the solvents, the NMR yields were obtained by 
HF
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MeMe
OH
MeMe
OH
F
[Au] cat., ligand
2 equiv. PhI(OAc)2
CH3CN, 50 oC
30
31 32a
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19F NMR analysis of the crude mixture with the internal standard of trifluorobenzene. The results 
were summarized in Table S1. 
 
Table S1. Comprehensive screening of conditions 
 
 
B. General procedure for gold-catalyzed synthesis of 1,3-diynes 
 
In a dried glass tube, dppm(AuBr)2 (3.0 mg, 0.005 mmol, 2.5 mol %), Phen (3.6 mg, 0.02 mmol, 
10 mol %) were dissolved in CH3CN/1,4-dioxane (0.6 mL/0.2 mL), and then PhI(OAc)2 (128 
HR1 + R2H R2R1
2.5 mol % dppm(AuBr)2
10 mol % Phen
2 equiv. PhI(OAc)2
CH3CN/1,4-Dioxane (3:1), 50 oC
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mg, 0.4 mmol, 2 equiv.), aliphatic alkyne (0.26 mmol, 1.3 equiv.) and aromatic alkyne (0.2 
mmol, 1 equiv.) were added. The reaction mixture was stirred at 50oC for 15 min – 1h. After the 
reaction completed, the reaction mixture was directly purified by flash chromatography on silica 
gel (hexane/ethyl acetate) to give desired 1,3-diyne 3. 
 
III. Gold(I) Acetylide Formation 
A. The formation of 1-AuPPh3 through the stoichiometric reaction of 30 and Ph3PAuOAc 
 
In an NMR tube, 30 (0.05 mmol, 1 equiv.) was dissolved in CD3CN (0.3 mL) and was added 
PPh3AuOAc (0.05 mmol, 1 equiv.). The NMR was shaken vigorously and quickly subject to 1H 
NMR, 19F NMR and 31P NMR. The formation of 1-AuPPh3 is quantitative within 1 min as shown 
in Figure S1 (second spectrum) and Figure S2 (second spectrum). 
 
B. The formation of 2-AuPPh3 through the stoichiometric reaction of 31 and Ph3PAuOAc 
 
        In an NMR tube, 31 (0.05 mmol, 1 equiv.) was dissolved in CD3CN (0.3 mL) and was 
added PPh3AuOAc (0.05 mmol, 1 equiv.). The NMR was shaken vigorously and quickly subject 
to 1H NMR, 19F NMR and 31P NMR. The formation of 2-AuPPh3 is quantitative within 1 min. 
 
C. Selective formation of 2-AuPPh3 in the presence of 1 and 2 (1:1) with stoichiometric 
amount of Ph3PAuOAc 
HF
30
PPh3AuOAc 
(1.0 equiv)
CD3CN, rt, 5 min
Au-PPh3F 1-AuPPh3
100% convn.
H
MeMe
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Au-PPh3
Me
Me
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       In an NMR tube, 30 (0.05 mmol, 1 equiv.) and 31 (0.05 mmol, 1 equiv) were dissolved in 
CD3CN (0.3 mL) and was added PPh3AuOAc (0.05 mmol, 1 equiv.). The NMR was shaken 
vigorously and quickly subject to 1H NMR, 19F NMR and 31P NMR. The formation of 2-AuPPh3 
is selective as shown in Figure S3 (third spectrum) and Figure S4 (third spectrum). The yield 
was based on 1H NMR yield and 1,3,5-Trimethoxy benzene as internal standard, which gave 1-
AuPPh3 19%(0.095 mmol) yield and 2-AuPPh3 56%(0.028 mmol) yield. The result suggest of 
the selectivity of the gold toward different alkynes, which means that aliphatic alkynes 
majors(3:1) (Figure S1). 
 
Figure S1. 1H NMR spectra of reaction outcomes in stoichiometric experiment. 
 
D. Selective formation of 2-AuPPh3 in the presence of 1 and 2 (1:1) with catalytic amount of 
Ph3PAuOAc 
HF
H
MeMe
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+
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2-AuPPh3:1-AuPPh3 = 3:1
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In an NMR tube, 30 (0.05 mmol, 1 equiv.) and 31 (0.05 mmol, 1 equiv) were dissolved in 
CD3CN (0.3 mL) and was added PPh3AuOAc (0.15 equiv.). The NMR was shaken vigorously 
and quickly subject to 1H NMR, 19F NMR and 31P NMR. The formation of 2-AuPPh3 is selective 
as shown as shown in Figure S3 (fourth spectrum) and Figure S4 (fourth spectrum). The yield 
was based on 1H NMR yield and 1,3,5-Trimethoxy benzene as internal standard, which gave 1-
AuPPh3 4 %(0.002 mmol mmol) yield and 2-AuPPh3 12 %(0.0059 mmol) yield. The result 
suggest of the selectivity of the gold toward different alkynes, which means that aliphatic 
alkynes majors(3:1) (Figure S2). 
 
 
Figure S2. 1H NMR spectra of reaction outcomes in stoichiometric experiment 
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Figure S3. 19F NMR spectra of reaction outcomes. Top: authentic sample of 1; second top: 
reaction A; secondbottom: reaction C; bottom: reaction D. 
 
 
Figure S4. 1H NMR spectra of reaction outcomes. Top: authentic sample of 1; second top: 
reaction A; second bottom: reaction C; bottom: reaction D. 
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IV. Kinetics Experiments with Cu and Au Systems 
A. General procedure for AuCl3/Phen-catalyzed alkyne cross-coupling 
 
        In a series of dried glass tubes, AuCl3 (3.0 mg, 0.01 mmol), Phen (1.8 mg, 0.01 mmol) were 
dissolved in 0.6 mL CH3CN. The solution was stirred at room temperature for 15 min and then 
PhI(OAc)2 (128 mg, 0.4 mmol), 31 (0.26 mmol, 1.3 equiv.) and 30 (0.2 mmol, 1 equiv.) were 
added. The reaction mixture was stirred at 50 oC. The NMR yields were obtained by 19F NMR 
analysis of the crude mixture with the internal standard of trifluorobenzene. 
 
B. General procedure for CuCl/TMEDA-catalyzed alkyne cross-coupling 
In a series of dried glass tubes, CuCl (3.0 mg, 0.03 mmol), TMEDA (3.5 mg, 0.03 mmol) were 
dissolved in 1.0 mL acetone. And then 31 (0.26 mmol, 1.3 equiv.) and 30 (0.2 mmol, 1 equiv.) 
were added. The reaction mixture was stirred at 50 oC. The NMR yields were obtained by 19F 
NMR analysis of the crude mixture with the internal standard of trifluorobenzene. 
 
V. Monitoring the Oxidation of Phosphine Ligand 
Phosphine ligand is easily oxidized in the oxidative conditions, as shown in Figure S7, the 
phosphine changed quickly after addition of PhI(OAc)2 and alkyne, which suggest the oxidation 
is much quickly. 
 
A. General procedure for the oxidation of phosphine ligand 
HF
H
MeMe
OH
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+
2 eq. PhI(OAc)2 F
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In an NMR tube, dppm(AuBr)2 (0.005 mmol, 1 equiv.) was dissolved in CDCl3 (0.5 mL) and 
was added PhI(OAc)2 (PIDA, 0.1 mmol, 10 equiv.). The NMR was shaken vigorously and 
quickly subject to 1H NMR and 31P NMR. The reaction rate was then monitored and showed 
below (Figure S7), which showed that the phosphine ligand was easily oxidized with PIDA as 
oxidant. 
 
Figure S7. Oxidation of phosphine ligand 
 
VI. The Effect of Halide Counterion 
As shown in the Table S1, employing chloride containing gold precatalysts, including 
PPh3AuCl, AuCl3 or dppm(AuCl)2, the selectivity is general lower than corresponding bromide 
catalysts, which is also supported by the experiments below (Figure S8, S9), as additional 
P PPh
Ph
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Ph
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Ph PhI(OAc)2
CDCl3
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Ph
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chloride anion has great effect both on the reaction yield and selectivity. The major concern lies 
in the electrophilicity of the catalyst. In the case of gold chloride precatalysts, the catalyst can be 
considered less electrophilicity due to the chloride anion adjacent to the metal center, which 
results to less discrimination between two alkynes. Thus, the selectivity and efficiency of the 
reaction will be lower. This result is also in accordance with Russell’s conclusion.  
 
 
General Procedure: In a series of dried glass tubes, dppm(AuBr)2 (2.6 mg, 0.0025 mmol), 
phen(1.8 mg, 0.01 mmol) were dissolved in 0.3 mL CH3CN with stirring. And then nBu4NCl 
(0.005 mmol-0.1 mmol), PhI(OAc)2 (64 mg, 0.2 mmol), 31 (0.13 mmol, 1.3 equiv.) and 30 (0.1 
mmol, 1 equiv.) were added. The reaction mixture was stirred at 50oC. The NMR yields were 
obtained by 19F NMR analysis of the crude mixture with the internal standard of 
trifluorobenzene. 
 
Figure S8. The effect of additional nBu4NCl on the yield of cross-coupling product 32a 
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Figure S9. The effect of additional nBu4NCl on the selectivity of cross-coupling over homo-
coupling product 
 
 
VII. Compounds Characterization 
Compounds 32a-d, 32g, 32j and 32v were reported in literature. 
 
 
1H NMR (400 MHz, CDCl3) δ 7.46 (dd, J = 3.6, 5.6 Hz, 2H), 7.02 (t, J = 6.0 Hz, 2H), 1.97 (br s, 
1H), 1.58 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ 162.9 (d, J = 249.0 Hz), 134.4 (d, J = 9.2 Hz), 117.6 (d, J = 3.8 
Hz), 115.8 (d, J = 21.8), 86.8, 77.6, 73.0, 66.8, 65.6, 31.0. 
19F NMR (376 MHz, CDCl3) δ -108.6 (m, 1F). 
 
MeMe
OH
F
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1H NMR (400 MHz, CDCl3) δ 7.42 (d, J = 5.6 Hz, 2H), 7.33 (d, J = 6.0 Hz, 2H), 3.81 (s, 3H), 
1.57 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ160.4, 134.1, 114.1, 113.5, 86.2, 79.0, 72.0, 67.3, 67.1, 65.7, 
55.3, 31.2. 
 
 
1H NMR (400 MHz, CDCl3) δ 7.61 (d, J = 5.6 Hz, 2H), 7.55 (d, J = 5.6 Hz, 2H), 2.17 (br s, 3H), 
1.59 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ 132.9, 132.1, 126.6, 118.1, 112.5, 89.2, 77.4, 76.5, 66.4, 65.7, 
31.0. 
 
 
1H NMR (400 MHz, CDCl3) δ 7.42 (d, J = 5.6 Hz, 2H), 7.33 (d, J = 5.6 Hz, 2H), 2.07 (br s, 1H), 
1.58 (s, 6H), 1.30 (s, 9H). 
13C NMR (100 MHz, CDCl3) δ152.7. 132.3, 125.4, 118.5, 86.3, 79.1, 72.5, 67.3, 65.7, 34.9, 
31.1, 31.0. 
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1H NMR (400 MHz, CDCl3) δ 7.45 (t, J = 1.6 Hz, 1H), 7.33 (tt, J = 1.2, 13.2 Hz, 2H), 7.24 (t, J 
= 8.0 Hz,1 H), 2.14 (br s, 1H), 1.58 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ 134.3, 132.2, 130.6, 129.6, 129.5, 123.3, 87.4, 77.1, 74.3, 66.7, 
65.7, 31.0. 
HRMS: m/z (ESI) Calculated for [M-OH]+ 201.0471, Found 201.0479. 
 
 
1H NMR (400 MHz, CDCl3) δ 7.64 (dd, J = 5.2, 8.8 Hz, 2H), 7.50 (t, J = 5.2 Hz, 1H), 7.45 (t, J = 
5.2 Hz, 1H), 2.15 (br s, 1H), 1.59 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ 135.1, 132.6 (q, J = 80.0 Hz), 131.4, 128.8, 126.0 (q, J = 12.4 
Hz), 123.3 (q, J = 180.8 Hz), 120.0, 88.7, 78.4, 74.1, 66.8, 65.8, 31.0. 
19F NMR (376 MHz, CDCl3) δ -62.6 (s, 3F). 
HRMS: m/z (ESI) Calculated for [M-OH]+ 235.0735, Found 235.0731. 
 
 
1H NMR (400 MHz, CDCl3) δ 7.45 (d, J = 5.2 Hz, 2H), 7.32 (d, J = 5.6 Hz, 2H), 2.23 (br s, 1H), 
1.58 (s, 6H). 
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13C NMR (100 MHz, CDCl3) δ 133.8, 131.7, 123.7, 120.5, 87.3, 77.6, 74.3, 66.8, 65.7, 31.0, 
29.7. 
 
 
1H NMR (400 MHz, CDCl3) δ 7.45 (dd, J = 1.2, 8.0 Hz, 1H), 7.25 (m , 1H), 7.20 (m, 1H), 7.13 
(m, 1H), 2.44 (s, 3H), 2.16 (br s, 1H), 1.58 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ 141.7, 132.9, 129.5, 129.2, 125.6, 121.3, 87.1, 77.8, 67.1, 65.8, 
31.1, 20.6. 
HRMS: m/z (ESI) Calculated for [M-OH]+ 181.1017, Found 181.1025. 
 
 
1H NMR (600 MHz, CDCl3) δ 8.65 (m, 1H), 8.62 (d, J = 8.4 Hz, 1H), 8.39 (m., 1H), 8.05 (s, 
1H), 7.82 (d, J = 7.8 Hz, 1H), 7.68 (m, 3H), 7.59 (t, J = 7.2 Hz, 1H), 2.23 (br s, 1H), 1.66 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ 134.0, 131.1, 130.8, 130.5, 129.9, 128.6, 128.0, 127.3, 127.2, 
127.0, 126.7, 122.8, 122.6, 118.0, 87.5, 77.4, 77.3, 67.3, 65.8, 31.1. 
HRMS: m/z (ESI) Calculated for [M-OH]+ 267.1174, Found 267.1168. 
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1H NMR (600 MHz, CDCl3) δ 7.93 (s, 1H), 7.65 (dd, J = 9.0, 16.2 Hz, 2H), 7.44 (d, J = 8.4 Hz, 
1H), 7.15 (dd, J = 2.4, 9.0 Hz, 1H), 7.08 (s, 1H), 3.91 (s, 3H), 2.03 (br s, 1H), 1.59 (s, 6H). 
13C NMR (150 MHz, CDCl3) δ 158.7, 134.6, 132.8, 129.4, 129.1, 128.2, 126.9, 119.6, 116.2, 
105.8, 86.5, 79.5, 72.8, 67.3, 65.8, 55.3, 31.1. 
 
 
1H NMR (600 MHz, CDCl3) δ 7.94 (d, J = 8.4 Hz, 1H), 7.80 (s, 1H), 7.76 (d, J = 8.4 Hz, 2H), 
7.61 (d, J = 7.8 Hz, 1H), 7.34 (t, J = 7.8 Hz, 1H), 7.27 (t, J = 7.8 Hz, 1H), 7.21 (d, J = 7.8 Hz, 
2H), 2.31 (s, 3H), 1.59 (s, 6H). 
13C NMR (150 MHz, CDCl3) δ 145.5, 134.6, 133.9, 131.0, 130.6, 130.0, 126.9, 125.7, 123.9, 
120.5, 113.6, 103.6, 87.2, 77.2, 70.2, 67.0, 65.7, 31.0, 21.5. 
HRMS: m/z (ESI) Calculated for [M+H]+ 377.1086, Found 377.1077. 
 
 
1H NMR (400 MHz, CDCl3) δ 7.55 (d, J = 2.0 Hz, 1H), 7.26 (t, J = 2.8 Hz, 2H), 7.13 (d, J = 3.6 
Hz), 2.11 (br s, 1H), 1.57 (s, 6H). 
13C NMR (100 MHz, CDCl3) δ 131.3, 130.1, 125.5, 120.6, 86.5, 74.0, 72.8, 67.0, 65.7, 31.0. 
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HRMS: m/z (ESI) Calculated for [M-OH]+ 173.0425, Found 173.0423. 
 
 
1H NMR (600 MHz, CDCl3) δ 8.54 (t, J = 2.4 Hz, 1H), 7.64 (dt, J = 1.8, 9.6 Hz, 1H), 7.45 (d, J = 
7.2 Hz, 1H), 7.25 (m, 1H), 1.57 (s, 6H). 
13C NMR (150 MHz, CDCl3) δ 150.0, 142.0, 136.3, 128.2, 123.6, 88.3 (d, J = 64.2 Hz), 76.9, 
73.6 (d, J = 60.0 Hz), 66.4 (d, J = 22.8 Hz), 65.4 (d, J = 22.8 Hz), 31.0. 
HRMS: m/z (ESI) Calculated for [M+H]+ 186.0919, Found 186.0911. 
 
 
1H NMR (600 MHz, CDCl3) δ 8.89 (d, J = 1.8 Hz), 8.55 (dd, J = 1.8, 4.8 Hz, 1H), 7.79 (dt, J = 
1.8, 7.8 Hz, 1H), 7.30 (dd, J = 4.8, 7.8 Hz, 1H), 1.58 (s, 6H). 
13C NMR (150 MHz, CDCl3) δ 152.8, 148.6, 139.7, 123.2, 119.4, 89.0, 76.7, 66.2, 65.1, 31.0. 
HRMS: m/z (ESI) Calculated for [M+H]+ 186.0919, Found 186.0911. 
 
 
1H NMR (600 MHz, CDCl3) δ 7.46 (dd, J = 4.8, 7.8 Hz, 2H), 7.01 (t, J = 9.0 Hz, 2H), 3.80 (t, J = 
6.6 Hz, 2H), 2.64 (t, J = 6.0 Hz, 2H). 
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13C NMR (150 MHz, CDCl3) δ 162.9 (d, J = 249.6 Hz), 134.5 (d, J = 9.2 Hz), 117.8 (d, J = 3.5 
Hz), 115.8 (d, J = 22.9 Hz), 81.0, 74.3, 73.7, 66.7, 60.8, 24.0. 
19F NMR (376 MHz, CDCl3) δ -108.9 (m, 1F). 
HRMS: m/z (ESI) Calculated for [M+H]+ 189.0716, Found 189.0712. 
 
 
1H NMR (600 MHz, CDCl3) δ 7.45 (dd, J = 4.8, 7.8 Hz, 2H), 7.00 (t, J = 8.4 Hz, 2H), 2.41 (t, J = 
6.0 Hz, 2H), 2.39 (t, J = 4.2 Hz, 2H), 1.79 (m, 2H), 1.64 (m, 2H). 
13C NMR (150 MHz, CDCl3) δ 179.4, 162.8 (d, J = 249.5 Hz), 134.5 (d, J = 8.1 Hz), 118.0 (d, J 
= 3.5 Hz), 115.8 (d, J =21.8 Hz), 83.7, 74.0, 73.9, 65.5, 33.3, 29.7, 27.5, 23.8, 19.3. 
19F NMR (376 MHz, CDCl3) δ -109.3 (m, 1F). 
HRMS: m/z (ESI) Calculated for [M+H]+ 245.0978, Found 245.0985. 
 
 
1H NMR (600 MHz, CDCl3) δ 7.87 (dd, J = 3.0, 5.4 Hz, 2H), 7.73 (dd, J = 3.0, 5.4 Hz, 2H)), 
7.43 (dd, J = 5.4, 9.0 Hz, 2H), 6.99 (t, J = 9.0 Hz, 2H), 3.92 (t, J = 7.2 Hz, 2H), 2.79 (t, J = 7.2 
Hz, 2H). 
13C NMR (150 MHz, CDCl3) δ 167.8, 162.8 (d, J = 249.5 Hz), 134.5 (d, J = 8.0 Hz), 134.0, 
131.9, 123.4, 117.8 (d, J = 3.5 Hz), 115.7 (d, J =22.8 Hz), 79.9, 74.4, 73.7, 36.2, 19.5. 
19F NMR (376 MHz, CDCl3) δ -109.0 (m, 1F). 
HRMS: m/z (ESI) Calculated for [M+H]+ 318.0930, Found 318.0926. 
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1H NMR (600 MHz, CDCl3) δ 7.53 (dd, J = 1.8, 8.4 Hz, 2H), 7.48 (dd, J = 5.4, 8.4 Hz, 2H), 7.02 
(t, J = 8.4 Hz, 2H), 6.56 (s, 1H), 2.13 (s, 3H). 
13C NMR (150 MHz, CDCl3) δ 169.6, 163.4 (d, J = 249.5 Hz), 136.1, 134.7 (d, J = 8.0 Hz), 
129.2, 128.8, 127.7, 117.3 (d, J = 3.5 Hz), 115.9 (d, J =21.7 Hz), 78.5, 78.4, 72.9, 71.5, 65.9, 
20.9. 
19F NMR (376 MHz, CDCl3) δ -108.0 (m, 1F). 
HRMS: m/z (ESI) Calculated for [M+H]+ 293.0978, Found 293.0985. 
 
 
1H NMR (600 MHz, CDCl3) δ 7.53 (d, J = 7.2 Hz, 2H), 7.48 (dd, J = 5.4, 9.0 Hz, 2H), 7.40 (m, 
3H), 7.01 (t, J = 8.4 Hz, 2H), 6.52 (dd, J = 7.2, 14.4 Hz, 1H), 5.62 (s, 1H), 4.55 (dd, J = 1.8, 14.4 
Hz, 1H), 4.25 (dd, J = 2.4, 6.6 Hz, 1H). 
13C NMR (150 MHz, CDCl3) δ 163.2 (d, J = 250.5 Hz), 149.3, 136.7, 134.7 (d, J = 9.2 Hz), 
129.0, 128.8, 127.3, 117.3 (d, J = 3.5 Hz), 115.9 (d, J =23.2 Hz), 90.9, 78.9, 78.5, 72.9, 72.7, 
70.9. 
19F NMR (376 MHz, CDCl3) δ -108.1 (m, 1F). 
HRMS: m/z (ESI) Calculated for [M+H]+ 277.1029, Found 277.1021. 
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1H NMR (600 MHz, CDCl3) δ 7.54 (dd, J = 5.4, 9.0 Hz, 2H), 7.06 (t, J = 9.0 Hz, 2H), 3.82 (s, 
3H). 
13C NMR (150 MHz, CDCl3) δ 163.7 (d, J = 252.9 Hz), 153.3, 135.3 (d, J = 9.8 Hz), 116.1 (d, J 
= 21.8 Hz), 82.5, 71.9, 71.5, 71.1, 53.0. 
19F NMR (376 MHz, CDCl3) δ -106.0 (m, 1F). 
HRMS: m/z (ESI) Calculated for [M+H]+ 203.0508, Found 203.0519. 
 
 
1H NMR (600 MHz, CDCl3) δ 7.87 (dd, J = 3.0, 6.6 Hz, 2H), 7.44 (t, J = 6.0 Hz, 2H), 7.39 (dd, J 
= 3.6, 7.2 Hz, 2H), 6.99 (t, J = 8.4 Hz, 2H),4.92 (t, J = 7.8 Hz, 2H), 3.22 (t, J = 7.2 Hz, 2H). 
13C NMR (150 MHz, CDCl3) δ 163.0 (d, J = 249.6 Hz), 144.5, 134.5 (d, J = 9.2 Hz), 126.6, 
118.1, 117.7 (d, J = 3.5 Hz), 115.8 (d, J = 21.8 Hz), 78.7, 74.9, 73.5, 67.4, 54.4, 29.7, 21.2. 
19F NMR (376 MHz, CDCl3) δ -108.7 (m, 1F). 
HRMS: m/z (ESI) Calculated for [M+H]+ 290.1094, Found 290.1086. 
 
 
1H NMR (600 MHz, CDCl3) δ 7.86 (s, 1H), 7.78 (d, J = 7.2 Hz, 2H), 7.43 (m, 4H), 7.35 (t, J = 
7.8 Hz, 1H), 6.99 (t, J = 8.4 Hz, 2H), 4.65 (t, J = 7.2 Hz, 2H), 3.08 (t, J = 7.2 Hz, 2H). 
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13C NMR (150 MHz, CDCl3) δ 162.9 (d, J = 249.6 Hz), 148.1, 134.5 (d, J = 8.0 Hz), 131.3, 
130.2, 128.9, 128.5, 125.9, 117.7 (d, J = 3.5 Hz), 115.8 (d, J = 21.8 Hz), 110.0, 79.1, 74.8, 73.5, 
67.2, 542.9, 21.0. 
19F NMR (376 MHz, CDCl3) δ -108.9 (m, 1F). 
HRMS: m/z (ESI) Calculated for [M+H]+ 316.1250, Found 316.1242. 
 
 
1H NMR (400 MHz, CDCl3) δ 7.50 (d, J = 5.2 Hz, 1H), 7.38 (t, J = 5.2 Hz, 1H), 7.33 (t, J = 4.8 
Hz, 1H)), 7.28 (t, J = 4.8 Hz, 1H), 5.36 (d, J = 8.8 Hz, 1H), 5.27 (d, J = 8.8 Hz, 1H), 5.05 (d, J = 
6.4 Hz, 1H), 4.30 (dd, J = 2.8, 6.0 Hz, 1H), 2.36 (t, J = 4.8 Hz, 2H), 2.20 (m, 1H), 1.58 (m, 2H), 
1.44 (s, 9H), 1.41 (m, 2H), 1.35 (m, 2H), 0.97 (d, J = 4.8 Hz, 3H), 0.92 (t, J = 4.8 Hz, 3H), 0.89 
(t, J = 4.8 Hz, 3H). 
13C NMR (100 MHz, CDCl3) δ 172.2, 155.7, 138.3, 133.4, 128.9, 128.5, 128.2, 121.7, 86.3, 
79.7, 79.3, 71.7, 65.2, 64.9, 58.6, 31.3, 31.0, 28.3, 27.9, 22.1, 19.6, 19.0, 17.5, 13.8. 
HRMS: m/z (ESI) Calculated for [M+H]+ 412.2488, Found 412.2495. 
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1H NMR (600 MHz, CDCl3) δ 7.44 (dd, J = 5.4, 9.0 Hz, 2H), 6.99 (t, J = 8.4 Hz, 2H), 5.88 (d, J 
= 3.6 Hz, 1H), 5.27 (d, J = 2.4 Hz, 1H), 4.47 (d, J = 3.6 Hz, 1H), 4.20 (m, 2H), 4.08 (dd, J = 5.4, 
9.0 Hz, 1H), 4.00 (dd, J = 4.2, 9.0 Hz, 1H), 2.38 (m, 4H), 1.18 (m, 2H), 1.62 (m, 2H), 1.51 (s, 
3H), 1.39 (s, 3H), 1.31(s, 3H), 1.29 (s, 3H). 
13C NMR (150 MHz, CDCl3) δ 169.9, 162.9 (d, J = 250.6 Hz), 148.4, 138.2, 137.8, 134.5 (d, J = 
8.1 Hz), 126.4, 121.5, 118.6, 117.7 (d, J = 3.5 Hz), 115.8 (d, J = 21.8 Hz), 85.9, 80.6, 77.9, 73.2, 
70.6, 49.9, 47.9, 43.6, 39.0, 38.9, 33.0, 29.5, 26.9, 26.2, 22.9, 21.1, 12.7. 
19F NMR (376 MHz, CDCl3) δ -108.6 (m, 1F). 
HRMS: m/z (ESI) Calculated for [M+H]+ 487.2131, Found 487.2121. 
 
 
1H NMR (400 MHz, CDCl3) δ 7.23 (m, 3H), 2.86 (dd, J = 2.8, 5.6 Hz, 2H), 2.51 (dd, J = 5.6, 
12.4 Hz, 1H), 2.39 (t, J = 3.6 Hz, 1H), 2.27 (m, 1H), 2.14 (m, 1H), 1.98 (m, 2H), 1.52 (m, 9 H), 
1.25 (m, 1H), 0.91 (s, 3H). 
13C NMR (100 MHz, CDCl3) δ 220.3, 141.5, 136.8, 132.9, 129.9, 125.5, 118.9, 86.4, 79.1, 72.6, 
67.2, 65.8, 50.6, 47.9, 44.6, 37.9, 35.8, 34.1, 31.6, 31.2, 29.0, 26.3, 25.6, 21.6, 13.8. 
HRMS: m/z (ESI) Calculated for [M-OH]+ 343.2062, Found 343.2060. 
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1H NMR (600 MHz, CDCl3) δ 7.47 (dd, J = 5.4, 9.0 Hz, 2H), 7.28 (d, J = 8.4 Hz, 1H), 7.01 (t, J 
= 8.4 Hz, 2H), 6.84 (d, J = 7.8 Hz, 1H), 6.79 (d, J = 1.8 Hz, 1H), 2.86 (m, 2H), 2.39 (m, 2H), 
2.27 (m, 4H), 2.06 (m, 1H), 1.88 (dd, J = 4.2, 14.4 Hz, 2H), 1.79 (m, 2H), 1.70 (m, 1H), 1.44 (m, 
5H), 0.89 (s, 3H). 
13C NMR (150 MHz, CDCl3) δ 169.9, 162.9 (d, J = 250.6 Hz), 148.4, 138.2, 137.8, 134.5 (d, J = 
8.1 Hz), 126.4, 121.5, 118.6, 117.7 (d, J = 3.5 Hz), 115.8 (d, J = 21.8 Hz), 85.9, 80.6, 77.9, 73.2, 
70.6, 49.9, 47.9, 43.6, 39.0, 38.9, 33.0, 29.5, 26.9, 26.2, 22.9, 21.1, 12.7. 
19F NMR (376 MHz, CDCl3) δ -108.6 (m, 1F). 
HRMS: m/z (ESI) Calculated for [M+H]+ 457.2179, Found 457.2186. 
 
 
1H NMR (400 MHz, CDCl3) δ 7.48 (dd, J = 5.2, 9.2 Hz, 2H), 7.01 (t, J = 8.0 Hz, 2H), 1.08 (s, 21 
H).  
13C NMR (100 MHz, CDCl3) δ 163.3 (d, J = 251.2 Hz), 135.1 (d, J = 9.1 Hz), 117. 0(d, J = 3.8 
Hz), 116.0 (d, J = 22.8 Hz), 89.6, 86.8, 75.4, 74.2, 67.3, 60.3, 18.5, 11.3. 
19F NMR (376 MHz, CDCl3) δ -107.4 (m, 1F). 
HRMS: m/z (ESI) Calculated for [M]+ 324.1710, Found 324.1715. 
 
  
F
34
TIPS
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4.3 Diazonium salt-triggered Au(I)/(III) redox cycle 
 
4.3.1 Introduction 
Gold redox catalysis has garnered much attention over the past several years with several 
examples of novel systems being reported.36 Inherent to these systems is a fast C-C reductive 
elimination from transient Au(III) species.  Interestingly, Au(III) catalysts also maintain similar 
reactivity to that of Au(I) if a productive reductive pathway is not available. Thus, harnessing the 
strength of Au(III) as a carbophilic Lewis-acid in accordance with novel redox reactivity offers 
more precise reaction control and greatly extends the scope of homogeneous gold catalysis.37 In 
this system, through a mild oxidation of Au(I), a more reactive Au(III) intermediate is formed in 
situ, which allows the activation of less reactive substrates such as alkenes or internal alkynes 
(challenging substrates for Au(I) catalysts). 38  In addition, Au(III) intermediates offer the 
possibility of rapid reductive elimination to form challenging C-C and C-X bonds.  The use of 
electrophilic diazonium as a substrate/oxidant permits an efficient catalytic cycle under mild 
conditions.  The utility of this new system is further demonstrated through a series of challenging 
dual functionalization reactions.   
As mentioned earlier, a major challenge in Au-redox catalysis is the mild and efficient 
oxidation of Au(I) to Au(III).  This is especially apparent in this dual activation approach as 
alkene/alkyne activation prior to oxidation is undesirable.  With the high oxidation potential of 
Au(I), strong oxidants, such as selectfluor or hypervalent iodide, are typically required for Au(I) 
oxidation (Figure 40A). The dependence on these strong oxidants also constricts substrate 
compatibility.  As an improvement, Glorius’ and Toste’s group have reported a photocatalytic 
diazonium decomposition for promoting gold redox chemistry under mild conditions. More 
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recently, Hashmi and co-workers further improved this protocol, achieving photocatalytic gold 
redox catalysis without the use of a photo-sensitizer (Figure 40B).39 These pioneering works 
have therefore established a solid foundation for the development of gold redox catalysis. 
 
 
Figure 40. Gold redox catalysis for p-system activation 
 
Over the past two years, our group has revealed a Lewis-base assisted diazonium activation 
as an alternative strategy to achieve gold oxidation and incorporation within catalytic protocol. 
The most important feature of our strategy is to achieve diazonium decomposition (towards gold 
oxidation) via a chemical activation pathway without photocatalyst or photo-sensitizer.40 It is 
important to note that photo-activation conditions are extremely high atom and chemical 
economy.  However, to achieve satisfactory results, strict exclusion of oxygen and moisture is 
usually required with long reaction time (>20 h).  More importantly, the dynamic range of 
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reaction conditions associated with chemical activation will permit access to challenging 
transformations that cannot be promoted through photo-activation approaches. Herein, we report 
the nucleophile assisted diazonium activation in promoting gold redox catalysis to achieve 
challenging alkene dual functionalization without using external promoters or visible light.41 
This reaction could be further extended to alkyne or allene activation with good chemo-, regio- 
and stereo-selectivity.  Importantly, compared with the alternative photo-activation conditions, 
this new strategy provided significantly improved reactivity, giving the desired products in good 
yields under mild conditions (Figure 40C). 
Our newly developed nucleophile-promoted diazonium activation for the oxidation of Au has 
two important features. First, coordinatively-saturated Au(I) complexes, such as PPh3AuCl, 
which are typically inert p-acids, could be successfully employed without preactivation for redox 
catalysis.  Thus, cationic Au(I) p-activation could be fully suppressed.  Another aspect is that the 
in-situ Au(III) species, generated from diazonum reduction, could be superior catalysts for p-
activation and operable intermediates for oxidative coupling.  To test this hypothesis, we 
evaluated the oxyarylation of alkene 1a under both photo-activation and chemical activation 
conditions. 
 
4.3.2 Alkene oxyarylation 
As shown in Table 13, no product 3a was observed without gold (entry 1), which confirmed 
the crucial role of the gold catalyst for this transformation. Under photo-activation conditions, 
solvent degassing was also crucial as described in previously reported optimal conditions (with 
or without photo-sensitizer).  Significantly low yields were observed without rigorous degassing 
(entries 2-3, yields in parenthesis).  Notably, methanol solvent was also extremely important in 
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the photo-activation conditions.  Switching solvent to acetonitrile gave much lower yield even 
with the optimal catalysts (entry 4).   
 
Table 13. Alkene oxyarylation by gold redox catalysis a, b 
 
Entry Reaction conditions time Conv. (1a) 3a 
1 No [Au], UVA or blue LED, MeOH 24 h <5% - 
2 10% (p-CF3C6H4)3PAuCl, degassed 
MeOH, hv, rt 
24 h 100% 63% 
(25%) 
3 
 
10% PPh3AuNTf2, 5% [Ru(bpy)3](PF6)2 
degassed MeOH, hv, rt 4 h 100% 
88% 
(35%) 
4 Same as entry 3 except in CH3CN 12 h 100% 20% 
5 10% PPh3AuCl, CH3CN, 60 oC 24 h <10% 0% 
6 
 
10% PPh3AuCl, 2 eq 3-Cl-Py, CH3CN, 
60 oC 
2 h 100% 83% 
7 Same as entry 6 except 2 eq NaHCO3 2 h 100% 78% 
  
aGeneral reaction conditions: 36a (0.2 mmol), [Au] (7 %), [Ru] (2.5 %), 37a (0.4 mmol), CH3CN 
(0.4 M), r.t. - 60 oC; bDetermined by 1H NMR using p-xylene as internal standard. 
 
In our initial investigations, both gold catalysts and nucleophiles were evaluated.  Following 
some condition modifications (see detailed screening in SI), PPh3AuCl and 3-Cl-pyridine were 
identified as the optimal choice, giving 38a in 83% yield even without degassed solvent and 
photo activation (entry 6).  However it was clear that either external nucleophile or base is 
critical for this reaction, as the desired product (38a) was not formed in the absence of 3-Cl-
pyridine (entry 5).  Additionally, the decomposition of gold was also evident over time.  
However, aryl phosphonium salt was detected as the major product through 31P NMR 
monitoring, suggesting the oxidation of Au(I) to Au(III) and subsequent reductive elimination 
for the P-C bond. We thus postulated that alcohol 1a might be an effective nucleophile toward 
diazonium activation, provided additional external base was present.  Some readily available 
[ArN2][BF4]
O Arcat. [Au]
Ar = p-F-C6H4-
OH
+
36a 37a 38a
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Brønsted bases were then applied to substitute 3-Cl-Py (see SI) with  NaHCO3 being identified 
as an effective base in promoting the reaction, giving 38a in 78% yield (entry 7).  These results 
were encouraging and strongly suggested that the synthetically appealing dual functionalization 
of alkenes could be achieved by simply using gold catalyst.  To validate the generality of this 
reaction, we evaluated both oxy- and aminoarylation with this chemical activation strategy.   
 
4.3.3 Substrates scope  
As shown in Table 14, this nucleophilic activation method worked well for both oxy- and 
aminoarylation.  Importantly, this chemical activation strategy generally gave better performance 
than the photo-activation approach.  In all cases, 5-exo cyclization of oxy-arylation occurred 
without 6-endo products observed.  Secondary alcohol also reacted well under this condition 
(38f), along with 1,2-disubstituted alkenes (38d, 38e).  Good diastereoselectivity was obtained, 
which was consistent with the proposed intramolecular hydroxyl trans-addition to a gold-
activated alkene (38d).  Impressively, the challenging 6- and 7-membered ring structures were 
successfully achieved through controlled exo-cyclization (38b, 38c) with good yields and 
regioselectivity (no endo products observed).  This result highlighted the unique advantage of 
this gold catalysis approach over traditional Lewis-acid activation systems (usually gave poor 
selectivity). In addition to amide and alcohol nucleophiles, carboxylic acid was also a suitable 
nucleophile for this transformation albeit with slightly reduced yields (38h-38j). Some sugar 
derivatives (38k, 38l) were expediently prepared using this approach, implying the good 
potential of this method for the preparation of chemically and biologically important 
frameworks. 
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Table 14. Photo-activation-free gold redox catalysisa, b 
 
a General reaction conditions: alkene (0.2 mmol), PPh3AuCl (7 %), 2 (0.4 mmol), NaHCO3 (0.4 mmol) in 
CH3CN (0.4 M), 60 oC, 2 h; b isolated yield; c Ar = p-Cl-C6H4; d 87% conversion; e 91% conversion. 
 
The aminoarylation also worked well under the chemical activation conditions, various 
pyrrolidine products were obtained in excellent yields (>90%, 39a-39c) under these mild 
conditions. Notably, no pretreatment of solvents (such as degassing) or Ar protection was 
needed. Sulfonyl-protected amino nucleophiles generally worked well under this condition (39d, 
39e) while Cbz protected amine was not an effective substrate (39f).  This likely suggested a 
critical balance of Nitrogen nucleophilicity for efficiency in the intermediate cyclization step.  
Furthermore, di-substituted alkene worked well under the optimal conditions (39g).  The reaction 
could also be applied to piperidine synthesis through 6-exo cyclization with high yield and 
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regioselectivity (39o, 39p), which demonstrated the utility of this method in the synthesis of 
nitrogen-containing heterocycles. Further extension to 7-exo cyclization gave significantly 
reduced reactivity. 
 
 
Figure 41. Arylative ring expansion 
 
The successful achievement of oxy- and amino-arylation demonstrated the significantly high 
efficiency of the chemical activation in promoting gold redox catalysis.  This approach was 
further applied to the arylative ring expansion reaction.  As shown in Figure 41, ring expansion 
of alkene 40a could not be achieved under laborious photo-activation conditions without the 
assistance of photocatalyst.  With the help of 2.5% Ru(bpy)3(PF6)2, ketone 41a was formed in 
good yield.  Through chemical activation, significantly higher yields were obtained with 
untreated acetonitrile as the solvent.  Some representative substrates are shown in Figure 41.  
Both electron-rich and electron-deficient diazonium could be utilized in this arylative ring 
expansion as an easy route towards functionalized cyclic ketones under mild conditions. 
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4.3.4 Arylative ring expansion 
Encouraged by these results, we directed our attention to the activation of other unsaturated 
molecules, with a focus on internal alkyne and substituted allenes.  Compared to alkenes, highly 
selective tandem nucleophilic-addition/cross-coupling reactions of alkynes are more challenging.  
A more pronounced issue arises as Au(I) cations can easily activate alkyne and allene leading to 
alternative hydrofunctionalization under non-anhydrous conditions.  Moreover, low selectivity 
for cross-coupling was also observed as competing homodimerization was associated with this 
process. Our in-situ Au(III) formation strategy may provide better control to overcome these 
problems.  More specifically, through chemical activation of diazonium salts and oxidation of 
Au(I) to Au(III), coordination to the p-system may only take place once an arylgold(III) species 
was formed.  Therefore, through nucleophilic addition and rapid reductive elimination, 
challenging alkyne di-functionalization should be achieved with good selectivity.  Based on this 
preliminary analysis, we first investigated the alkyne di-functionalization of propargyl ester. 
 
4.3.5 Activation of alkynes or allenes 
The gold-catalyzed propargyl acetate rearrangement was first reported by Zhang and 
coworkers in 2009 using Selectfluor as an external oxidant. This work was established as one of 
the seminal examples supporting the possibility of gold redox chemistry.  However, in their 
study, the competing formations of enones, enone dimers, and fluoroenones were observed due 
to proto-deauration, homo-coupling and fluorination side reactions.  As we proposed, by using 
our chemical activation conditions (7% PPh3AuCl and 2 equiv NaHCO3 in CH3CN, 1 h), the 
propargyl rearrangement was successfully achieved with a-arylenone as the only product (78% 
isolated yield, single E-isomer, Table 15).  
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Table 15. Chemoselectivity: activation of alkyne or allene over alkenea, b 
 
a General reaction conditions: alkyne or allene (0.2 mmol), PPh3AuCl (7 %), 2 (0.4 mmol), 
NaHCO3 (0.4 mmol) in CH3CN (0.4 M), 60 oC, 1 h. b isolated yield. 
 
Finally, we further extended this approach to the challenging cyclization of allenes, which 
are generally more reactive toward cationic Au(I) catalysts and often suffer from hydration 
pathways. 42  The absence of these non-productive pathways clearly demonstrates the high 
efficiency of this chemical activation strategy.  
Various alkyne and allene substrates were then prepared to investigate the reaction scope.  
Good yields and excellent stereoselectivity were obtained for the propargyl ester rearrangement 
with only E-isomer formed in all cases. Aromatic and aliphatic substituted alkynes  (R2 position) 
were both tolerated, giving the desired enone products.   For the substituents at the propargyl 
position (R1 position), aryl and alkyl groups were both compatible, highlighting the broad 
substrate scope of this method.   
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Similar excellent reaction scope was obtained for the allene cyclization.  With amine 
nucleophiles, various aryl diazonium salts were applied.  Electron-deficient substituents 
generally gave better reactivity as reported in literature.  Notably, both aryl iodine (44c) and 
lactone (44f) were suitable, which highlighted the mild conditions and potential application of 
this method.  Oxygen nucleophiles were also employed as successful substrates to give the final 
cyclization-coupling products.  In contrast to alkene substrates where 5-exo oxy- or 
aminoarylation were dominant, 6-endo cyclization was primarily obtained in the case of allene 
substrates. 
 
4.3.6 Mechanistic insight 
To gain some mechanistic insight, kinetic investigations were performed as shown in Figure 
42. 
 
Figure 42. Reaction kinetic profiles with different gold catalysts 
 
In order to generate a stable Au(III) intermediate, a modified diazonium (ArN2Cl) was used 
to react with PPh3AuCl to generate a coordinatively-saturated Au(III) complex A based on 
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literature procedure.  Stoichiometric reaction of complex A with alkene 1a (without diazonium) 
under the otherwise identical conditions gave desired product 3a in quantitative yield, indicating 
that Au(III) species should be involved in the catalytic cycle.  Kinetic studies were then 
performed for reactions between 36a and diazonium 37a with electronically varied gold 
catalysts.  A difference in reaction kinetics was observed for different primary ligands with the 
order of reactivity: (p-Me-C6H4)3PAuCl > PPh3AuCl > (p-CF3-C6H4)3PAuCl, which suggested a 
critical role of the phosphine in the oxidation step (electron rich ligand favoring oxidation).  A 
clear induction period was also observed with the PPh3AuCl catalyzed reaction suggesting the 
formation of a new species in the catalytic cycle.  The stable Au(III) complex A could also 
catalyze the reaction with very similar reaction kinetics as PPh3AuCl.  This result strongly 
supported the proposed gold(III) intermediate as the key intermediate in the catalytic cycle.  
Interestingly, PPh3AuNTf2 catalyst offered a much slower reaction rate relative to PPh3AuCl, 
suggesting that the Cl anion was also crucial in the success of this reaction.  Furthermore, using 
DMSAuCl as catalyst gave the same cyclization product 38a albeit with lower yield (43% yield, 
81% 36a conversion), likely caused by fast gold decomposition.  Both results supported the 
dissociation of PPh3 ligand during the reaction process.  Comprehensive mechanistic 
investigations are currently ongoing within our group. 
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4.3.7 Summary and conclusion 
 
 
Figure 43. Gold(I/III) redox catalysis summary 
 
In summary, we report herein the chemical activation of diazonium in promoting gold redox 
catalysis under mild conditions. Dual functionalization of unactivated alkenes, internal alkynes 
and allenes was achieved through gold redox catalysis without using sacrificial oxidants or 
photocatalysts.  Key to the success of these reactions is a Lewis base assisted diazonium 
activation leading to gold(III) complexes, which serve as both a p-acid catalyst and an effective 
intermediate for reductive elimination.  Compared with previously reported gold redox catalysis 
using either strong external oxidants or photocatalysts, this strategy gave higher efficiency and 
improved reactivity under significantly simplified conditions. 
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4.3.8 Experimental data 
 
I. General Methods and Materials 
All of the reactions dealing with air and/or moisture-sensitive reactions were carried out 
under an atmosphere of nitrogen using oven/flame-dried glassware. Unless otherwise noted, all 
commercial reagents and solvents were obtained from the commercial provider and used without 
further purification. PPh3AuCl, PPh3AuNTf2 were synthesized according to literature reports 
Analytical thin layer chromatography was performed with pre-coated, glass-baked plates (250µ) 
and visualized by fluorescence or charring with potassium permanganate stain. Flash column 
chromatography was performed on 230-430 mesh silica gel. 1H NMR, 13C NMR and 19F NMR 
spectra were recorded on Agilent 400 MHz or Varian 500 MHz spectrometers. Chemical shifts 
were reported relative to internal tetramethylsilane (δ 0.00 ppm) or CDCl3 (δ 7.26 ppm) for 1H, 
CDCl3 (δ 77.0 ppm) for 13C and CFCl3 (δ 0.00 ppm) for 19F. Data are presented as follows: 
chemical shift (ppm), multiplicity (s = singlet, d = doublet, t =triplet, dd = doublet of doublets, m 
= multiplet, br = broad), coupling constant J(Hz) and integration. ESI-MS spectra were collected 
using a Thermo Scientific Orbitrap Q Extractive Plus (Bremen, Germany) in the positive ion 
mode. The samples were infused with a flow rate of 10 µL/min and sprayed at a high voltage of 
5 kV.  
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II. General Procedures  
A. Procedure for synthesizing alkenol substrates. 
The alkenol (36a-36g) and alkene acid (36h-36j) substrates are commercial available and 
purchased from Aldrich and TCI companies. The sugar substrates (36k-36l) were synthesized 
according to a previously reported literature procedure. 
 
B. General procedure of conditions for Au(I) catalyzed Oxy-arylation of alkene 
        
In a dried glass tube, 36 (0.1 mmol), [Au] (0.01 mmol, 7 mol %), aryl diazonium 37 (0.2 
mmol, 2 equiv) and additive (0.2 mmol, 2 equiv) were dissolved in CH3CN (0.3 mL). The 
reaction mixture was stirred at 60 oC for 1-12 h. After the reaction completed, the reaction was 
filtered through a pad of silica gel. After evacuation of the solvents, the NMR yields were 
obtained by 1H NMR analysis of the crude mixture with p-xylene as the internal standard. The 
results are summarized in Table S1. 
 
 
 
 
 
 
 
[ArN2][BF4]
O Ar [Au]
Ar = p-F-C6H4-
OH
+
36 37 38
Additive (2 equiv)
CH3CN, 60 oC2 eq
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Table S1. Comprehensive screening of conditions 
Entry Catalyst (mol%) Add. (equiv) T (oC) t (h) Conv.(%) 38(%)a, b 
1 None None 60 12 <5 0 
2 PPh3AuCl (10) None 60 12 <5 0 
3 PPh3AuCl (10) 3-Cl-Py (2) 70 12 81 59c 
4 PPh3AuCl (10) NaHCO3 (2) 60 3 100 78 
5 PPh3AuCl (10), no light  NaHCO3 (2) 60 3 100 75 
6 PPh3AuCl (10) Na2CO3 (2) 60 12 90 59 
7 PPh3AuCl (10) K2CO3 (2) 60 12 87 57 
8 PPh3AuCl (10) K3PO4 (2) 60 12 80 43 
9 PPh3AuCl (10) NaOAc (2) 60 12 60 37 
10 PPh3AuCl (10) KOAc (2) 60 12 53 36 
11 PPh3AuCl (10) NaHCO3 (2) 50 5 50 39 
12 (p-Me-C6H4)3PAuCl (10) NaHCO3 (2) 60 3 100 77 
13 (p-F-C6H4)3PAuCl (10) NaHCO3 (2) 60  3 100 75 
14 (p-CF3-C6H4)3PAuCl 
(10) 
NaHCO3 (2) 60 5 93 65 
15 Ph3PAuNTf2 (10) NaHCO3 (2) 60 5 76 35 
16 DMSAuCl (10) NaHCO3 (2) 60 8 83 45 
17 PPh3AuCl (7) NaHCO3 (2) 60 3 100 78 
18 (p-CF3-C6H4)3PAuCl 
(10) 
none r.t. in 
MeOH 
24 70 30 
a Reaction conditions: 36 (0.1 mmol), Au (10 mol%), aryl diaoznium 37 (0.2 mmol),  additives 
(0.2 mmol) and solvent (0.33 M); b Determined by 1H NMR using p-xylene as internal standard; c 
The major byproduct is biaryl.  
 
 
C. Procedure for synthesizing amino-alkene substrates. 
The amino-alkene substrates were synthesized according to a previously reported literature 
procedure. 
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D. General procedure of conditions for Au(I) catalyzed Amino-arylation of alkene 
 
In a dried glass tube, 36a’ (0.1 mmol), [Au] (0.007 mmol,  7 mol %), aryl diazonium 37 (0.2 
mmol, 2 equiv) and additive (0.2 mmol, 2 equiv) were dissolved in CH3CN (0.3 mL). The 
reaction mixture was stirred at 60 oC for 1-12 h. After the reaction completed, the reaction was 
filtered through a pad of silica gel. After evacuation of the solvents, the NMR yields were 
obtained by 1H NMR analysis of the crude mixture with p-xylene the internal standard. The 
results were summarized in Table S2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ts
N Ar [Au]
Additive (2 equiv)
CH3CN, 60 oC
NHTs
+ [ArN2][BF4]
Ar = p-F-C6H4-
39a3736a'
2 eq
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Table S2. Comprehensive screening of conditions 
Entry Catalyst (mol%) Add. (equiv) T (oC) t (h) Conv.(%) 39a(%)a
, b 
1 None None 60 12 <5 0 
2 PPh3AuCl (10) None 60 12 <5 0 
3 PPh3AuCl (10) 3-Cl-Py (2) 60 12 60 35c 
4 PPh3AuCl (10) NaHCO3 (2) 60 3 100 91 
5 PPh3AuCl (10), no light  NaHCO3 (2) 60 3 100 90 
6 PPh3AuCl (10) Na2CO3 (2) 60 12 85 39 
7 PPh3AuCl (10) K2CO3 (2) 60 12 83 55 
8 PPh3AuCl (10) K3PO4 (2) 60 12 70 53 
9 PPh3AuCl (10) NaOAc (2) 60 12 50 34 
10 PPh3AuCl (10) KOAc (2) 60 12 73 46 
11 PPh3AuCl (10) NaHCO3 (2) 60 in Tol 12 <10 <5 
12 PPh3AuCl (10) NaHCO3 (2) 60 in DCE 12 69 30 
13 PPh3AuCl (10) NaHCO3 (2) 50 5 50 35 
14 (p-Me-C6H4)3PAuCl (10) NaHCO3 (2) 60 3 100 90 
15 (p-F-C6H4)3PAuCl (10) NaHCO3 (2) 60  3 100 80 
16 (p-CF3-C6H4)3PAuCl (10) NaHCO3 (2) 60 5 75 35 
17 Et3PAuCl (10) NaHCO3 (2) 60 3 100 75 
18 Ph3PAuCl (7) NaHCO3 (2) 60 3 100 90 
19 Ph3PAuCl (5) NaHCO3 (2) 60 7 92 81 
20 (p-CF3-C6H4)3PAuCl (10) None r.t. in MeOH 24 70 30 
a Reaction conditions: 36a’ (0.1 mmol), Au (10 mol%), aryl diaoznium 37a (0.2 mmol),  
additives (0.2 mmol) and solvent (0.33M); b Determined by 1H NMR using p-xylene as internal 
standard; c The major byproduct is biaryl. 
E. General procedure for Au(I) catalyzed Amino/Oxy-arylation of alkenes 
 
In a dried glass tube, alkenes (0.2 mmol, 1 equiv), PPh3AuCl (0.014 mmol, 7 mol%), aryl 
diazonium (0.4 mmol, 2 equiv) and NaHCO3 (0.4 mmol, 2 equiv) were dissolved in CH3CN (0.6 
mL). The reaction mixture was stirred at 60 oC for 1-3 h. After the reaction completed, the 
reaction mixture was directly submitted to flash column chromatography for purification and 
yield determination (5-8:1 Hexanes: Ethyl Acetate as eluent).  
 
F. Procedure for synthesizing cyclobutanol substrates 
The cyclobutanol substrates were synthesized according to a previously reported literature 
procedure. 
 
G. General procedure for Au(I) catalyzed cyclobutanol ring expansion and coupling 
 
In a dried glass tube, allene (0.2 mmol, 1 equiv), PPh3AuCl (0.014 mmol, 7 mol %), aryl 
diazonium (0.4 mmol, 2 equiv) and NaHCO3 (0.4 mmol, 2 equiv) were dissolved in CH3CN (0.6 
mL). The reaction mixture was stirred at 60 oC for 1-3 h. After the reaction completed, the 
reaction mixture was directly submitted to flash column chromatography for purification and 
yield determination (10-15:1 Hexanes: Ethyl Acetate as eluent). 
 
X Ar7% Ph3PAuCl
NaHCO3 (2 equiv)
CH3CN, 60 oC
XH
R
n
+  ArN2BF4
R nAr = p-F-C6H4-
2 eq
2 eq
7% Ph3PAuCl
NaHCO3 (2 equiv)
CH3CN, 60 oC
+ ArN2BF4
Ar = p-F-C6H4-
OH O
Ar
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H. Procedure for synthesizing allene substrates. 
The allene substrates are commercial available and purchased from Aldrich company. 
 
I. General procedure for Au(I) catalyzed allene cylcization 
 
In a dried glass tube, allene (0.2 mmol, 1 equiv), PPh3AuCl (0.014 mmol, 7 mol %), aryl 
diazonium (0.4 mmol, 2 equiv) and NaHCO3 (0.4 mmol, 2 equiv) were dissolved in CH3CN (0.6 
mL). The reaction mixture was stirred at 50 oC for 1-3 h. After the reaction completed, the 
reaction mixture was directly submitted to flash column chromatography for purification and 
yield determination (5-8:1 Hexanes: Ethyl Acetate as eluent). 
 
J. Procedure for synthesizing propargyl esters. 
The propargyl esters substrates were synthesized according to a previously reported literature 
procedure. 
 
K. General procedure for Au(I) catalyzed propargyl rearrangement and coupling 
 
In a dried glass tube, propargyl acetate (0.2 mmol, 1 equiv), PPh3AuCl (0.014 mmol, 7 mol 
%), aryl diazonium (0.4 mmol, 2 equiv) and NaHCO3 (0.4 mmol, 2 equiv) were dissolved in 
CH3CN (0.6 mL). The reaction mixture was stirred at 60 oC for 1-3 h. After the reaction 
2 eq
7% Ph3PAuCl
NaHCO3 (2 equiv)
CH3CN, 50 oC
+ ArN2BF4
Ar = p-F-C6H4-
XH
X
Ar
X = NTs, O
2 eq
7% Ph3PAuCl
NaHCO3 (2 equiv)
CH3CN, 60 oC
+ ArN2BF4
Ar = p-F-C6H4-
R1
OAc
R2
R1
H
R2
Ar
O
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completed, the reaction mixture was directly submitted to flash column chromatography for 
purification and yield determination (6-10:1 Hexanes: Ethyl Acetate as eluent). 
 
 
 
III.  Mechanism Study 
 
A) 31P NMR for PPh3AuCl catalyzed Oxy-arylation 
In a dried glass tube, 36a (0.1 mmol, 1 equiv), 37a (0.2 mmol, 2 equiv), PPh3AuCl (0.01 
mmol, 10 mol%), and NaHCO3 (0.2 mmol, 2 equiv) were dissolved in CD3CN (0.3 mL). The 
reaction mixture was stirred at 60 oC for 3h. Through 31P NMR kinetic study, the formation of 
different phosphine species could be observed via 31P NMR. Results are shown in Figure S1.  
 
[ArN2][BF4]
O Arcat. [Au]
Ar = p-F-C6H4-
OH
+
36a 37a 38a
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Figure S1. 31P NMR of PPh3AuCl catalyzed oxy-arylation of alkene 
 
 
B) 31P NMR for stoichiometric reaction in d6-DMSO 
In a dried glass tube, 37a-Cl (0.03 mmol, 1 equiv) and PPh3AuCl (0.03 mmol, 1 equiv) were 
dissolved in d6-DMSO (0.3 mL). The reaction mixture was stirred at 50 oC for 2 hours to 
generate Au(III) species, which was monitored by 31P NMR. Alkene 36a (0.3 mmol), NaHCO3 
(2 equiv) and AgBF4 (1 equiv) were later added to the reaction mixture, and stirred for another 2 
hours at 60 oC. 31P NMR was applied to monitor the reaction, and the results are shown in Figure 
S2.  
34 32 30 28 26 24 22 20
F
PPh3
CH3CN, 50 oC, 24 h
no reaction
e) 37a + PPh3AuCl + 36a + 3-Cl-Py
d) 37a + PPh3AuCl + 36a + NaHCO3
b) 37a + PPh3AuCl + 36a
c) 37a + PPh3AuCl + 36a + NaHCO3
3 hour
3 hour
31P NMRa) 37a + PPh3AuCl
1 hour
37a : [Ar][N2BF4]
36a OH
10 hour Ar-PPh3
Ar-PPh3
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Figure S2. 31P NMR for stoichiometric reaction in d6-DMSO 
 
C) 31P NMR for stoichiometric reaction in CD3CN 
In a dried glass tube, 37a-Cl (0.03 mmol, 1 equiv) and PPh3AuCl (0.03 mmol, 1 equiv) were 
dissolved in CD3CN (0.3 mL). The reaction mixture was stirred at 50 oC for 2 hours to generate 
Au(III) species, which was monitored by 31P NMR. Alkene 36a (0.3 mmol), NaHCO3 (2 equiv) 
and AgBF4 (1 equiv) were later added to the reaction mixture, and stirred for another 2 hours at 
60 oC. 31P NMR was applied to monitor the reaction, and the results are shown in Figure S3.   
 
Figure S3. 31P NMR for stoichiometric reaction in CD3CN 
Au(III)
a) Au(III) + 36a (1 equiv)
PPh3AuCl Ar-PPh3
O2N
N2Cl
PPh3AuCl DMSO
50 oC
Au Cl
PPh3
Cl
O2N
OH
Au(III)
d6-DMSO, 60 oC
b) Au(III) + 36a (10 equiv)
c) Au(III) + 36a (10 equiv)
NaHCO3
with AgBF4, 2 h
without AgBF4, 2 h
with AgBF4, 2 h
36a
37a-Cl
Au(III)
a) Au(III) + 37a (10 equiv)
PPh3AuCl Ar-PHPh3
O2N
N2Cl
PPh3AuCl CD3CN
50 oC
Au Cl
PPh3
Cl
O2N
OH
Au(III)
CD3CN, 60 oC
b) Au(III) + 37a (10 equiv)
NaHCO3
with AgBF4, 2 h
without AgBF4, 2 h
36a
37a-Cl
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D). Kinetic study for Oxy-arylation of alkene with various gold catalysts 
General procedure for gold catalyzed oxy-arylation: In a dried glass tube, 37a (0.2 mmol, 1 
equiv), 36a (0.4 mmol, 2 equiv), catalyst (0.02 mmol, 10 mol%) and NaHCO3 (0.4 mmol, 2 
equiv) were dissolved in CD3CN (0.6 mL). The reaction mixture was stirred at 60 oC. Through 
direct 1H NMR monitoring at different time periods, the corresponding 1H NMR yield was 
collected with p-xylene as internal standard. The results were shown in Figure S4.  
 
Figure S4. Gold catalyzed oxy-arylation of alkene with diazonium 
Ph3PAuCl
pregen. Au(III)
Ph3PAuNTf2
(p-Me-C6H4)3PAuCl
(p-CF3-C6H4)3PAuCl
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IV. Comparison of Gold Catalysis with Photosensitizer Free Conditions 
General procedure for gold catalysis: In a dried glass tube, alkene (0.1 mmol, 1 equiv), 
PPh3AuCl (0.010 mmol, 10 mol %), aryl diazonium (0.2 mmol, 2 equiv) and NaHCO3 (0.2 
mmol, 2 equiv) were dissolved in CH3CN (0.3 mL). The reaction mixture was stirred at 60 oC for 
3 h. Upon reaction completion, the crude mixture was filtered through a pad of silica gel. After 
evacuation of the solvents, the NMR yields were obtained by 1H NMR analysis of the crude 
mixture using p-xylene as internal standard.  
General procedure for photosensitizer-free gold catalysis: A Pyrex tube was charged with 
alkene (0.1 mmol, 1 equiv), (4-CF3-C6H4)3PAuCl (0.010 mmol, 10 mol %) and aryl diazonium 
(0.4 mmol, 4 equiv) in MeOH (0.3 mL) under N2 atmosphere. The reaction mixture was 
degassed using Freeze-Pump-Thaw methods for three cycles. The tube was sealed with a screw 
cap and placed under the 12 W Blue LEDs photo-reactor for 24 h.  The reaction was then filtered 
through a pad of silica gel. After evacuation of the solvents, the NMR yields were obtained by 
1H NMR analysis of the crude mixture using p-xylene as the internal standard.  
 
Figure S7. Comparison for oxy-arylation of alkenes 
 
Conditions
PPh3AuCl + 3-Cl-Py in CH3CN, 70 oC
PPh3AuCl + NaHCO3 in CH3CN, 60 oC
(p-CF3-C6H4)3PAuCl in MeOH, hv, r.t.
Time(h)
3 h
3 h
24 h
Yield(%)
83
78
63
O Ar10% [Au]
OH
+ [ArN2][BF4]
Ar = p-F-C6H4-
Conv.(%)
100
100
100
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Figure S8. Comparison for amino-arylation of alkenes 
 
Figure S9. Comparison for allene cyclization 
 
Figure S10. Comparison for ring-expansion 
 
 
Figure S11. Comparison for propargyl rearrangement  
Conditions
PPh3AuCl + 3-Cl-Py in CH3CN, 70 oC
PPh3AuCl + NaHCO3 in CH3CN, 60 oC
(p-CF3-C6H4)3PAuCl in MeOH, hv, r.t.
Time(h)
12 h
3 h
24 h
Yield(%)
35
85
30
Ts
N Ar10% [Au]
NHTs
+ [ArN2][BF4]
Ar = p-F-C6H4-
Conv.(%)
60
100
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Conditions
PPh3AuCl + 3-Cl-Py in CH3CN, 70 oC
PPh3AuCl + NaHCO3 in CH3CN, 60 oC
(p-CF3-C6H4)3PAuCl in MeOH, hv, r.t.
Time(h)
3 h
2 h
24 h
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51
83
<10
10% [Au]+ [ArN2][BF4]
Ar = p-F-C6H4-
Conv.(%)
100
100
100
NHTs
Nu
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Conditions
PPh3AuCl + 3-Cl-Py in CH3CN, 70 oC
PPh3AuCl + NaHCO3 in CH3CN, 60 oC
(p-CF3-C6H4)3PAuCl in MeOH, hv, r.t.
Time(h)
3 h
2 h
24 h
Yield(%)
51
83
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10% [Au]+ [ArN2][BF4]
Ar = p-F-C6H4-
Conv.(%)
100
100
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O
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OAc
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Conditions
PPh3AuCl + 3-Cl-Py in CH3CN, 70 oC
PPh3AuCl + NaHCO3 in CH3CN, 60 oC
(p-CF3-C6H4)3PAuCl in MeOH, hv, r.t.
Time(h)
3 h
2 h
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V. Compounds Characterization 
 
Compounds 38a,[1] and 38g,[2] were reported in literatures. 
38a 
1H NMR (300 MHz, CDCl3): δ 7.19 (dd, J = 8.4, 5.6 Hz, 2H), 6.98 (t, J = 8.7 Hz, 2H), 4.04 (m, 
1H), 3.88 (m, 1H), 3.74 (dd, J = 14.3, 7.7 Hz, 1H), 2.87 (dd, J = 13.8, 6.7 Hz, 1H), 2.74 (dd, J = 
13.8, 6.0 Hz, 1H), 1.89 (m, 3H), 1.59 (m, 1H).  
13C NMR (75 MHz, CDCl3): δ 161.5 (d, J = 244 Hz), 134.6 (d, J = 3 Hz), 131.6 (d, J = 8 Hz), 
115.0 (d, J = 21 Hz), 79.9 (d, J = 1 Hz), 67.9, 41.0, 30.9, 25.6.  
19F NMR (400 MHz, CDCl3): δ -117.9.  
 
38b 
1H NMR (500 MHz, CDCl3): δ 7.16 (dd, J = 6.0, 9.0 Hz, 2H), 6.96 (t, J = 9.0 Hz, 2H), 3.96 
(dddd, J = 2.0, 4.0, 12.0 Hz, 1H), 3.44 (dddd, J = 2.0, 6.5, 12.5 Hz, 1H), 3.40 (ddd, J = 2.5, 12.0 
Hz, 1H), 2.81 (dd, J = 7.0, 14.0 Hz, 1H), 2.62 (dd, J = 6.0, 13.5 Hz, 1H), 1.81 (m, 1H), 1.49 (m, 
4H), 1.27 (m, 1H).  
13C NMR (125 MHz, CDCl3): δ 161.4 (d, J = 242.4 Hz), 134.4, 130.6 (d, J = 7.5 Hz), 114.9 (d, J 
= 20.9 Hz), 78.6 (d, J = 1.4 Hz), 68.6, 42.2, 31.4, 26.0, 23.4.  
																																																								
8	B.	Sahoo,	M.	N.	Hopkinson,	F.	Glorius,	J.	Am.	Chem.	Soc.	2013,	135,	5505.	
9	D.	A.	Hamilton,	D.	A.	Nicewicz,	J.	Am.	Chem.	Soc.	2012,	134,	18577.	
O
F
O
F
			 159	
19F NMR (400 MHz, CDCl3): δ -118.0.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 217.1005, Found 217.1042.  
 
38c 
1H NMR (500 MHz, CDCl3): δ 7.16 (dd, J = 5.5, 8.5 Hz, 2H), 6.96 (t, J = 8.5 Hz, 2H), 3.81 (m, 
1H), 3.65 (m, 1H), 3.45 (ddd, J = 4.0, 8.0, 11.5 Hz, 1H), 2.79 (dd, J = 7.0, 13.5 Hz, 1H), 2.61 
(dd, J = 5.5, 13.5 Hz, 1H), 1.74 (m, 3H), 1.63 (m, 3H), 1.47 (m, 2H). 13C NMR (125 MHz, 
CDCl3): δ 161.4 (d, J = 241.9 Hz), 135.2 (d, J = 3.3 Hz), 130.6 (d, J = 7.6 Hz), 114.9 (d, J = 20.9 
Hz), 80.5 (d, J = 1.5 Hz), 68.4, 42.2, 35.3, 31.0, 26.6, 25.8. 19F NMR (400 MHz, CDCl3): δ -
118.2. HRMS: m/z (ESI) Calculated for [M+Na]+ 231.1161, Found 231.1169. 
 
38d 
1H NMR (500 MHz, CDCl3): δ 7.17 (dd, J = 6.0, 9.0 Hz, 2H), 6.98 (t, J = 9.0 Hz, 2H), 4.00 
(ddd, J = 1.0, 7.5 Hz, 1H), 3.73 (m, 1H), 3.65 (m, 1H), 2.49 (ddd, J = 2.0, 4.5, 11.0 Hz, 1H), 1.96 
(m, 1H), 1.72 (m, 4H), 1.51 (m, 1H) 0.75 (t, J = 7.0 Hz, 3H).  
13C NMR (125 MHz, CDCl3): δ 161.5 (d, J = 242.0 Hz), 138.1 (d, J = 3.4 Hz), 130.0 (d, J = 7.6 
Hz), 114.9 (d, J = 20.5 Hz), 82.6 (d, J = 0.9 Hz), 68.0, 52.1, 29.8, 25.8, 25.7, 12.0.  
19F NMR (400 MHz, CDCl3): δ -117.9.   
HRMS: m/z (ESI) Calculated for [M+Na]+ 231.1161, Found 231.1154. 
 
O F
O
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38e 
dr: 1:1 
diastereoisomer 1: 1H NMR (500 MHz, CDCl3): δ 7.18 (dd, J = 5.5, 8.0 Hz, 2H), 6.96 (t, J = 8.5 
Hz, 2H), 4.03 (m, 1H), 3.97 (m, 1H), 2.90 (dd, J = 6.0, 13.5 Hz, 1H), 2.72 (dd, J = 6.5, 13.5 Hz, 
1H), 1.92 (m, 2H), 1.59 (m, 1H), 1.41 (m, 1H), 1.23 (d, J = 6.0 Hz, 3H). 13C NMR (125 MHz, 
CDCl3): δ 161.5 (d, J = 242.4 Hz), 134.5 (d, J = 3.3 Hz), 130.6 (d, J = 7.1 Hz), 114.9 (d, J = 21.4 
Hz), 79.9 (d, J = 2.0 Hz), 75.5, 41.6, 32.7, 30.7, 21.4. 19F NMR (400 MHz, CDCl3): δ -117.9. 
HRMS: m/z (ESI) Calculated for [M+H]+ 238.9708, Found 238.9688. 
 diastereoisomer 2: 1H NMR (500 MHz, CDCl3): δ 7.16 (dd, J = 5.5, 8.5 Hz, 2H), 6.96 (t, J = 
8.5 Hz, 2H), 4.21 (m, 1H), 4.11 (m, 1H), 2.88 (dd, J = 6.0, 13.5 Hz, 1H), 2.68 (dd, J = 6.0, 13.5 
Hz, 1H), 1.91 (m, 2H), 1.59 (m, 1H), 1.43 (m, 1H), 1.21 (d, J = 6.5 Hz, 3H). 13C NMR (125 
MHz, CDCl3): δ 161.5 (d, J = 242.4 Hz), 134.4 (d, J = 2.9 Hz), 130.7 (d, J = 8.1 Hz), 115.0 (d, J 
= 20.9 Hz), 79.3 (d, J = 2.0 Hz), 74.9, 41.3, 33.7, 31.7, 21.3. 19F NMR (400 MHz, CDCl3): δ -
117.9.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 217.1005, Found 217.1044.  
 
 38f 
dr: 3.5:1 
major: 1H NMR (500 MHz, CDCl3): δ 7.17 (dd, J = 5.5, 8.5 Hz, 2H), 6.97 (t, J = 8.5 Hz, 2H), 
3.87 (dd, J = 8.0, 14.5 Hz, 1H), 3.83 (t, J = 6.5 Hz, 1H), 3.76 (dt, J = 1.5, 7.5 Hz, 1H), 2.75 (m, 
1H), 1.77 (m, 2H), 1.67 (m, 2H), 1.33 (d, J = 7.0 Hz, 3H).  
O F
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13C NMR (125 MHz, CDCl3): δ 161.4 (d, J = 242.4 Hz), 140.2 (d, J = 3.3 Hz), 129.1 (d, J = 7.6 
Hz), 114.9 (d, J = 20.9 Hz), 83.9 (d, J = 0.9 Hz), 68.1, 49.8, 32.3, 26.5, 18.6.  
19F NMR (400 MHz, CDCl3): δ -117.6. 
minor: 1H NMR (500 MHz, CDCl3): δ 7.12 (dd, J = 5.5, 9.0 Hz, 2H), 6.98 (t, J = 9.0 Hz, 2H), 
4.00 (dddd, J = 2.0, 4.0, 11.5 Hz, 1H), 3.55 (dt, J = 2.5, 12.0 Hz, 1H), 3.47 (m 1H), 2.38 (ddd, J 
= 4.0, 10.0, 11.5 Hz, 1H), 1.93 (m, 1H), 1.77 (m, 2H), 1.42 (m, 1H), 0.96 (d, J = 6.5 Hz, 3H).  
13C NMR (125 MHz, CDCl3): δ 161.5 (d, J = 242.9 Hz), 139.4 (d, J = 3.4 Hz), 128.9(d, J = 8.0 
Hz), 115.2 (d, J = 20.9 Hz), 78.3 (d, J = 2.0 Hz), 68.1, 44.4, 29.7, 25.7, 20.0.  
19F NMR (400 MHz, CDCl3): δ -117.6.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 217.1005, Found 217.1040. 
 
 38g 
1H NMR (400 MHz, CDCl3) δ 7.20 (d, J = 8.5 Hz, 2H), 7.11 (d, J = 8.4 Hz, 2H), 4.15 (dddd, J = 
9.0, 6.4 Hz, 1H), 3.48 (d, J = 8.1 Hz, 1H), 3.40 (d, J = 8.1 Hz, 1H), 2.83 (dd, J = 13.7, 6.9 Hz, 
1H), 2.69 (dd, J = 13.7, 5.9 Hz, 1H), 1.68 (dd, J = 12.2, 6.4 Hz, 1H), 1.36 (dd, J = 12.3, 9.1 Hz, 
1H), 1.03 (s, 3H), 1.02 (s, 3H). 13C NMR (100 MHz, CDCl3) δ 137.42, 131.98, 130.54, 128.38, 
80.14, 79.79, 46.49, 41.77, 39.59, 26.80, 26.51. 
 
 38h 
O
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O
O
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1H NMR (500 MHz, CDCl3): δ 7.20 (dd, J = 5.5, 8.5 Hz, 2H), 7.01 (t, J = 8.5 Hz, 2H), 4.70 (m, 
J = 6.5 Hz, 1H), 3.02 (dd, J = 6.0, 14.0 Hz, 1H), 2.93 (dd, J = 6.0, 14.0 Hz, 1H), 2.47 (m, 1H), 
2.39 (ddd, J = 5.0 Hz, 1H), 2.27 (dddd, J = 4.5, 7.0, 9.5 Hz, 1H), 1.93 (m, 1H).  
13C NMR (125 MHz, CDCl3): δ 176.9, 161.9 (d, J = 243.9 Hz), 131.6 (d, J = 3.4 Hz), 130.9 (d, J 
= 8.0 Hz), 115.4 (d, J = 21.4 Hz), 80.6, 40.5, 28.6, 27.1.  
19F NMR (400 MHz, CDCl3): δ -116.3.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 217.0641, Found 217.0650. 
 
 38i 
1H NMR (500 MHz, CDCl3): δ 7.20 (dd, J = 5.5, 8.5 Hz, 2H), 7.00 (t, J = 8.5 Hz, 2H), 4.60 (m, 
1H), 3.04 (dd, J = 7.0, 14.5 Hz, 1H), 2.88 (dd, J = 6.0, 14.0 Hz, 1H), 2.09 (dd, J = 5.5, 12.5 Hz, 
1H), 1.80 (dd, J = 10.5, 13.0 Hz, 1H), 1.24 (s, 6H).  
13C NMR (125 MHz, CDCl3): δ 181.6, 161.9 (d, J = 243.9 Hz), 131.9 (d, J = 3.3 Hz), 130.8 (d, J 
= 8.0 Hz), 115.4 (d, J = 20.9 Hz), 42.8, 40.7, 40.4, 24.9, 24.4.  
19F NMR (400 MHz, CDCl3): δ -117.9.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 245.0954, Found 245.0947. 
 
 38j 
dr: 1:1 
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diastereoisomer 1: 1H NMR (500 MHz, CDCl3): δ 7.19 (dd, J = 5.5, 8.5 Hz, 2H), 7.00 (t, J = 8.5 
Hz, 2H), 4.72 (m, 1H), 2.97 (dd, J = 6.0, 14.0 Hz, 1H), 2.90 (dd, J = 5.5, 14.0 Hz, 1H), 2.43 (m, 
1H), 2.19 (dd, J = 5.0, 9.5 Hz, 1H), 1.96 (dt, J = 8.0, 12.5 Hz, 1H), 1.24 (d, J = 2.5 Hz, 3H).  
13C NMR (125 MHz, CDCl3): δ 179.2, 161.9 (d, J = 243.9 Hz), 131.7 (d, J = 3.3 Hz), 130.8 (d, J 
= 8.0 Hz), 115.4(d, J = 23.9 Hz), 78.5 (d, J = 1.5 Hz), 40.5, 36.8, 33.9, 15.0. 
19F NMR (400 MHz, CDCl3): δ -116.2.  
diastereoisomer 2: 1H NMR (500 MHz, CDCl3): δ 7.19 (dd, J = 5.5, 8.5 Hz, 2H), 7.00 (t, J = 8.5 
Hz, 2H), 4.52 (m, 1H), 3.05 (dd, J = 7.0, 15.0 Hz, 1H), 2.88 (dd, J = 6.5, 13.5 Hz, 1H), 2.65 (m, 
1H), 2.43 (m, 1H), 2.09 (dd, J = 5.5, 12.5 Hz, 1H), 1.57 (ddd, J = 10.5, 13.0 Hz, 1H), 1.23 (d, J = 
2.0 Hz, 3H).  
13C NMR (125 MHz, CDCl3): δ 179.7, 161.9 (d, J = 244.3 Hz), 131.9 (d, J = 2.9 Hz), 130.9 (d, J 
= 7.6 Hz), 115.5 (d, J = 21.4 Hz), 78.1 (d, J = 1.5 Hz), 40.4, 35.8, 34.4, 15.9.  
19F NMR (400 MHz, CDCl3): δ -116.4.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 231.0797, Found 231.0785. 
 
 38k 
dr: 2:1 
major: 1H NMR (500 MHz, CDCl3): δ 7.27 (dd, J = 5.0, 8.0 Hz, 2H), 6.97 (t, J = 8.5 Hz, 2H), 
4.74 (dd, J = 3.5, 6.0 Hz, 1H), 4.52 (dd, J = 4.0, 6.5 Hz, 1H), 4.02 (d, J = 11.0 Hz, 1H), 3.55 
(ddd, J = 3.5, 7.0 Hz, 1H), 3.44 (dd, J = 4.0, 10.5 Hz, 1H), 3.05 (dd, J = 7.0, 14.5 Hz, 1H), 2.98 
(dd, J = 7.0, 14.0 Hz, 1H), 1.55 (s, 3H), 1.35 (s, 3H).  
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13C NMR (125 MHz, CDCl3): δ 161.5 (d, J = 237.9 Hz), 134.1 (d, J = 3.4 Hz), 130.7 (d, J = 7.5 
Hz), 115.0 (d, J = 20.9 Hz), 112.0, 84.1, 83.5 (d, J = 1.4 Hz), 80.7, 72.8, 34.0, 26.1, 25.0.  
19F NMR (400 MHz, CDCl3): δ -117.6. 
minor: 1H NMR (500 MHz, CDCl3): δ 7.17 (dd, J = 5.5, 8.5 Hz, 2H), 6.99 (t, J = 9.0 Hz, 2H), 
4.80 (ddd, J = 2.0, 4.5, 6.5 Hz, 1H), 4.50 (dd, J = 2.0, 6.5 Hz, 1H), 4.24 (ddd, J = 2.0, 8.5 Hz, 
1H), 3.96 (dd, J = 2.0, 10.5 Hz, H), 3.90 (dd, J = 4.0, 10.5 Hz, 1H), 2.75 (dd, J = 8.0, 14.0 Hz, 
1H), 2.70 (dd, J = 6.5, 14.0 Hz, 1H), 1.49 (s, 3H), 1.32 (s, 3H).  
13C NMR (125 MHz, CDCl3): δ 161.6 (d, J = 243.4 Hz), 133.2 (d, J = 2.9 Hz), 130.5 (d, J = 8.0 
Hz), 115.3 (d, J = 20.9 Hz), 112.9, 85.1 (d, J = 0.9 Hz), 81.0, 80.9, 71.9, 36.3, 26.6, 25.1.  
19F NMR (400 MHz, CDCl3): δ -117.1. 
HRMS: m/z (ESI) Calculated for [M+Na]+ 275.1059, Found 275.1065. 
 
 38l 
dr: 1:1 
diastereoisomer 1: 1H NMR (500 MHz, CDCl3): δ 7.28 (dd, J = 5.5, 8.0 Hz, 2H), 7.02 (t, J = 8.5 
Hz, 2H), 4.79 (d, J = 4.5 Hz, 1H), 4.65 (dd, J = 3.5, 5.0 Hz, 1H), 4.57 (dd, J = 3.5, 7.5 Hz, 1H), 
3.15 (d, J = 7.5 Hz, 2H), 1.54 (s, 3H), 1.42 (s, 3H).  
13C NMR (125 MHz, CDCl3): δ 173.7, 161.9 (d, J = 244.4 Hz), 134.0, 131.0 (d, J = 8.1 Hz), 
115.5 (d, J = 21.4 Hz), 114.1, 80.0 (d, J = 1.4 Hz), 76.4, 76.3, 34.5, 26.9, 26.0.  
19F NMR (400 MHz, CDCl3): δ -114.9. 
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diastereoisomer 2: 1H NMR (500 MHz, CDCl3): δ 7.17 (dd, J = 5.5, 8.5 Hz, 2H), 7.04 (t, J = 8.5 
Hz, 2H), 4.84 (dd, J = 5.0 Hz, 1H), 4.55 (d, J = 6.0 Hz, 1H), 3.99 (d, J = 6.0 Hz, H), 3.07 (dd, J = 
5.5, 14.5 Hz, 1H), 2.96 (dd, J = 5.5, 14.5 Hz, 1H), 1.44 (s, 3H), 1.33 (s, 3H).  
13C NMR (125 MHz, CDCl3): δ 173.7, 162.2 (d, J = 246.3 Hz), 134.2, 131.3 (d, J = 8.0 Hz), 
116.0 (d, J = 21.4 Hz), 113.6, 82.1, 78.6, 74.6, 38.3, 26.7, 25.6.  
19F NMR (400 MHz, CDCl3): δ -116.2. 
HRMS: m/z (ESI) Calculated for [M+H]+ 289.0852, Found 289.0861. 
 
39a 
1H NMR (500 MHz, CDCl3): δ 7.75 (d, J = 8.0 Hz, 2H), 7.32 (d, J = 8.5 Hz, 2H), 7.20 (dd, J = 
5.5, 8.5 Hz, 2H), 6.98 (t, J = 9.0 Hz, 2H), 3.79 (m, 1H), 3.36 (ddd, J = 4.0, 5.5, 11.0 Hz, 1H), 
3.17 (dd, J = 3.5, 13.0 Hz, 1H), 3.13 (m, 1H), 2.78 (dd, J = 9.0, 13.5 Hz, 1H), 2.43 (s, 3H), 1.59 
(m, 2H), 1.45 (m, 2H).  
13C NMR (125 MHz, CDCl3): δ 161.7 (d, J = 242.9), 143.4, 134.6, 134.0 (d, J = 3.4 Hz), 131.0 
(d, J = 8.1 Hz), 129.7, 127.5, 115.2 (d, J = 20.9 Hz), 61.4 (d, J = 1.4 Hz), 49.2, 41.7, 29.8, 23.8, 
21.5.  
19F NMR (400 MHz, CDCl3): δ -117.2.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 356.1096, Found 356.1096. 
  
39b 
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1H NMR (500 MHz, CDCl3): δ 7.66 (d, J = 8.5 Hz, 2H), 7.26 (m, 4H), 7.22 (d, J = 8.0 Hz, 2H), 
7.19 (t, J = 6.0 Hz, 1H), 7.10 (m, 3H), 7.02 (dd, J = 1.5, 6.0 Hz, 2H), 6.98 (t, J = 6.0 Hz, 1H), 
6.97 (t, J = 8.5 Hz, 2H), 6.95 (t, J = 9.0 Hz, 1H), 4.37 (d, J = 10.0 Hz, 1H), 3.86 (m, 1H), 3.66 (d, 
J = 10.5 Hz, 1H), 3.34 (dd, J = 3.0, 13.0 Hz, 1H), 2.43 (dd, J = 3.5, 12.5 Hz, 1H), 2.39 (s, 3H), 
2.29 (dd, J = 5.0, 12.5 Hz, 1H), 2.20 (dd, J = 11.0, 13.5 Hz, 1H).  
13C NMR (125 MHz, CDCl3): δ 161.5 (d, J = 243.4), 145.3, 144.8, 143.3, 134.3, 134.1 (d, J = 
3.4 Hz), 130.7 (d, J = 7.6 Hz), 129.7, 128.6, 128.5, 127.4, 126.8, 126.6, 126.4, 115.3 (d, J = 20.9 
Hz), 61.2, 58.3, 52.3, 41.5, 40.9, 21.5.  
19F NMR (400 MHz, CDCl3): δ -117.1.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 508.1722, Found 508.1711. 
 
39c 
1H NMR (500 MHz, CDCl3): δ 7.74 (d, J = 8.0 Hz, 2H), 7.33 (d, J = 7.5 Hz, 2H), 7.20 (dd, J = 
5.5, 8.5 Hz, 2H), 6.99 (t, J = 9.0 Hz, 2H), 4.19 (m, 2H), 3.96 (d, J = 11.5 Hz, 1H), 3.92 (m, 2H), 
3.85 (dd, J = 7.0, 11.5 Hz, 1H), 3.84 (d, J = 12.0 Hz, 1H), 3.34 (dd, J = 3.5, 13.5 Hz, 1H), 2.77 
(dd, J = 10.0, 13.5 Hz, 1H), 2.43 (s, 3H), 2.25 (dd, J = 7.5, 13.5 Hz, 1H), 2.15 (dd, J = 6.5, 13.5 
Hz, 1H), 1.23 (t, J = 7.5 Hz, 3H), 1.12 (t, J = 7.0 Hz, 3H).  
13C NMR (125 MHz, CDCl3): δ 169.1, 168.9, 161.7 (d, J = 243.4), 143.7, 134.5, 133.2 (d, J = 
3.4 Hz), 131.0 (d, J = 8.0 Hz), 129.7, 127.6, 115.3 (d, J = 21.4 Hz), 62.2, 62.0, 61.1 (d, J = 1.4 
Hz), 54.2, 40.7, 37.0, 21.5, 13.9, 13.7.  
19F NMR (400 MHz, CDCl3): δ -116.9.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 500.1519, Found 500.1513. 
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39d 
1H NMR (500 MHz, CDCl3): δ 8.39 (d, J = 8.5 Hz, 2H), 8.07 (d, J = 9.0 Hz, 2H), 7.18 (dd, J = 
5.5, 8.5 Hz, 2H), 6.99 (t, J = 9.0 Hz, 2H), 3.88 (ddd, J = 4.0, 9.0, 1H), 3.41 (dd, J = 4.0, 14.0 Hz, 
1H), 3.19 (d, J = 10.5 Hz, 1H), 3.19 (d, J = 10.5 Hz, 1H), 2.81 (dd, J = 9.5, 13.5 Hz, 1H), 1.52 
(m, 2H), 0.99 (s, 3H), 0.50 (s, 3H).  
13C NMR (125 MHz, CDCl3): δ 161.7 (d, J = 243.4), 149.9, 144.3, 133.2 (d, J = 3.3 Hz), 131.0 
(d, J = 7.5 Hz), 128.4, 124.3, 115.3 (d, J = 21.4 Hz), 61.7 (d, J = 1.5 Hz), 61.5, 45.3, 41.5, 37.5, 
26.0, 25.7.  
19F NMR (400 MHz, CDCl3): δ -116.7.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 415.1104, Found 415.1098. 
 
39e 
1H NMR (500 MHz, CDCl3): δ 7.83 (d, J = 9.0 Hz, 2H), 7.19 (dd, J = 5.5, 8.0 Hz, 2H), 7.01 (d, 
J = 8.5 Hz, 2H), 6.98 (t, J = 9.0 Hz, 2H), 3.87 (s, 3H), 3.75 (ddd, J = 3.0, 8.0, 1H), 3.45 (dd, J = 
3.0, 13.5 Hz, 1H), 3.08 (q, J = 6.0 Hz, 1H), 2.83 (dd, J = 9.0, 13.0 Hz, 1H), 1.46 (d, J = 8.5 Hz, 
2H), 0.97 (s, 3H), 0.46 (s, 3H).  
13C NMR (100 MHz, CDCl3): δ 162.8, 161.6 (d, J = 243.0), 134.0 (d, J = 3.1 Hz), 131.0 (d, J = 
8.0 Hz), 129.9, 129.5, 115.1 (d, J = 21.0 Hz), 114.1, 61.6, 61.3, 55.6, 45.5, 41.7, 37.2, 26.4, 25.8.  
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19F NMR (400 MHz, CDCl3): δ -117.3.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 400.1359, Found 400.1357. 
 
39g 
1H NMR (400 MHz, CDCl3): δ 7.78 (d, J = 8.0 Hz, 2H), 7.29 (d, J = 7.2 Hz, 2H), 7.28 (dd, J = 
8.0 Hz, 2H), 6.99 (t, J = 8.0 Hz, 2H), 3.18 (d, J = 5.2 Hz, 1H), 3.03 (d, J = 9.6 Hz, 1H), 2.84 (d, J 
= 10.0 Hz, 1H), 2.42 (s, 3H), 2.03 (d, J = 12.8 Hz, 1H), 1.50 (s, 3H), 1.31 (d, J = 13.2 Hz, 1H), 
0.88 (s, 3H), 0.84 (s, 3H).  
13C NMR (125 MHz, CDCl3): δ 161.8 (d, J = 243.4), 142.7, 138.5, 133.5 (d, J = 3.4 Hz), 132.4 
(d, J = 8.1 Hz), 129.3, 127.3, 114.8 (d, J = 20.9 Hz), 68.9 (d, J = 1.4 Hz), 61.8, 51.5, 47.0, 36.0, 
27.6, 27.5, 27.1, 21.4.  
19F NMR (400 MHz, CDCl3): δ -117.2.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 398.1566, Found 398.1560. 
 
39h 
dr: 1:1 
diastereoisomer 1: 1H NMR (500 MHz, CDCl3): δ 7.77 (d, J = 8.0 Hz, 2H), 7.34 (dd, J = 3.0, 
8.5 Hz, 2H), 7.28 (d, J = 8.5 Hz, 2H), 6.98 (dt, J = 2.0, 8.5 Hz, 2H), 5.61 (m, 1H), 4.98 (d, J = 
16.0 Hz, 1H), 4.75 (d, J = 16.0 Hz, 1H), 3.78 (m, 1H), 3.44 (dt, J = 3.0, 13.5 Hz, 2H), 3.11 (d, J 
= 1.5 Hz, 2H), 2.43 (s, 3H), 1.99 (dd, J = 5.5 Hz, 2H), 1.59 (m, 2H), 0.95 (s, 3H).  
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13C NMR (125 MHz, CDCl3): δ 161.6 (d, J = 243.4), 143.4, 135.1, 133.9 (d, J = 3.3 Hz), 133.8, 
130.9 (d, J = 6.6 Hz), 129.6, 127.4, 118.0, 115.1 (d, J = 20.9 Hz), 60.9 (d, J = 1.5 Hz), 59.9, 
44.1, 42.5, 41.5, 40.2, 23.8, 21.5.  
19F NMR (400 MHz, CDCl3): δ -117.2. 
diastereoisomer 2: 1H NMR (500 MHz, CDCl3): δ 7.77 (d, J = 8.0 Hz, 2H), 7.34 (dd, J = 3.0, 
8.5 Hz, 2H), 7.28 (d, J = 8.5 Hz, 2H), 6.99 (t, J = 2.0, 8.5 Hz, 2H), 5.47 (m, 1H), 5.00 (d, J = 
10.5 Hz, 1H), 4.92 (d, J = 10.0 Hz, 1H), 3.78 (m, 1H), 3.16 (d, J = 10.5 Hz, 1H), 3.03 (d, J = 
10.5 Hz, 1H), 2.43 (s, 3H), 1.49 (m, 2H), 1.39 (m, 2H), 0.39 (s, 3H).  
13C NMR (125 MHz, CDCl3): δ 161.6 (d, J = 243.4), 143.4, 135.1, 133.9, 133.8 (d, J = 3.3 Hz), 
130.9 (d, J = 6.6 Hz), 129.6, 127.4, 118.0, 115.1 (d, J = 20.9 Hz), 60.9 (d, J = 1.5 Hz), 60.1, 
43.6, 43.0, 41.6, 40.2, 23.1, 21.5.  
19F NMR (400 MHz, CDCl3): δ -117.2. 
HRMS: m/z (ESI) Calculated for [M+Na]+ 410.1566, Found 410.1564. 
 
39i 
diastereoisomer 1: 1H NMR (500 MHz, CDCl3): δ 7.75 (d, J = 8.0 Hz, 2H), 7.28 (d, J = 8.0 Hz, 
2H), 7.21  (dd, J = 6.0, 8.5 Hz, 2H), 6.97 (t, J = 8.5 Hz, 2H), 4.21 (m, 1H), 3.45 (dd, J = 3.5, 13.0 
Hz, 1H), 2.65 (ddd, J = 3.5, 11.5 Hz, 1H), 2.42 (s, 3H), 2.37 (dq, J = 3.0, 12.5 Hz, 1H), 1.89 (m, 
1H), 1.79 (dd, J = 3.0, 13.0 Hz, 2H), 1.64 (m, 2H), 1.36 (m, 2H), 1.17 (m, 2H), 0.90 (m, 2H).  
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13C NMR (125 MHz, CDCl3): δ 161.6 (d, J = 242.9), 142.7, 134.5, 133.7(d, J = 3.3 Hz), 131.0 
(d, J = 7.5 Hz), 129.5, 115.1 (d, J = 20.9 Hz), 65.8, 61.8 (d, J = 1.5 Hz), 42.8, 42.1, 36.4, 29.9, 
29.5, 25.1, 25.0, 21.4.  
19F NMR (400 MHz, CDCl3): δ -117.3. 
diastereoisomer 2: 1H NMR (500 MHz, CDCl3): δ 7.72 (d, J = 8.5 Hz, 2H), 7.33 (d, J = 8.0 Hz, 
2H), 7.21  (dd, J = 6.0, 8.5 Hz, 2H), 6.99 (t, J = 2.0, 8.5 Hz, 2H), 3.76 (ddd, J = 3.0, 9.0 Hz, 1H), 
3.21 (dd, J = 3.0, 13.5 Hz, 1H), 2.74 (dd, J = 9.5, 13.0 Hz, 1H), 2.51 (dq, J = 3.0, 12.5 Hz, 1H), 
2.43 (s, 3H), 2.28 (ddd, J = 3.5, 11.0 Hz, 1H), 1.73 (dd, J = 3.0, 13.0 Hz, 2H), 1.56 (dd, J = 5.0, 
7.0 Hz, 1H), 1.37 (m, 2H), 1.16 (m, 2H), 1.05 (m, 1H), 0.90 (m, 2H).  
13C NMR (125 MHz, CDCl3): δ 161.6 (d, J = 242.9), 143.4, 134.5, 133.7, 131.0 (d, J = 7.6 Hz), 
129.6, 115.1 (d, J = 20.9 Hz), 66.9, 62.3 (d, J = 1.5 Hz), 45.1, 42.7, 33.2, 32.6, 29.7, 25.3, 24.6, 
21.5.  
19F NMR (400 MHz, CDCl3): δ -117.3. 
HRMS: m/z (ESI) Calculated for [M+Na]+ 410.1566, Found 410.1567. 
 
39j 
1H NMR (500 MHz, CDCl3): δ 7.77 (d, J = 8.5 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 7.19 (dd, J = 
6.0, 8.5 Hz, 2H), 6.98 (t, J = 8.5 Hz, 2H), 3.71 (m, 1H), 4.46 (dd, J = 3.5, 13.5 Hz, 1H), 3.20 (d, 
J = 10.5 Hz, 1H), 3.11 (d, J = 10.5 Hz, 1H), 2.82 (dd, J = 9.5, 13.5 Hz, 1H), 2.43 (s, 3H), 1.55 
(m, 5H), 1.41 (m, 3H), 0.91 (m, 1H), 0.83 (m, 1H).  
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13C NMR (100 MHz, CDCl3): δ 161.6 (d, J = 243.0), 143.4, 134.9, 134.1 (d, J = 3.4 Hz), 130.9 
(d, J = 8.0 Hz), 129.6, 127.5, 115.1 (d, J = 21.0 Hz), 61.6, 60.0, 48.4, 43.1, 41.7, 36.5, 36.4, 24.4, 
24.2, 21.5.  
19F NMR (400 MHz, CDCl3): δ -117.3.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 410.1566, Found 410.1563. 
 
39k 
1H NMR (500 MHz, CDCl3): δ 7.77 (d, J = 8.5 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 7.20  (dd, J = 
6.0, 9.0 Hz, 2H), 6.98 (t, J = 9.0 Hz, 2H), 3.70 (dddd, J = 3.0, 8.5 Hz, 1H), 3.42 (dd, J = 3.5, 13.5 
Hz, 1H), 3.30 (d, J = 11.0 Hz, 1H), 3.02 (d, J = 10.5 Hz, 1H), 2.83 (dd, J = 9.0, 13.5 Hz, 1H), 
2.43 (s, 3H), 1.52 (dd, J = 7.5, 13.0 Hz, 1H), 1.40 (dd, J = 8.0, 12.5 Hz, 1H), 1.36 (m, 2H), 1.26 
(m, 2H), 1.13 (m, 4H), 0.69 (ddd, J = 4.5, 9.0, 13.5 Hz, 1H), 0.59 (m, 1H).  
13C NMR (100 MHz, CDCl3): δ 161.6 (d, J = 243.3), 143.3, 134.9, 133.9 (d, J = 4.3 Hz), 131.0 
(d, J = 7.6 Hz), 129.5, 127.4, 115.1 (d, J = 21.0 Hz), 60.4, 58.7, 43.5, 41.7, 41.0, 36.3, 34.0, 25.7, 
23.6, 22.8, 21.4.  
19F NMR (400 MHz, CDCl3): δ -117.3.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 424.1722, Found 424.1716. 
 
39l 
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1H NMR (400 MHz, CDCl3): δ 7.77 (d, J = 8.4 Hz, 2H), 7.30  (dd, J = 5.6, 8.4 Hz, 2H), 7.28 (d, 
J = 8.4 Hz, 2H), 6.99 (t, J = 8.4 Hz, 2H), 3.19 (d, J = 13.2 Hz, 1H), 3.17 (d, J =10.4 Hz, 1H), 
3.09 (d, J = 13.6 Hz, 1H), 2.84 (d, J = 10.4 Hz, 1H), 2.42 (s, 3H), 2.00 (d, J = 13.6 Hz, 1H), 1.45 
(s, 3H), 1.34 (d, J = 13.2 Hz, 1H), 1.26 (m, 10H).  
13C NMR (125 MHz, CDCl3): δ 161.8 (d, J = 243.4), 142.7, 138.6, 133.6 (d, J = 3.4 Hz), 132.5 
(d, J = 7.6 Hz), 129.3, 127.2, 114.8 (d, J = 20.9 Hz), 68.0 (d, J = 1.5 Hz), 59.3, 49.5, 47.0, 39.7, 
36.3, 36.2, 27.7, 25.7, 23.4, 23.1, 21.4.  
19F NMR (400 MHz, CDCl3): δ -117.3.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 438.1879, Found 438.1874. 
 
39m 
1H NMR (500 MHz, CDCl3): δ 7.97 (d, J = 8.5 Hz, 2H), 7.33 (d, J = 8.0 Hz, 2H), 7.21  (dd, J = 
5.5, 8.5 Hz, 2H), 7.03 (t, J = 8.5 Hz, 2H), 4.39 (m, 1H), 3.70 (dd, J = 3.5, 13.0 Hz, 1H), 2.68 (dd, 
J = 9.5, 12.5 Hz, 1H), 2.43 (s, 3H), 1.85 (dd, J = 8.0, 13.5 Hz, 1H), 1.71 (dd, J = 5.0, 13.5 Hz, 
1H), 1.59 (m, 4H), 1.29 (m, 6H).  
13C NMR (125 MHz, CDCl3): δ 178.6, 161.9 (d, J = 243.9), 145.0, 135.8, 132.3 (d, J = 3.4 Hz), 
131.0 (d, J = 7.6 Hz), 129.5, 128.3, 115.6 (d, J = 21.4 Hz), 58.1 (d, J = 1.4 Hz), 45.4, 41.7, 33.9, 
33.7, 33.4, 25.0, 21.7, 21.6, 21.4.  
19F NMR (400 MHz, CDCl3): δ -116.2.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 438.1515, Found 438.1508. 
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39n 
1H NMR (500 MHz, CDCl3): δ 7.65 (d, J = 8.0 Hz, 1H), 7.55 (d, J = 8.0 Hz, 2H), 7.20  (dd, J = 
5.5, 8.5 Hz, 3H), 7.15 (d, J = 8.5 Hz, 2H), 7.00 (d, J = 7.5 Hz, 2H), 6.97 (t, J = 8.5 Hz, 2H), 4.42 
(m, 1H), 3.25 (dd, J = 4.5, 13.5 Hz, 1H), 2.80 (dd, J = 9.5, 13.5 Hz, 1H), 2.63 (dd, J = 9.5, 16.5 
Hz, 1H), 2.54 (dd, J = 2.5, 16.5 Hz, 1H), 2.34 (s, 3H).  
13C NMR (125 MHz, CDCl3): δ 161.8 (d, J = 243.3), 143.8, 141.3, 135.2, 132.8 (d, J = 3.4 Hz), 
131.6, 131.1 (d, J = 7.6 Hz), 129.6, 127.8, 126.9, 125.2, 124.7, 117.3, 115.3 (d, J = 20.9 Hz), 
63.4 (d, J = 1.5 Hz), 41.7, 32.8, 21.5.  
19F NMR (400 MHz, CDCl3): δ -116.8.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 410.1566, Found 410.1557. 
 
39o 
1H NMR (500 MHz, CDCl3): δ 7.59 (d, J = 8.5 Hz, 2H), 7.22 (d, J = 8.5 Hz, 2H), 7.08  (dd, J = 
5.5, 8.5 Hz, 2H), 6.93 (t, J = 8.5 Hz, 2H), 4.39 (m, 1H), 4.23 (ddd, J = 2.0, 7.5, 11.0 Hz, 1H), 
3.78 (dd, J = 4.0, 13.5 Hz, 1H), 3.07 (dt, J = 2.5, 13.5 Hz, 1H), 2.82 (d, J = 3.5 Hz, 1H), 2.80 (d, 
J = 1.5 Hz, 1H), 2.39 (s, 3H), 1.60 (m, 3H), 1.41 (m, 3H).  
13C NMR (125 MHz, CDCl3): δ 161.5 (d, J = 242.9), 142.8, 138.3, 134.2 (d, J = 2.9 Hz), 130.5 
(d, J = 7.5 Hz), 129.5, 126.9, 115.2 (d, J = 20.9 Hz), 40.8, 35.0, 26.1, 24.8, 21.4, 18.3.  
19F NMR (400 MHz, CDCl3): δ -117.2.  
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HRMS: m/z (ESI) Calculated for [M+Na]+ 370.1253, Found 370.1252. 
 
39p 
1H NMR (500 MHz, CDCl3): δ 7.68 (d, J = 8.5 Hz, 2H), 7.25 (d, J = 8.5 Hz, 2H), 7.03  (dd, J = 
5.5, 8.5 Hz, 2H), 6.91 (t, J = 8.5 Hz, 2H), 4.16 (ddd, J = 4.5, 10.0 Hz, 1H), 3.38 (d, J = 13.5 Hz, 
1H), 2.81 (d, J = 12.5 Hz, 1H), 2.78 (dd, J = 10.5, 13.0 Hz, 1H), 2.52 (dd, J = 4.5, 13.5 Hz, 1H), 
2.39 (s, 3H), 1.66 (tt, J = 4.5, 13.5 Hz, 1H), 1.50 (ddd, J = 3.5, 13.5 Hz, 1H), 1.33 (d, J = 14.0 
Hz, 1H), 1.25 (d, J = 10.5 Hz, 1H), 0.95 (s, 3H), 0.89 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 161.5 (d, J = 243.2), 142.8, 138.3, 134.2 (d, J = 2.9 Hz), 130.4 
(d, J = 7.7 Hz), 129.5, 126.9, 115.2 (d, J = 21.3 Hz), 54.0, 51.3, 33.6, 31.6, 30.3, 29.0, 23.4, 22.1, 
21.4.  
19F NMR (400 MHz, CDCl3): δ -117.1.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 398.1566, Found 398.1561.  
 
42a 
1H NMR (500 MHz, CDCl3) δ 7.08 (dd, J = 8.5, 5.5 Hz, 2H), 6.96 (dd, J = 8.5, 8.5 Hz, 2H), 2.85 
(d, J = 13.5 Hz, 1H), 2.59 (d, J = 13.5 Hz, 1H), 2.32 (ddd, J = 18.5, 8.0, 5.0 Hz, 1H), 2.00 (m, 
1H), 1.94 (dt, J = 12.5, 8.0 Hz, 1H), 1.78 (m, 2H), 1.60 (m, 1H), 1.03 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 223.1, 161.7 (d, J = 244.5 Hz), 133.6 (d, J = 3.4 Hz), 131.6 (d, J 
= 7.9 Hz), 115.0 (d, J = 21.0 Hz), 49.8, 41.8, 38.0, 34.5, 22.7, 18.6.  
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42b 
1H NMR (500 MHz, CDCl3) δ 7.25 (d, J = 8.0 Hz, 2H), 7.06 (d, J = 8.0 Hz, 2H), 2.85 (d, J = 
13.5 Hz, 1H), 2.59 (d, J = 13.5 Hz, 1H), 2.32 (ddd, J = 18.5, 8.0, 5.0 Hz, 1H), 2.10 (m, 1H), 1.92 
(dt, J = 12.5, 8.0 Hz, 1H), 1.79 (m, 2H), 1.67 (m, 1H), 1.03 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 223.0, 136.5, 132.3, 131.6, 128.3, 49.7, 41.9, 38.0, 34.5, 22.7, 
18.6. 
 
42c 
1H NMR (500 MHz, CDCl3) δ 7.52 (d, J = 8.0 Hz, 2H), 7.23 (d, J = 8.0 Hz, 2H), 2.92 (d, J = 
13.0 Hz, 1H), 2.67 (d, J = 13.5 Hz, 1H), 2.33 (m, 1H), 2.06 (m, 1H), 1.90 (dt, J = 13.0, 7.5 Hz, 
1H), 1.80 (m, 2H), 1.66 (m, 1H), 1.60 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 222.6, 142.1 (d, J = 1.3 Hz), 130.5, 128.7 (q, J = 32.2 Hz), 125.0 
(q, J = 3.6 Hz), 124.2 (d, J = 270.4 Hz), 49.7, 42.3, 37.8, 34.6, 22.6, 18.5. 
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1H NMR (500 MHz, CDCl3) δ 7.60 (d, J = 8.0 Hz, 2H), 7.53 (d, J = 8.0 Hz, 2H), 7.45 (t, J = 8.0 
Hz, 2H), 7.36 (t, J = 8.0 Hz, 1H), 7.21 (d, J = 8.0 Hz, 2H), 2.92 (d, J = 13.5 Hz, 1H), 2.67 (d, J = 
13.5 Hz, 1H), 2.34 (ddd, J = 18.5, 8.0, 5.0 Hz, 1H), 2.10 (m, 1H), 2.03 (dt, J = 13.0, 7.5 Hz, 1H), 
1.83 (m, 2H), 1.70 (m, 1H), 1.08 (s, 3H). 
13C NMR (125 MHz, CDCl3) δ 223.4, 140.8, 139.2, 137.1, 130.7, 128.8, 127.2, 127.0, 126.8, 
49.9, 42.3, 38.1, 34.7, 22.7, 18.7.   
 
43a 
1H NMR (500 MHz, CDCl3): δ 7.63 (s, 1H), 7.17 (m, 7H), 7.02 (d, J = 1.5 Hz, 2H), 2.60 (t, J = 
7.0 Hz, 2H), 1.61 (m, 2H), 1.31 (m, 2H), 0.89 (t, J = 2.5 Hz, 3H).  
13C NMR (125 MHz, CDCl3): δ 201.5 (d, J = 0.9 Hz), 162.4 (d, J = 245.8 Hz), 139.9, 138.5, 
134.6, 132.7 (d, J = 3.8 Hz), 131.4 (d, J = 8.0 Hz), 130.7, 129.2, 128.3, 116.1 (d, J = 21.4 Hz), 
39.3, 26.6, 22.3, 13.9.  
19F NMR (400 MHz, CDCl3): δ -114.4.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 305.1318, Found 305.1338. 
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1H NMR (500 MHz, CDCl3): δ 7.59 (s, 1H), 7.12 (dd, J = 2.5, 6.0 Hz, 2H), 7.01 (dd, J = 5.5, 8.5 
Hz, 2H), 6.87 (t, J = 8.5 Hz, 2H), 2.57 (t, J = 7.5 Hz, 2H), 1.61 (m, 2H), 1.31 (m, 2H), 0.89 (t, J 
= 7.5 Hz, 3H).  
13C NMR (125 MHz, CDCl3): δ 201.3, 162.9 (d, J = 250.0 Hz), 162.4 (d, J = 246.8 Hz), 139.5 
(d, J = 1.9 Hz), 137.2, 132.6 (d, J = 8.5 Hz), 132.5 (d, J = 3.8 Hz), 131.4 (d, J = 8.1 Hz), 130.7 
(d, J = 3.4 Hz), 116.2 (d, J = 21.4 Hz), 115.5 (d, J = 21.4 Hz), 39.4, 26.5, 22.3, 13.9.  
19F NMR (400 MHz, CDCl3): δ -110.9, -114.1.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 323.1223, Found 323.1211. 
 
43c 
1H NMR (500 MHz, CDCl3): δ 7.58 (s, 1H), 7.15 (d, J = 8.0 Hz, 2H), 7.12 (s, 2H), 7.01 (d, J = 
3.0 Hz, 2H), 6.95 (d, J = 8.5 Hz, 2H), 2.57 (t, J = 7.5 Hz, 2H), 1.61 (m, 2H), 1.31 (m, 2H), 0.89 
(t, J = 7.5 Hz, 3H).  
13C NMR (125 MHz, CDCl3): δ 201.3, 162.5 (d, J = 246.3 Hz), 140.3, 136.9, 135.1, 133.0, 
132.3 (d, J = 3.4 Hz), 131.8, 131.3 (d, J = 8.0 Hz), 128.6, 116.2 (d, J = 21.3 Hz), 39.4, 26.5, 
22.3, 13.9.  
19F NMR (400 MHz, CDCl3): δ -113.6, -113.9.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 339.0928, Found 339.0925. 
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43d 
1H NMR (500 MHz, CDCl3): δ 7.76 (d, J = 7.0 Hz, 2H), 7.52 (t, J = 7.5 Hz, 1H), 7.43 (t, J = 7.5 
Hz, 2H), 7.23 (dd, J = 5.5, 8.5 Hz, 2H), 7.08 (t, J = 8.5 Hz, 2H), 6.49 (t, J = 7.5 Hz, 1H), 2.21 (q, 
J = 7.5 Hz, 2H), 1.47 (m, 2H), 0.90 (t, J = 7.5 Hz, 3H).  
13C NMR (125 MHz, CDCl3): δ 197.2, 162.1 (d, J = 245.3 Hz), 145.7, 140.8, 138.3, 132.0, 
131.2 (d, J = 8.0 Hz), 129.6, 128.2, 115.2 (d, J = 21.4 Hz), 31.6, 22.3, 13.9.  
19F NMR (400 MHz, CDCl3): δ -115.2.  
HRMS: m/z (ESI) Calculated for [M+ Na]+ 291.1161, Found 291.1157. 
 
43e 
1H NMR (500 MHz, CDCl3): δ 7.06 (d, J = 2.5 Hz, 2H), 7.05 (s, 1H), 6.87 (t, J = 7.5 Hz, 2H), 
2.56 (t, J = 7.5 Hz, 2H), 2.03 (q, J = 7.5 Hz, 2H), 1.58 (m, 2H), 1.45 (m, 2H), 1.31 (m, 2H), 0.89 
(t, J = 7.5 Hz, 3H), 0.88 (t, J = 7.5 Hz, 3H).  
13C NMR (125 MHz, CDCl3): δ 201.1, 162.1 (d, J = 244.8 Hz), 143.5, 142.0, 132.1 (d, J = 3.3 
Hz), 131.2 (d, J = 7.5 Hz), 115.2 (d, J = 21.4 Hz), 38.9, 31.6, 26.7, 22.4, 22.1, 13.9, 13.8.  
19F NMR (400 MHz, CDCl3): δ -115.5.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 271.1474, Found 271.1464. 
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43f 
1H NMR (500 MHz, CDCl3): δ 7.70 (s, 1H), 7.28 (d, J = 7.5 Hz, 2H), 7.21 (dt, J = 6.5, 8.0 Hz, 
2H), 7.15 (t, J = 7.5 Hz, 2H), 7.11 (d, J = 7.5 Hz, 2H), 7.06 (d, J = 7.0 Hz, 4H), 7.01 (d, J = 7.5 
Hz, 2H), 3.92 (s, 2H).  
13C NMR (125 MHz, CDCl3): δ 198.7, 162.5 (d, J = 246.3 Hz), 139.9, 139.3, 134.5, 134.4, 
132.3 (d, J = 3.4 Hz), 131.6 (d, J = 8.0 Hz), 130.8, 129.4, 129.3, 128.5, 128.3, 126.8, 116.1 (d, J 
= 21.4 Hz), 46.5.  
19F NMR (400 MHz, CDCl3): δ -114.2.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 339.1161, Found 339.1147. 
 
43g 
1H NMR (500 MHz, CDCl3): δ 7.55 (s, 1H), 7.21 (q, J = 7.0 Hz, 2H), 7.16 (t, J = 7.5 Hz, 2H), 
7.12 (dd, J = 5.5, 8.5 Hz, 2H), 7.08 (t, J = 8.5 Hz, 2H), 7.03 (d, J = 8.0 Hz, 2H), 2.88 (tt, J = 3.0, 
11.0 Hz, 1H), 1.78 (m, 4H), 1.44 (q, 11.0 Hz, 2H), 1.23 (m, 4H).  
13C NMR (125 MHz, CDCl3): δ 205.1, 162.4 (d, J = 245.8 Hz), 139.7, 138.2, 134.7, 132.7 (d, J 
= 3.3 Hz), 131.4 (d, J = 8.0 Hz), 130.6, 129.0, 128.3, 115.9 (d, J = 21.3 Hz), 45.8, 29.3, 25.8, 
25.7.  
19F NMR (400 MHz, CDCl3): δ -114.3, -114.5.  
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HRMS: m/z (ESI) Calculated for [M+Na]+ 331.1474, Found 331.1474. 
 
43h 
1H NMR (500 MHz, CDCl3): δ 7.68 (s, 1H), 7.21 (q, J = 8.0 Hz, 2H), 7.18 (m, 3H), 7.09 (t, J = 
8.5 Hz, 2H), 7.06 (m, 2H), 2.10 (m, 1H), 1.16 (m, 2H), 0.89 (m, 2H).  
13C NMR (125 MHz, CDCl3): δ 201.3, 162.4 (d, J = 245.9 Hz), 140.0, 138.0, 134.7, 132.9 (d, J 
= 3.6 Hz), 131.6 (d, J = 7.9 Hz), 130.7, 129.1, 128.3, 115.1 (d, J = 21.3 Hz), 23.6, 18.4, 12.2.  
19F NMR (400 MHz, CDCl3): δ -114.3, -114.4.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 289.1005, Found 289.1018. 
 
44a 
1H NMR (500 MHz, CDCl3): δ 7.76 (d, J = 8.0 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 7.05 (dd, J = 
5.5, 8.5 Hz, 2H), 6.95 (t, J = 8.5 Hz, 2H), 5.55 (t, J = 4.0 Hz, 1H), 3.68 (t, J = 5.5 Hz, 2H), 2.43 
(s, 3H), 2.21 (q, J = 5.5 Hz, 2H), 1.50 (s, 6H).  
13C NMR (125 MHz, CDCl3): δ 161.9 (d, J = 244.8 Hz), 145.8, 142.7, 140.5, 136.8 (d, J = 3.3 
Hz), 131.5 (d, J = 8.1 Hz), 129.5, 125.7, 125.6, 114.4 (d, J = 21.4 Hz), 45.8, 29.3, 25.8, 25.7.  
19F NMR (400 MHz, CDCl3): δ -116.2.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 382.1253, Found 382.1255. 
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44b 
1H NMR (500 MHz, CDCl3): δ 7.75 (d, J = 8.0 Hz, 2H), 7.29 (d, J = 8.0 Hz, 2H), 7.24 (d, J = 
8.5 Hz, 2H), 7.03 (d, J = 8.0 Hz, 2H), 5.55 (t, J = 4.0 Hz, 1H), 3.68 (t, J = 5.5 Hz, 2H), 2.43 (s, 
3H), 2.21 (dd, J = 5.5, 10.0 Hz, 2H), 1.50 (s, 6H).  
13C NMR (125 MHz, CDCl3): δ 145.7, 142.8, 140.5, 139.4, 133.0, 131.3, 129.5, 127.8, 126.9, 
125.6, 61.5, 41.4, 26.1, 25.8, 21.5.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 398.0957, Found 398.0946. 
 
44c 
1H NMR (500 MHz, CDCl3): δ 7.75 (d, J = 8.0 Hz, 2H), 7.60 (d, J = 8.5 Hz, 2H), 7.28 (d, J = 
8.0 Hz, 2H), 6.84 (d, J = 8.0 Hz, 2H), 5.54 (t, J = 4.0 Hz, 1H), 3.67 (t, J = 5.5 Hz, 2H), 2.43 (s, 
3H), 2.21 (dd, J = 5.5, 10.0 Hz, 2H), 1.49 (s, 6H).  
13C NMR (125 MHz, CDCl3): δ 145.8, 142.8, 140.6, 140.5, 136.7, 131.9, 129.5, 126.9, 125.5, 
92.7, 61.4, 41.4, 26.1, 25.8, 21.5.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 490.0314, Found 490.0304. 
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1H NMR (500 MHz, CDCl3): δ 7.75 (d, J = 7.5 Hz, 2H), 7.53 (d, J = 8.5 Hz, 2H), 7.29 (d, J = 
8.0 Hz, 2H), 7.22 (d, J = 9.0 Hz, 2H), 5.57 (t, J = 4.0 Hz, 1H), 3.70 (t, J = 5.5 Hz, 2H), 2.43 (s, 
3H), 2.24 (dd, J = 5.5, 9.5 Hz, 2H), 1.51 (s, 6H).  
13C NMR (125 MHz, CDCl3): δ 145.8, 144.7 (q, J = 1.0 Hz), 142.9, 140.4, 130.3, 129.5, 129.3 
(d, J = 32.2 Hz), 126.9, 125.9, 124.5 (q, J = 3.8 Hz), 124.1 (d, J = 270.9 Hz), 61.4, 41.4, 26.1, 
25.8, 21.5.  
19F NMR (400 MHz, CDCl3): δ -63.0.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 432.1221, Found 432.1214. 
 
44e 
1H NMR (500 MHz, CDCl3): δ 8.14 (d, J = 8.5 Hz, 2H), 7.75 (d, J = 8.0 Hz, 2H), 7.29 (d, J = 
8.5 Hz, 4H), 5.60 (t, J = 4.0 Hz, 1H), 3.72 (t, J = 5.5 Hz, 2H), 2.43 (s, 3H), 2.26 (dd, J = 5.5, 9.5 
Hz, 2H), 1.52 (s, 6H).  
13C NMR (125 MHz, CDCl3): δ 148.0, 147.0, 145.3, 143.0, 140.3, 130.8, 129.5, 126.9, 126.4, 
122.9, 61.2, 41.4, 26.1, 26.0, 21.5.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 409.1198, Found 409.1181. 
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1H NMR (500 MHz, CDCl3): δ 7.76 (d, J = 7.0 Hz, 2H), 7.51 (d, J = 8.0 Hz, 1H), 7.30 (d, J = 
8.5 Hz, 2H), 7.08 (d, J = 1.5 Hz, 1H), 7.06 (dd, J = 1.5, 8.5 Hz, 1H), 6.28 (q, J = 1.0 Hz, 1H), 
5.61 (t, J = 3.5 Hz, 1H), 3.72 (t, J = 5.0 Hz, 2H), 2.44 (s, 3H), 2.43 (d, J = 1.0 Hz, 3H), 2.26 (dd, 
J = 6.0, 10.0 Hz, 2H), 1.53 (s, 6H).  
13C NMR (125 MHz, CDCl3): δ 160.7, 152.8, 152.0, 145.5, 145.1, 142.9, 140.3, 129.5, 126.9, 
126.1, 126.0, 123.7, 118.7, 118.3, 115.0, 61.4, 41.4, 26.1, 26.0, 21.5, 18.6.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 446.1402, Found 446.1390. 
 
44g 
1H NMR (500 MHz, CDCl3): δ 7.13 (dd, J = 5.5, 9.0 Hz, 2H), 6.97 (t, J = 8.5 Hz, 2H), 5.58 (t, J 
= 9.0 Hz, 1H), 3.89 (t, J = 6.0 Hz, 2H), 2.22 (ddd, J = 4.0, 5.5 Hz, 2H), 1.30 (s, 6H).  
13C NMR (125 MHz, CDCl3): δ 161.9 (d, J = 243.9 Hz), 145.7, 137.7 (d, J = 3.3 Hz), 130.4 (d, J 
= 8.2 Hz), 123.8 (d, J = 1.0 Hz), 114.5 (d, J = 21.4 Hz), 74.3, 59.0, 26.6, 25.8.  
19F NMR (400 MHz, CDCl3): δ -116.7.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 229.1005, Found 229.1008. 
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1H NMR (500 MHz, CDCl3): δ 7.35 (dd, J = 5.5, 8.5 Hz, 2H), 7.01 (t, J = 8.5 Hz, 2H), 5.34 (s, 
1H), 5.25 (s, 1H), 4.79 (t, J = 7.5 Hz, 1H), 4.01 (ddd, J = 1.5, 8.0, 13.5 Hz, 1H), 3.87 (q, J = 7.5 
Hz, 1H), 2.07 (m, 1H), 1.91 (m, 2H), 1.62 (m, 1H).  
13C NMR (125 MHz, CDCl3): δ 162.2 (d, J = 245.3 Hz), 148.5, 135.9 (d, J = 3.4 Hz), 128.4 (d, J 
= 7.6 Hz), 115.0 (d, J = 21.4 Hz), 111.9 (d, J = 1.4 Hz), 80.2, 68.4, 31.6, 25.6.  
19F NMR (400 MHz, CDCl3): δ -115.6.  
HRMS: m/z (ESI) Calculated for [M+Na]+ 215.0848, Found 215.0892. 
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